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PROTEASES IN GENERAL 
Proteolytic enzymes are involved in a great variety of physiological processes and 
their action can be divided into two different categories: 
Limited proteolysis, in which a protease cleaves only one or a limited number of 
peptide bonds of a target protein leading to the activation or maturation of the formely 
inactive protein e.g conversion of prohormones to hormones. 
Unlimited proteolysis, in which proteins are degraded into their amino acid 
constituents. The proteins to be degraded are usually first conjugated to multiple 
molecule of the polypeptide ubiquitin. This modification marks them for rapid 
hydrolysis by the proteasome in the presence of ATP. Another pathway consists in the 
compartmentation of proteases e.g in lysosomes. Proteins transferred into this 
compartment undergo a rapid degradation. 
The International Union of Biochemistry and Molecular Biology (1984) has 
recommended to use the term peptidase for the subset of peptide bond hydrolases ( 
Subclass E.C 3.4.). The widely used term protease is synonymous with peptidase. 
Peptidases comprise two groups of enzymes: the endopeptidases and the 
exopeptidases, which cleave peptide bonds at points within the protein and remove 
amino acids sequentially from either N or C-terminus respectively. The term 
proteinase is also used as a synonym for endopeptidase and four mechanistic classes 
of proteinases are recognized by the lUBMB as detailed below. The modern scheme 
of nomenclature is thus: 
Peptidases (or proteases) 
(E.C 34-.-) 
Exopeptidases 
(E.C 3.4.11-19.-) 
Endopeptidases (or proteinases) 
(EC 3.421-99.-) 
CLASSIFICATION OF PROTEINASES 
Proteinases are classified according to their catalytic mechanisms. Four mechanistic 
classes have been recognized by the International Union of Biochemistry and 
Molecular Biology: 
The serine proteinases 
The aspartic proteinases 
The metallo proteinases 
The cysteine proteinases 
This classification by catalytic types has been suggested to be extended by a 
classification by families based on the evolutionary relationships of proteases 
(Rawlings and Barrett, 1993).In addition to these four mechanistic classes, there is a 
section of the Enzyme nomenclature, which is allocated for proteases of unidentified 
catalytic mechanism. This indicates that the catalytic mechanism has not been 
identified but the possibility remains that novel types of proteases do exist. 
Serine proteinases: This class comprises of two distinct families. The chymotrypsin 
family which includes the mammalian enzymes such as chymotrypsin, trypsin or 
elastase or kallikrein and the substilisin family which include the bacterial enzymes 
such as subtilisin. The general 3D structure is different in the two families but they 
have the same active site geometry and then catalysis proceeds via the same 
mechanism. The serine proteinases exhibit different substrate specificities which are 
related to amino acid substitutions in the various enzyme subsites interacting with the 
substrate residues. Some enzymes have an extended interaction site with the substrate 
whereas others have a specificity restricted to the PI substrate residue. Three residues 
which form the catalytic triad are essential in the catalytic process i.e. His 57, Asp 102 
and Ser 195 (chymotrypsinogen numbering). The first step in the catalysis is the 
formation of an acyl enzyme intermediate between the substrate and the essential 
serine. Formation of this covalent intermediate proceeds through a negatively charged 
tetrahedral transition state intermediate and then the peptide bond is cleaved. During 
the second step or deacylation, the acyl-enzyme intermediate is hydrolyzed by a water 
molecule to release the peptide and to restore the Ser-hydroxyl of the enzyme. The 
deacylation which also involves the formation of a tetrahedral transition state 
intermediate, proceeds through the reverse reaction pathway of acylation. A water 
molecule is the attacking nucleophile instead of the Ser residue. The His residue 
provides a general base and accept the OH group of the reactive Ser. 
Aspartic proteinases: Most of the aspartic proteinases belong to the pepsin family. 
The pepsin family includes digestive enzymes such as pepsin and chymosin as well as 
lysosomal cathepsins D and processing enzymes such as renin, and certain fungal 
proteases (penicillopepsin, rhizopuspepsin, endothiapepsin). Second family comprises 
of viral proteinases such as the protease from the AIDS virus (HIV) also called 
retropepsin. Crystallographic studies shows that these enzymes are bilobed molecules 
with the active site located between two homologous lobes. Each lobe contributes one 
aspartate residue of the catalytically active diad of aspartates. These two aspartyl 
residues are in close geometric proximity in the active molecule and one aspartate is 
ionized whereas the second one is unionized at the optimum pH range of 2-3. 
Retropepsins, are monomeric, i.e. carry only one catalytic aspartate and then 
dimerization is required to form an active enzyme. In contrast to serine and cysteine 
proteases, catalysis by aspartic proteinases do not involve a covalent intermediate 
though a tetrahedral intermediate exists. The nucleophilic attack is achieved by two 
simultaneous proton transfer: one from a water molecule to the diad of the two 
carboxyl groups and a second one from the diad to the carbonyl oxygen of the 
substrate with the concurrent CO-NH bond cleavage. This general acid-base catalysis, 
which may be called a "push-pull" mechanism leads to the formation of a non 
covalent neutral tetrahedral intermediate 
Metallo proteinases: The metallo proteinases may be one of the older classes of 
proteinases and are found in bacteria, fungi as well as in higher organisms. They 
differ widely in their sequences and their structures but the great majority of enzymes 
contain a zinc atom which is catalytically active. In some cases, zinc may be replaced 
by another metal such as cobalt or nickel without any loss of the activity. Bacterial 
thermolysin has been well characterized and its crystallographic structure indicates 
that zinc is bound by two histidines and one glutamic acid. Many enzymes contain the 
sequence HEXXH, which provides two histidine ligands for the zinc whereas the third 
ligand is either a glutamic acid (thermolysin, neprilysin, alanyl aminopeptidase) or a 
histidine (astacin). Other families exhibit a distinct mode of binding of the Zn atom. 
The catalytic mechanism leads to the formation of a non covalent tetrahedral 
intermediate after the attack of a zinc-bound water molecule on the carbonyl group of 
the scissile bond. This intermediate is ftirther decomposed by transfer of the glutamic 
acid proton to the leaving group. 
Cysteine proteinases: This family includes the plant proteases such as papain, 
actinidin or bromelain, several mammalian lysosomal cathepsins, the cytosolic 
calpains (calcium-activated) as well as several parasitic proteases (e.g Trypanosoma, 
Schistosoma). Papain is the archetype and the best studied member of the family. 
Recent elucidation of the X-ray structure of the Interleukin-1-beta converting enzyme 
has revealed a novel type of fold for cysteine proteinases. Like the serine proteinases, 
catalysis proceeds through the formation of a covalent intermediate and involves a 
cysteine and a histidine residue. The essential Cys25 and His 159 (papain numbering) 
plays the same role as Serl95 and His57 respectively. The nucleophile is a thiolate 
ion rather than a hydroxyl group. The thiolate ion is stabilized through the formation 
of an ion pair with neighbouring imidazolium group of HisI59. The attacking 
nucleophile is the thiolate-imidazolium ion pair in both steps and then a water 
molecule is not required. 
Cysteine proteases encompass a large and diverse group of enzymes and have 
been classified by Rawlings and Barrett (1994) into clans and families. A family is 
considered to be a group of enzymes which show an evolutionary relationship to at 
least one other enzyme, while a clan comprise a group of families for which there are 
indications of an evolutionary relationship despite the lack of statistically significant 
sequence similarities. The largest family of cysteine proteases identified to date by 
sequence homology is the papain family whose members include wide range of 
enzymes from both prokaryotes and eucaryotes, encompassing bacteria, plants, 
invertebrates and vertebrates (Berti and Storer ,1995). Mammalian papain-Iike 
cysteine proteases play a major role in the lysosomal protein degradation system ( 
Kirscke and Barrett, 1987) and are also present in the extracellular matrix. This group 
includes cathepsins B,L,K,0,S and the recently discovered cathepsin W (Linnevers et 
al, 1997). Although the descriptor "cathepsin" includes protease of the serine 
(cathepsin G) and aspartic (cathepsin D and E) classes, by far the most abundant 
enzymes bearing this designation are cysteine proteases. It has become common to 
use "cathepsin" as a general term for the lysosomal cysteine proteases. Cathepsins are 
present in most cell types, although some appear to have selective cathepsin S, ( 
Kirschke et al, 1989) or specific cathepsin K (Tezuka et al, 1994) cellular distribution. 
The best characterized of these mammalian enzymes are cathepsins B and L. The 
recent increased interest in cathepsin is due to accumulating evidence for their 
involvement in pathology where they play an extracellular role. Some of the processes 
in which they have been implicated include tumor invasion of metastasis (Yagel et al, 
1989) bone resorption (Inui et al, 1997) and rheumatoid arthritis (Trabandt et al, 
1991). 
Essentially all papain like cysteine proteases are synthesized as inactive 
proenzymes which require processing to form the active enzyme. Their activation 
occurs through proteolytic cleavage of the N-terminal fragment of the enzyme, the so 
called pro-region, and its removal from the enzyme. The proregions are not only 
inhibitors of the enzymatic activity but they likely fulfill other roles as well. In 
cathepsin L, the proregion is crucial for the correct folding of the newly synthesized 
enzyme and stabilizes the protein to the denaturing effects of neutral to alkaline pH, 
conditions which rapidly inactivate the mature enzyme (Tao et al, 1994). A detailed 
analysis of the sequence of papain like enzymes by Karrer et al (1993) led to the 
recognition of two subfamilies within this family. In terms of the mammalian 
members of the papain family, these subfamilies can be designated cathepsin L-like 
and cathepsin B-like enzymes, with the majority of enzymes belonging to the former 
group.While there is strong overall homology between the cathepsin L and cathepsin 
B subfamilies, and the main difference are restricted to a few short stretches where 
they have distinct fingerprint sequences. 
OVERALL STRUCTURE OF PAPAIN-LIKE ENZYMES 
The three dimensional structures of several enzymes from the papain family are 
presently known. The structure of papain, the prototypical enzyme from this family, 
has been known for almost 30 years (Dreuth,1968) and the structural determination of 
several other enzymes from this family followed ( actinidin. Baker and Drenth, 1987; 
calotropin D, Heinemann et al, 1982; caricain, Pickersgill et al, 1991; cathepsin B, 
Musil et al, 1991; chymopapain, Maes et al, 1992; cathepsin L,Fujishima et al, 1997). 
They show a high degree of structural similarity corresponding to the level expected 
from sequence homologies. Two domain can be distinguished within the enzymes: the 
N-terminal domain is mostly a -helical, the C-terminal domain contains 
predominantly p -sheets ( Fig I). The active site consists of Cys25 and His 159 (papain 
numbering) and is supplemented by AsnI75 hydrogen bonded to His 159, and by 
Gin 19, the latter forming part of the oxyanion hole which stabilizes the negative 
charge on the tetrahedral intermediate. This site is located at the interface between the 
two domains. The substrate follows the extended groove between the domains in the 
direction from the bottom (N-terminal) to the top ( C-terminal). The inhibitory action 
of proregions in both subfamilies is similar and occurs by obstructing the access of the 
substrate to the active site. The N-terminal fragment of the proregion is attached to the 
enzyme through the interactions with the PBL on one side of the active site (top). 
C-tenii 
Figl 3-Dimensional structure of papain famify:Asterereodrawing of the ribbon 
representation of cathepsin B in the standard orientatioa The N-terminal, mosty p domain is 
on the left and the C- terminal, mostly a helical domain is on the right. The occuluding loop 
insertion, typical for this subfamily and shown in shaded gray, is not present in the 
procathepsin L subfamily. The substrate binding groove is in the centre and extends from 
top bottom. The active site residues, Cys 29, His 199 and Asn 219 are shown in full. 
opposite to the N-terminal residue of the mature form (bottom) to which the proregion 
is covalently attached. The extended segment of the proregion follows the groove 
between the two domains of the enzyme along the same path as taken by the substrate. 
Papain from papaya {Carica papaya) 
The latex of the papaya plant and its green fruits contains two proteolytic en2ymes, 
papain and chymopapain. The latter is most abundant but papain is twice as potent as 
chymopapain. Papain, a powerfiil proteolytic enzyme, belongs to cysteine protease 
family and is a plant endo protease. Its amino acid sequence (Mitchel et al 1970) 
(Fig.2 ), detailed X-ray structure (Kamphuis,1984) , three dimensional structure 
(Fig. 3 ) and extensive kinetic data, have generated new concepts and data on structure 
function relationship of this enzyme. Although derived from a plant source, papain 
displays some structural and fimctional similarities to other cysteine protease of both 
plant and animal origin. Papain consists of a single polypeptide chain of mol. wt. 23 
Kd with 212 amino acid residues (Mitchel et al 1970). The papain molecule is folded 
to form two interactmg domams resulting in a cleft at the surface of the enzyme ( 
Drenth et al, 1971 ; Glazer and Smith, 1971). The L-domain is alpha helical rich and 
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Fig. 2 Amino acid sequence of papain from papaya latex 
Fig.3 3-DimensionaI structure of papain 
10 
it contains residues 10-111 and 208-212. It has got three alpha-helics in the secondary 
structural features. The R-domain is mainly made up of anti parallel (3 -sheet structure, 
but it also contains 2 helics, which are located at the opposite ends of the central (3-
structure. The active site residues Cys-25 and His-159 are located at the interface of 
this cleft on opposite domains of the molecule. Here Cys-25 is part of the LI alpha 
helix at the surface of the left domain, while His-159 is in a P-sheet of the right 
domain. Apart from Cys and His, Asn 175 also plays a very important role in the 
catalytic mechanism and also in thermal stability of papain (Vemet et al 1995) 
CATALYTIC MECHANISM OF CYSTEINE PROTEINASE, PAPAIN 
Catalysis proceeds through the formation of a covalent intermediate and involves a 
cysteine and a histidine residue. The essential Cys25 and His 159 (papain numbering) 
play the same role as Serl95 and His57 respectively. The nucleophile is a thiolate ion 
rather than a hydroxyl group. The thiolate ion is stabilized through the formation of an 
ion pair with neighbouring imidazolium group of His 159. The attacking nucleophile is 
the thiolate-imidazolium ion pair in both steps and then a water molecule is not 
required (Fig. 4). 
INDUSTRIAL AND THERAPEUTIC POTENTIAL OF PAPAIN AND CYSTEINE 
PROTEINASES OF PAPAIN FAMILY 
Papain is used in various industries for a variety of functions (see Table 1). The 
functions and applications in Table 1. are listed in random order.Some recent findings 
have shown the role of cysteine proteinases in cancer progression and their chemical 
relevance for prognosis ( Lah and Kos, 1998). They have proposed that an imbalance 
between cathepsins and cystatins, associated with the metastatic tumor cell phenotype, 
may facilitate tumor cell invasion and metastasis and can be responsible for early 
relapse of the disease after removal of the primary tumor. Desser et al (2001) have 
shown that the therapy with oral proteolytic enzymes (OET) with combination drug 
products containing papain, bromelain, trypsin and chymotrypsin is beneficial in 
11 
Table I: Uses of papain 
Industry 
Brewing 
Food 
Yeast hydrolysis 
Pharmaceutical 
Pet Food 
Health Food 
Detergents 
Veterinary 
Uses 
clarifying cold beer 
meat tenderization, spices, hydrolysates 
yeast hydrolysates 
contact lens cleaner 
palatability, viscosity reduction 
digestive aid 
blood stain remover 
antitussive agents in preparations 
12 
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Fig.4 Catalytic mechanism of cysteine proteinase, papain 
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clinical setting such as radiotherapy induced fibrosis, bleomycin pneumotoxicity and 
immunosuppression in cancer, all of which are nowadays known to be accompanied 
by excessive transforming growth factors-P ( TGF-P ) production. It has been 
demonstrated that proteolytic enzymes reduce TGF-P levels in serum by converting 
the protease inhibitor a2 macroglobulin ( a2M) from the "slow" form to "fast" form, 
whereby the "fast" form binds and inactivate the TGF-P irreversibly. Plant extracts 
with a high content of proteolytic enzymes have been used for a long time in the 
traditional medicine of Central and South America ( Vanhoof and Cooreman, 1997; 
De Feo, 1992). Cysteine proteinases are also effective in second-degree bums and 
inhibit inflammation ( Latha et al, 1997, 1998). In a clinical study of 156 patients with 
rheumatoid arthiritis, an effect of orally administered proteinases on the level of 
cytokines was found ( Mazurov et al, 1997 ). Mazurov et al (1997) showed that the 
serum levels of interferons were reduced to almost normal values after 6 months of 
therapy in the • enzyme treated group ( a combination of 
pancreatin/papain/bromelain/trypsin/chymotrypsin in addition to methotrexate). 
Leipner and Sailer (2000) have shown the effect and mode of action of systemic 
enzyme therapy in oncology where endoproteinases stem bromelain and papain were 
found to be most effective among other proteinases. The effectiveness of enzyme 
therapy has been shown in inoperable broncho-pulmonary carcinoma, gastric 
carcinoma, carcinoma of head and neck, ovarian carcinoma, multiple myeloma and 
large bowel carcinoma ( Wrbka and Kodras, 1978; Schedler et a/, 1980; Lahousen, 
1995; Sakalova et al, 1998 ).In these studies there was an improvement in general 
condition and quality of life, improvement in life expectancy, rise in ratio of T 
lymphocytes, total lymphocytes, more rapid fall in AST,ALT, AP and LDH in the 
enzyme treated groups, survival of patients with stage II multiple myeloma and no 
patients showed a toxic pulmonary reaction to bleomycin. Systemic enzyme therapy 
would be a variation of the successftil use of proteinase inhibitors in oncology. This 
mode of action would explain the therapeutic efficacy of systemic enzyme therapy 
although low activities of administered enzymes were detected in the plasma of 
patients. It also explains the influence of systemic enzyme therapy on cytokines 
metabolism. Since proteinases are neither pro-oxidants nor antioxidants, their effect 
on the formation or on the scavenging of reactive oxygen species seems to be indirect 
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or an artefact rather than a mode of action of orally administered enzymes in oncology 
(Leipner and Saller,2000). 
Wald et al (2001a) have also shown that the proteinase administration reduces 
growth of human breast and pancreatic cancer in nude mice and diminishes 
expression of some tumorigenesis biomarkers. A specific mixture of serine and 
cysteine proteinases has been shown to significantly reduce tumor growth, metastatic 
potential and proliferation activity in animal tumors, as well as markedly prolong 
survival time in experimental animals. A very close correlation was found between 
the early start of treatment and growth of syngenous melanoma B 16 in C57B16 mice 
( Wald et al, 2001b; Wald et al, 1998a, Wald et al 1998b; Wald et al, 1998c; Batkin et 
al, 1988). Zavadova (2001) have examined the in vitro effects of treating Dendric 
Cells (DC) in peripheral blood samples and in ascites obtained from ovarian cancer 
patients using cytokines or Proteolytic Enzymes (PE) on leukocyte surface 
differentiation markers and on DC function. They have demonstrated that DC 
obtained from the peritoneal cavity and blood of ovarian cancer patients, cultured in 
the presence of PE undergoes differentiation to cells that show high expression of cell 
surface differentiation antigens and IL-12 production. These findings are important to 
ongoing multicancer clinical trials with PE in which it is being utilized as an oral 
agent that has an acceptable level of toxicity. 
Recent technological advances, such as knockout mice, and the isolation of 
cysteine proteases with limited tissue distributions have contributed to the discovery 
of more sophisticated roles of these enzymes. Two enzymes have been shown to 
participate in MHC class I peptide presentation ( Nakagawa et al, 1998; Riese et al, 
1998), and the balanced activity of another is critical for bone health ( Gelb et al, 
1996). As detection and identification techniques become increasingly sophisticated 
and sensitive, more and more cysteine proteases that exhibit narrow tissue distribution 
are being characterized. Some will almost certainly function in crucial physiological 
processes. Thus, structural information is important for understanding the subtleties of 
how these proteins function and for the precise design of inhibitors to serve as 
therapeutics when activity leads to pathology. 
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FREE RADICALS AND OXIDATIVE DAMAGE 
Free radicals, also known as reactive oxygen species, are extremely reactive, unstable 
molecules or fragments of molecules, with unpaired electrons in their outer orbital. 
Free radicals strive to balance their unpaired electrons by combining with electrons in 
other substances that have opposite spins( Siodin et al, 1990). The property of readily 
accepting electrons, combined with the abundance of oxygen in the cells, is one 
reason that oxygen-centred free radicals are primary or secondary mediators of many 
free radical reactions (Alessio, 1993). Free radicals are generated by disturbances in 
the metabolic system as a result of oxidative stress. During low intensity activities 
most of the oxygen consumed during energy metabolism in the mitochondria 
combines with hydrogen to form water via the electron transport chain. If 
circumstances cause oxidative stress or if there is electron leakage in the electron 
transport chain, some of this oxygen is converted to free radicals (McArdle et al, 
1996). Oxidative stress occurs during activities demanding high energy or oxygen 
utilisation such as intense exercise, tissue inflammation, cigarette smoking, 
environmental pollution, ionising radiation and certain medications (McArdle et al, 
1996). This leads to an accumulation of hydrogen ions/electrons flowing through the 
electron transport chain in the mitochondria. Oxygen reacts highly with the hydrogen 
ions so with increased oxygen demand there is increased need for alternate electron 
acceptors. 
THE PRINCIPLES O F FREE RADICAL CHEMISTRY 
In order to appreciate the role of free radicals in biology firstly it is necessary to 
understand their chemical nature. In general, molecular bond formation is dependent 
on the interaction of paired electrons. They have properties which enable them to spin 
about their own axes, and to confer bond stability they must be paired in opposite 
spins. Free radicals and molecular oxygen have properties which do not conform with 
their normal requirements of bonding. When a conventional molecular bond is 
broken, the two composite electrons usually split heterolytically: 
16 
A : B ^ A : + B or A+B: 
However, under certain circumstances it is also possible for bonds to break 
homolytically: 
A :B-^A + B' 
This is a free radical reaction. In non-biological systems, free radicals can be 
produced via the effects of ionising radiation, temperature and various photochemical 
events. Often, free radical reaction involve, either directly or indirectly, the formation 
of oxyradicais. Molecular oxygen is, in fact, a bi-radical possessing two unpaired 
electrons of parallel spin. These electrons exist in their lowest energy level when 
unpaired and when they have spins in the same direction. This configuration is called 
the ground or triplet state and it describes the paramagnetic and electronic behaviour 
of oxygen. Most molecules have electrons with opposite spins and are termed as 
diamagnetic, their ground states are described as singlets. The transfer of electrons to 
oxygen can also lead to the production of toxic free radical species. The best evidence 
of these is the superoxide radical. A two electron reduction of oxygen results in the 
formation of the peroxide ion . This is not a free radical, but is very reactive and at 
physiological pH protonates to form hydrogen peroxide (H2O2). The reaction of 
hydrogen peroxide with superoxide radical can lead to a series of reactions, which 
produce additional reactive species. These are described below. 
Haber - Weiss and Fenton reactions: Haber proposed a reaction between 
superoxide radical and hydrogen peroxide 
H* + UzOz + O'z- -> O2 + HzO + OH' 
The product is the hydroxyl free radical (0H-), reputed to be one of the most reactive 
molecules known in chemistry. This original reaction was later found to occur in two 
steps, now called "Fenton reaction". Firstly, the superoxide radical reduces the ferric 
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ion: 
Secondly, this interacts with H2O2 to produce the OH- radical: 
Fe^^ + IrkOz ^ F e ^ * + OH' + OH" 
The total sequence of events can be summerized as: 
0'2- + H2O2 "^'^ '^^ "'^  ) O2 + OH + OH" 
There is still some controversy over the Fenton reaction particularly in vivo, and it is 
thought that OH- may not be the only oxidising radical found in systems containing 
Fe^ *'^ "^ , O 2- and H2O2. The high reactivity of these other species makes them very 
difficult to study and they have been aptly named the "crypto 0H-" radicals. When 
protonated in aqueous solutions, O2- forms the reactive molecule, H02. It is thought 
that this species is also produced in vivo. 
Termination and propagation reactions: The fate of the free radicals is an 
important consideration when evaluating their toxicity. Because of the intrinsic need 
for their electrons to pair, they are highly reactive and has very short half life (OH-
has half life of 10"' seconds). Of course, some radicals such as semiquinone radical 
present in tobacco smoke has a half life of several days. The termination reactions of 
the free radical reactions have been categorised into several types: 
(1) Dimerization 
A' + B -^ A-B 
(2) Disproportional 
A + B-C-D — A-B + C = D 
(2) Electron transfer 
A' + B - • A^ + B~ or A~ + B' 
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Free radicals often reacts with other molecules in a manner that initiates the formation 
of many more free radical species. It is this self-propagating ability that makes them 
so toxic to living organisms. Thus, free radicals are generated by several mechanisms: 
(1) Addition reaction to double bonds 
A + B = C - ^ A - B + C' 
(2) Cleavage 
A - B - C ^ A + B=C 
(3) Electron transfer 
A + B- -^ B' + A-
A single initiation event which lead to the production of one free radical can soon 
produce many more; this is called "cascade", and it can be prevented via the 
termination steps as described above. In cells, termination also occurs by the 
interaction of protective mechanism and antioxidants. 
Singlet oxygen: However, as stated earlier a second and most important reaction of 
oxygen is the spin reversal of one of the parallel electrons in the outer orbital. This 
new arrangement of the molecule is called as singlet state, and hence the term singlet 
oxygen ('O2). Two singlet states exist. The first type of singlet oxygen is most 
important in vivo while second type is energetically unstable and usually decays to 
first state before it has time to react with other molecules. It is important, of course, to 
note that ('O2) is not a free radical, but because of its electronic arrangement it 
displays properties which are similar to the free radical species of molecular oxygen, 
and there are some important non-photochemical reactions with this type of oxygen. 
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(1) Dismutation of O 2-
HOi + Ox + H"" ^ ^02 + H2O2 
(2) Fenton type reactions 
O2- H2O2 ^ '^ ) ©^2 + OH. + OH" 
(3) Interaction of hypochlorite 
OCl- + H2O2 -^ 'O2 + CI- + H2O2 
(4) Reaction with hjdroxjl radicals 
O2- + 0 H - ^ ^ 0 2 + 0 H -
(5) Reaction with diacj^ peroxides 
O O 
2O2- + R-C-0-0-C-R^2^O2 + RCOf 
BlOCHEMISTRY OF RADICAL MEDIATED PROTEIN OXIDATION 
Radical-mediated protein oxidation has been studied throughout the century. In the 
first decade, Dakin (1906,1908) published detailed chemical studies of the oxidation 
of leucine and other amino acids by Fenton systems (transition-metal ions plus 
hydrogen peroxide), and protein aggregation and (apparently) fragmentation were 
detected by others. Soon after the discovery of glutathione, Hopkins appreciated that 
this reductant could be both an anti- and a pro-oxidant, the latter depending on the 
presence of transition-metal ions (Hopkins, 1925), and so could inactivate proteins. 
Several authors assessed the proteolytic susceptibility of oxidized proteins, and 
demonstrated biphasic effects, whereby limited oxidation leads to enhanced 
susceptibility, while more extensive oxidation may be associated with increasing 
resistance (Bevilotti,1945; Drake et a/,1957).Recent findings have shown that 
glycated proteins accumulated in vivo provide stable active sites for catalyzing the 
formation of free radicals (Yim et al, 2001). 
Sources of radicals in experimental and biological systems: The primary free 
radical in most oxygenated biological systems is the superoxide radical (O2""), which 
is in equilibrium with its protonated form, the hydroperoxyl radical (HO). The major 
sources of these radicals are modest leakages from the electron transport chains of 
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mitochondria, chloroplasts and endoplasmic reticulum. Although O2 is relatively 
unreactive in comparison with many other radicals, biological systems can convert it 
into other more reactive species, such as peroxyl (ROO"), alkoxyl (RO) and 
hydroxyl (HO") radicals. The last of these can originate from the Fenton reaction, in 
which the metal ion redox cycles, with reduction effected by O2 ' and oxidation by its 
dismutation product, hydrogen peroxide (H2O2). Iron and copper are biologically 
important transition-metal ions, with their reduced forms capable of rapidly cleaving 
organic (including lipid) hydroperoxides, forming radicals that can initiate chain 
reactions, ultimately giving stable products such as lipid hydroxides( Kim et al, 2002; 
Courtois et al, 2002; Schoneich and Williams, T.D., 2002). Experimentally, many 
biologically important radicals can be generated in defined qualities and quantities by 
the c-radiolysis of water. Linear fluxes of ROO" can also be generated by 
decomposition of thermolabile azo compounds such as 2,2'- azobis-(2-
amidinopropane) hydrochloride. More complex experimental systems can involve the 
metal-ion-catalysed autoxidation of a variety of molecules, such as sugars. In these 
cases, it is extremely difficult to quantify the radical fluxes. 
Damage by radiation-induced radicals: Earlier and most recent radiation studies on 
lysozyme (Aldrich et al, 1969;Edward et al, 2002), ribonuclease (Adams et a/, 1972) 
and other enzymes were carried out mainly in the absence of O2. They showed that 
HO" was the most effective inactivator, and characterized other more selective (but 
less efficiently inactivating) species such as (SCN)2 ", Br2 ", CI2 " and I2 '. For 
example, (SCN)2 ' was found to react with an important tryptophan residue in pepsin 
and so inactivate the enzyme, although damage could be reversed by the same radical 
(Adams et al, 1979). Inactivation by the hydrated electron has also been reported 
(Terato and Yamamoto,1994), but its significance, and that of the above-mentioned 
selective radicals, for biological systems may be limited. In studies on D-amino acid 
oxidase, it was found that removal of the coenzyme FAD enhanced radical damage 
and inactivation, illustrating that conformation (Anderson et al,l977) and ligands can 
affect the extent of inactivation. 
21 
Damage by metal-ion catalysed systems: Since 1981, Stadtman and colleagues have 
examined the inactivation of proteins in cell-free systems involving the metal-ion 
catalysed autoxidation of ascorbate and hydrogen peroxide; in some cases the metal 
ions were derived from metalloproteins. These systems are now termed as 'metal-
catalysed oxidation systems', instead of the previous confusing term 'mixedfunction 
oxidation systems'. 
These studies developed from earlier work on the oxidative inactivation of 
glutamine phosphoribosylpyrophosphate amidotransferase in extracts from Bacillus 
subtilis (Tumbough and Switzer, 1975a; 1975b). This system is 02-dependent and is 
perturbed by metal-ion chelators, but its chemistry has not been fully defined. A 
similar inactivation occurs in a mutant strain lacking important proteinases ; oxidation 
of a (4Fe-4S) centre appears to be important. Although metal-catalysed oxidation 
systems are mechanistically diverse, they are like Fenton systems and involve H2O2; 
thus they can be blocked by catalase. They inactivate a wide range of enzymes 
(Levine et a/,1981; Nakamura and Stadtman, 1984; Stadtman, 1991) and are suggested 
to be important for both proteolytic turnover ( Levine et a/, 1981) and the 
accumulation of proteins during aging (Fucci et al, 1983). The inactivation of one of 
the most studied enzymes, glutamine synthetase, is influenced by its adenylation state 
(Levine et al, 1981), which also regulates the enzyme and some multi-enzyme 
cascades (Stadtman and Chock, 1978; Stadtman, 1990). Some metal-catalysed 
oxidation systems can cause selective damage in cell-free systems, such as to the 
histidine residues in glutamate synthetase (Rivett et al, 1985), but this is accompanied 
by other alterations ; in this case, both protein fragmentation (Kim et al, 1985; Breccia 
et al, 2002; Dubinina et al, 2002) and changes in hydrophobicity. Limited oxidation 
increases hydrophilicity, while further oxidation increases hydrophobicity (Cervera 
and Levin, 1988). Early studies suggested that modification of one (of 16) histidines, 
both inactivated and increased proteolytic susceptibility (Levine, 1983) ; later studies 
showed that enhanced proteolytic susceptibility requires the modification of at least 
two histidines per subunit (Rivett and Levine, 1990). But the stage at which this takes 
place, other modifications also occur, e.g. at Arg-344 (Climent and Levine, 1991), yet 
only 0.7 mol of carbonyl/mol of protein is present (Rivett and Levine, 1990), so most 
altered histidine residues do not contain carbonyls. Incorporation of tritium (from 
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tritiated borohydride) into the enzyme at various stages of oxidation revealed eight 
(unidentified) radioactive peaks using amino acid HPLC after protein hydrolysis. 
Some of these may represent carbonyls. As the chromatographic pattern was 
relatively constant at different times, it was argued that the range of products is also 
constant. However, during the period when the first histidine was oxidized (60 min of 
oxidation), less than six of these species were formed. Bu at 120 min little further 
histidine oxidation had occurred, yet a further two or three amino acid derivatives 
were formed. Unfortunately, the earliest time reported was 20 min, making it difficult 
to conclude that the critical event for inactivation is the histidine oxidation, since 
other modifications had also occurred. Consumption of other individual amino acids 
was low when compared with that of histidine, and could not be detected; since the 
aggregate loss of all amino acids was not quantified, and may have been significant. 
In vivo studies of glutamine synthetase inactivation have been carried out in other 
species, such as the fungus Neurospora crassa, where the inactivated enzyme has 
been detected in vivo (Aguirre and Hansberg, 1986). Furthermore, when living 
Klebsiella pneumoniae (Chevalier et al, 1990) is switched from anaerobic to aerobic 
conditions (or exposed to H2O2), several enzyme activities, including that of glycerol 
dehydrogenase, are lost, apparently by oxidative inactivation. Purification of this 
enzyme when 90% inactivated (from cells exposed to H2O2) and comparison with the 
native form has shown no detectable differences in either subunit molecular size or 
amino acid composition (including -SH groups). The lack of such gross changes 
suggests that limited modifications are sufficient for inactivation, although the 
inactivated enzyme was more hydrophobic, and its intact oligomer migrated in gel 
filtration as if slightly larger than the native form. This emphasizes a major problem 
in studying oxidative inactivation in vivo: even analysis of the inactivated enzyme 
from these cells gave no evidence that inactivation was due to protein oxidation, 
although it was clearly initiated by an oxidative affront. 
Inactivation of non-enzymic proteins by metal-catalysed oxidation has also 
been studied extensively. Thus a proteinase inhibitor is inactivated on oxidation of a 
susceptible methionine residue, and H2O2 inactivates a neutrophil cytosolic serine 
proteinase inhibitor (serpin), possibly via a similar process (Thomas et al, 1991). In 
some cases, these reactions of H2O2 and methionine may be nucleophilic (molecular) 
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rather than radical-mediated. The proteinase subtilisin is dependent on a methionine 
residue both for its activity and for its susceptibility to H2O2 in vitro ; replacement of 
this residue by site-directed mutagenesis decreases inactivation of the enzyme by 
H2O2 (Estell et al, 1985). In contrast, Fenton systems produces a range of amino acid 
derivatives that inactivate ai-proteinase inhibitor (Kwon et a/, 1990) ; they also 
inactivate proteinase inhibitors and neutrophil elastase, which lack the susceptible 
methionine, with comparable efficiency (Dean et al, 1989). Thus methionine-
conta'm'mg inhibitors are not automaticaJly more vulnerable, and susceptibility 
depends on the radical or oxidizing conditions, which systems are important in vivo 
are not known. Mattana el al (2002) have shown that the metal catalyzed oxidation of 
extracellular matrix proteins promotes human mesengial cell apoptosis and is 
associated with the enhanced expression of bax and caspase activation. The protein 
fragmentation, enzyme inactivation and aggregation studies have also been performed 
by various metal catalyzed oxidation systems ( Shiraishi and Nishikimi, 2002; Stadler 
et al, 2001; Sandgerg et al, 2002). 
FLAVONOIDS/ POLYPHENOLIC COMPOUNDS 
The flavonoids are a large and complex group of polyphenolic plant metabolites 
found in human foods (Hollman and Arts, 2000; Lu and Foo, 2002; Cotelle, 2001). 
The term flavonoids was first used for the family of yellow-coloured compounds with 
a flavone moeity. It was later extended to various plant polyphenols to include less 
intensively coloured flavanones, colorless flavon-3-oIs and more colored red and blue 
anthocyanidins. So far, over 8,000 varieties of flavonoids have been identified. 
Individual differences within each group result from the variation in number and 
arrangement of hydroxyl groups as well as from the nature and extent of alkylation 
and/or glycosylation of these groups.The flavonoids are formed in plants, but not in 
animals, from the amino acids phenylalanine and tyrosine by combination with 
acetate units. Flavonoids are benzo-y-pyrone derivatives and consists of benzene ring 
(commonly known as A-ring) attached to a six-membered heterocycle (named C-ring) 
which at C2 carries a phenyl group(named B-ring) as a substituent. The C-ring is 
either a y-pyrone(flavones and flavonols) or its 2,3-dihydroderivative (flavanones and 
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flavanols). The most commonly occurring flavones and flavonols are those with 
dihydroxylation in position 5 and 7 (A-ring) and in position 3' and 4' (B-ring). 
e s 
CHEMICAL STRUCTURE OF FLAVONOID 
Various subgroups of flavonoids are classified according to the substitution patterns 
of ring C. Both the oxidation state of the heterocyclic ring and the position of ring B 
are important in the classification. 
Examples of the 6 major subgroups are: 
1. Chalcones 
2. Flavone (generally in herbaceous families, e.g. Labiatae, Umbelliferae, 
Compositae). 
Apigenin (Apium graveolens, Petroselinum crispum). 
Luteolin (Equisetum arvense) 
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3. Flavonol (generally in woody angiosperms) 
Quercitol (Ruta graveolens, Fagopyrum esculentum, Sambucus nigra) 
Kaempferol (Sambucus nigra. Cassia senna, Equisetum arvense, Lamium album, 
Polygonum bistorta). 
Myricetin . 
4. Flavanone 
HO 0 
5. Anthocyanins 
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6. Isoflavonoids 
Intestinal Absorption of Polyphenols: The major sources of flavonoids are shown in 
Table 2. Amongst the most common and thoroughly studied of these flavonoids are 
the flavonols, quercetin, myricetin and kaempferol. It has been estimated that even in 
industrialised societies, intakes of flavonoids could be as high as 1 gram per day 
(Kuhnau,1976), but this is probably an overestimation based on inadequate analytical 
data (Hertog and Hollman, 1996). The more conservative estimates of 23 mg per day 
in the Netherlands, 64 mg per day in Japan and 6 mg per day in Finland are probably 
much more realistic.( Hollman and Arts, 2000; Hertog et al, 1995). In Western 
Europe, flavonols and flavones are consumed predominantly in the form of water 
soluble glycosides in apples and onions, or as free solutes in black tea and wine 
(Hertog et al, 1993).Until very recently, it was believed that flavonol glycosides must 
be hydrolyzed prior to absorption and the low solubility of the liberated aglycones 
was regarded as a major rate-limiting factor for uptake into the circulation (Manach et 
al, 1996). Hollman et al (1996) have obtained direct evidence to show that they are 
readily absorbed in the human small bowel. Subjects were fed a meal of cooked 
onions containing quercetin aglycone. The level of quercetin in plasma, determined 
after deconjugation, rise rapidly within 1 hour of ingestion, peaked at approximately 
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Table 2: Flavonoids and their Sources 
FOOD 
Apples 
Broccoli 
Celery 
Eggplant skin 
Endive 
Grapes 
Grapefruit 
Leek 
Onions 
Orange juice 
Parsley 
Raspberries 
Red wine 
Soybeans 
Strawberries 
Tangerine peel 
Tea 
FLAVONOID 
catechins, 
quercetin 
kaempferol 
apigenin 
delphinidin 
kaempferol 
cyanidin 
kaempferol, 
naringin 
kaempferol 
quercetin 
hesperidin 
apigenin 
cyanidin 
oenin 
isoflavones 
cyanidin 
tangeretin 
catechins 
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200 ng/ml after 2.9 hours, and fell slowly to around 10 ng/ml after 48 hours. Several 
other studies have also shown that average concentration of querecetin in plasma 
after the meal is quite high and elimination of quercetin from the plasma is relatively 
slow, so that accumulation can occur if repeated oral doses of quercetin are taken over 
a prolonged period ( Manach et al, 1996; Hollman and Arts, 2000; Hollman and 
Katan, 1997; Hollman etal, 1997). 
FLAVONOIDS AS ANTIOXIDANTS 
Many studies have suggested that flavonoids exhibit biological acivities, including 
antiallergenic, antiviral, anti-inflammatory and vasodilating actions. These 
pharmacological effects are generally linked to the antioxidant properties of these 
molecules. Flavonoids can express these properties by (i) suppressing ROS formation 
by inhibiting some enzymes or chelating trace elements involved in free radical 
production, (ii) Scavenging radical species and more specially the ROS. (iii) Up-
regulating or protecting antioxidant defence. Flavonoids have been identified as 
fulfilling most of the se criteria described above. Thus their protective effects are 
multiple. In a study performed by Roig et al (2002), it has been shown that 
flavonoids such as catechin, epicatechin, quercetin and procyanidins protect the Fao 
cells against hydrogen peroxide induced oxidative stress. Cardoon {Cynara 
cardunculus) is a species containing considerable amounts of polyphenolic 
compounds, namely flavonoids and phenolic acids, which shows its antioxidant 
activiy against superoxide radical, hydroxyl radical, and hypochlorous acid ( Valentao 
et al, 2002). There are numerous evidences to show the beneficial, antioxidant, anti-
inflammatory and anticancer effects of various naturally occurring flavonoids ( Perez 
et al, 2002; Ficarra et al, 2002; Shahat et al, 2002; Salucci et al, 2002; Rezk et al, 
2002; Aviram and Fuhrman, 2002 ).The data obtained by these different findings 
confirm that the radical scavenging activity depends on the structure and the 
substituents of the heterocyclic and B-ring, as suggested by Bors et al (1990). The 
major determinants for radical scavenging capability are (i) the ortho-dihydroxy 
structure on the B-ring which has the best elecron-donating properties, confers higher 
stability to the radical form and participates in electron delocalization. (ii) The 2,3-
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double bond in conjugation with a 4-oxofunction in the C-ring is responsible for 
electron derealization from the B-ring. The antioxidant potency is related o the 
structure in terms of electron delocalization of the aromatic nucleus, (iii) The 3- and 
5- hydroxyl group with a 4-oxofunction in the A and C-ring for maximum radical 
scavenging potential. The maximum effectiveness for radical scavenging apparently 
requires a 3-OH group attached to the 2,3 double bond and adjacent tothe carbonyl in 
the C-ring. The 3-hydroxyl Group interacts with the B-ring through a hydrogen bond 
between the 3-OH and the 2' or 6' proton which, conformationally maintain the fi-
ring in he same plane as the A- and C-rings favoring the conjugation between the B-
and the C-ring. This might well explains the excellent antioxidant activity of 
flavonols. In flavones the B-ring is slightly twisted in relation to the plane of the A-
and C-rings (Cody and Luft, 1994). The glycosylation of this position (as in rutin ) 
reduces greatly the radical scavenging capacity. 
Pro-oxidant activity of flavonoids: The scavenging properties of antioxidant 
compounds are often associated with their ability to form stable radicals after being 
effective. In fact, those flavonoids containing hydroxyl groups, especially those 
having ortho, di- or trihydroxy-funcions on the A-ring (Gao et al, 1999) or B-ring 
(Cotelle et al, 1996), which can scavenge radicals effectively usually give rise to 
semiquinonic radicals in alkaline solution stable enough to be detected by EPR 
spectroscopy. Nevertheless, this molecular oxidative process ( or autooxidation which 
can also take place in the presence of transition metal catalysis) can be accompanied 
by the producion of pro-oxidant molecules such as reactive oxygen species (Hodnick 
et al, 1988) or secondary flavonoids radicals ( Roginsky et al, 1996), which are more 
reactive than the primary aroxyl radicals. Consequently these species are able to 
propagate chain reactions. The proposed mechanism generally accepted for 
antioxidant acivity or for autooxidation involves the formation of an intermediate 
aroxyl radical of flavonoids. This aroxyl radical can interact with oxygen or 
glutathione, generating an oxidized flavonoid and superoxide anion (Metodiewa et al, 
1999). Galati et al (2002) have observed that dietary polyphenolics with phenol rings 
were metabolized by peroxidase to form prooxidant phenoxyl radicals which, in some 
cases were sufficiently reactive to cooxidize GSH or NADH accompanied by 
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extensive oxygen uptake and reactive oxygen species formation. The order of 
catalytic effectiveness found for oxygen activation when polyphenolics were 
metabolized by peroxidase in the presence of GSH was phloretin>phloridzin>4,2'-
dihydroxychalconOp- coumaricacid >narigenin>apigenin>curcumin>resveratrol 
>isoliquiritigenin>capsaicin> kaempferol. Ueda et al (2002) have reported that aicalin 
induces apoptosis via mitochondrial pathway as prooxidant. Induction of apoptosis by 
baicalin was accompanied with the marginal generation of intracellular reactive 
oxygen species (ROS), the increase of the cytosolic fractions of cytochrome c, and the 
disruption of mitochondrial transmembrane potential prior to the activation of 
caspase-3. Ferguson (2001) has demonstrated that not all polyphenols and not all 
actions of individual polyphenols are necessarily beneficial. Some have mutagenic 
and/or pro-oxidant effects, as well as interfering with essential biochemical pathways 
including topoisomerase enzyme activities, prostanoid biosynthesis and signal 
transduction. A small number of adequately controlled human intervention studies 
suggested that some, but not all polyphenol extracts or high polyphenol diets may lead 
to transitory changes in the antioxidative capacity of plasma in humans. 
ENZYME IMMOBILIZATION 
Enzymes are normally tightly packed in cellular organelles or in enzyme cascade, 
such as fatty-acid synthetase complex, thus enabling catalytic processes to take place 
precisely when and where they are needed. Artificial applications of such 
compartmentation or packing go back to 1950s, when immobilized enzymes 
(enzymes with restricted mobility) were first prepared intentionally by inclusion in 
polymeric matrices or binding onto carrier materials. Immobilized enzymes are 
currently the subject of considerable interest because of their advantages over soluble 
enzymes or alternative technologies, and the steadily increasing number of 
applications for immobilized enzymes (Kamori et al, 2002; Gorokhova et al, 2002). 
There are several reasons to use immobilized enzymes. In addition to the conventional 
handling of enzyme preparations, the two main targeted benefits are (1) easy 
separation of enzyme from the product and (2) reuse of the enzyme. Easy separation 
of the enzyme from the product simplifies enzyme applications and permits reliable 
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and efficient reaction teclinology. Enzyme reuse provides a number of cost 
advantages, which are often an essential prerequisite for establishing an economically 
viable enzyme-catalyzed process. Biotechnological applications of immobilized 
biocatalysts include several fields of general interests and in particular, clinical and 
analytical chemistry, medicine, food and pharmaceutical technology, organic 
synthesis and industrial production of chemical compounds ( Rai and Taneja 1998; 
Fields 2001; Zhu and Snyder 2001; MacBeath 2001; Nazarov 2001). The immobilized 
enzymes can also be used in understanding the action and effect of various toxic 
molecules on enzymes, such as respiratory enzymes of mitochondria, the enzymes 
participating in photosynthesis and in protein synthesis, and the enzymes responsible 
for active transport, act in vivo while embedded in membranes or attached to 
subcellular particles. With the aid of simple model systems in which enzymes are 
bound to various synthetic carriers or embedded in simple membranes, it may be 
possible to study some of the parameters individually and thus obtain a better insight 
into the factors governing the activity of enzymes in biological membranes. The 
success of enzyme immobilization technology is dependent on the choice of carrier 
and method of immobilization. Several organic, inorganic and synthetic polymeric 
materials have been used as support for the immobilization of enzymes (Svobodova et 
al, 2002; Yakovleva et al, 2002; Yu and Ju , 2002; Xie et al, 2002). 
METHODS OF ENZYME IMMOBILIZATION 
Methods used for the immobilization of enzymes fall into four main categories: 
Physical adsorption onto an inert carriers 
Entrapment in the lattices of a polymerized gels 
Cross-linking of the protein with a bifiinctional reagents 
Covalent binding to a reactive insoluble supports 
Physical adsorption of an enzyme onto a solid supports is probably the 
simplest way of preparing immobilized enzymes. The method relies on non-specific 
physical interaction between the enzyme protein and the surface of the matrix. 
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brought about by mixing a concentrated solution of enzyme with the solid supports. 
Confining enzymes within the lattices of polymerized gels is another method for 
immobilization. This allows the free diffusion of low molecular weight substrates and 
reaction products. The usual method is to polymerize the hydrophilic matrix in an 
aqueous solution of the enzyme and break up the polymeric mass to the desired 
particle size. Immobilization of enzymes has been achieved by intermolecular cross-
linking of the protein, either to other protein molecules or to functional groups on an 
insoluble support matrix.. Cross-linking an enzyme to itself is both expensive and 
insufficient, as some of the protein material will inevitably be acting mainly as a 
support, resulting in relatively low enzymic activity. The most intensely studied of the 
insolubilization techniques is the formation of covalent bonds between the enzyme 
and the support matrix. When trying to select the type of reaction by which a given 
protein should be insolubilized, the choice is limited by the fact that the binding 
reaction must be performed under conditions that do not cause loss of enzymic 
activity, and the active site of the enzyme must be unaffected by the reagents used. 
A great number of techniques for the immobilization of enzymes exist ( Ruan 
et al, 2002; Podgomik and Tennikova, 2002; Xie et al, 2002). By selecting the proper 
carrier material and coupling procedure, it is usually possible to obtain immobilized 
derivatives with good activity and stability. However, most of them contain 
irreversibly bonded enzyme, which means that the carrier cannot be regenerated and 
reused. This problem can be circumvented by immobilization based on ion exchange 
(Chibata et al, 1972), hydrophobic interaction (Caldwell et al, 1975) or thiol disulfide 
interchange (Carlsson et al, 1975). Chaga (1994) has described a method for enzyme 
immobilization on immobilized metal-ion carriers. The method is based on the 
covalent modification with histidine and immobilization on bivalent metal ion-
iminodiacetic acid-agarose. Immobilized-metal-chelate regenerable carriers have also 
been used for the immobilization of pencillin G amidohydrolase (Anspach and 
Altmann-Haase, 1994). 
Calcium alginate gels are now one of the most widely used supports for the 
immobilization of enzymes and whole microbial cells (Klein et al, 1983; Smidsrod 
and Skjak-Braek, 1990). Entrapment of enzymes and cells in alginate is one of the 
simplest methods of immobilization (Kierstan and Bucke, 1977). Alginates are 
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available commercially as water soluble sodium alginate and have been used for more 
than 65 years in the food and pharmaceutical industries as thickening, emulsifying, 
film forming and gelling agents (Bickerstaff, 1997).Entrapment in insoluble calcium 
alginate gels is recognized as a rapid, nontoxic, inexpensive and versatile method for 
immobilization. Saccharomyces cerevisiae cells, Kluyveromyces marxianus cells, 
inulase, glucose oxidase, chloroplasts, and mitochondria were immobilized in calcium 
alginate gels by Kiersten and Bucke (2000). Ethanol production from glucose 
solutions by an immobilized preparation of S. cerevisiae was demonstrated over a 
total of twenty-three days, and the half-life of such a preparation was shown to be 
about ten days. Immobilized K. marxianus, inulase, and glucose oxidase preparations 
were used to demonstrate the porosity and retraining properties of calcium alginate 
gels. Calcium alginate-immobilized chloroplasts were shown to perform the Hill 
reaction. Das et al (1998) have entrapped urease from pigeonpea in polyacrylamide 
gel with 50% immobilization at 10% total monomer (containing 5% cross-linker) with 
high mechanical stability of the gel. The immobilized enzyme had a tl/2 of approx. 
200 days when stored in 0.1 M Tris/acetate buffer, pH 6.5, at 4 degrees C. The gel 
strips were used 4-5 times for urea assay over a period of 6 h with less than 2% loss of 
activity. Approximately 50% immobilization of urease in calcium alginate was 
observed at 3% alginate with 0.12 mg protein/ml alginate. The resultant enzyme beads 
showed a tl/2 of approx. 75 days when stored in 0.1 M Tris/acetate buffer, pH 6.5, at 
4 degrees C. The beads were used 4-5 times for urea assay over a period of 6 h with 
about 40% loss of activity. 
IMMOBILIZATION OF PAPAIN 
Papain, a thiol protease, is well characterized kinetically and structurally (Liu and 
Hanzlik, 1993; Mellor et al. 1993; Vemet et al. 1995) being a suitable model to 
compare the efficiency of various immobilization procedures. The need for the 
immobilization of papain has been due to its great industrial and medicinal potential. 
For example, papain is used as a chill proofing agent during beer finishing operations 
in the brewing process (Wiseman, 1993). This enzyme also facilitates the 
tenderization of meat in the meat industry (Swanson et al. 1992). The potential uses of 
34 
papain include its frequent use as a biocatalyst for amino acid ester and peptide 
synthesis (Lozano et al. 1993), as well as the treatment of acute destructive lactation 
mastitis (Storozhuk et al. 1985). The biopharmaceutical potential of immobilized 
papain can be well illustrated by the interaction of papain digested HLA class-I 
molecules with alloreactive cluster of differentiation and cytotoxic-T- lymphocytes in 
transplantation immunology (Hausmann et al. 1993) and in the treatment of red blood 
cells with immobilized papain prior to its use in antibody-dependent cell mediated 
cytotoxicity (ADCC) assays with lymphocytes (Kumpel and Bakacs, 1992). A carrier 
containing primary amine groups was synthesized by the reaction between nitrilon 
fibre and diethylenetriamine, and papain was immobilized on this kind of carrier by 
using glutaraldehyde as a coupling agent. The factors involved with the activity 
recovery of the immobilized papain and the enzymic properties of the resulting 
immobilized papain were studied in comparison with free papain, for which casein 
was chosen as a substrate. The results show that the activity recovery of immobilized 
papain can reach 47.3%, and that the immobilized papain exhibits better 
environmental adaptability and reusability than free papain (Li et al, 2001). 
Khan and Iqbal (2000) have insolubilized papain as enzyme-antibody adducts 
with the gamma-globulin fraction derived from the antiserum for its usefulness in 
pharmaceutical and other industries. In a study performed by Losel et al (1999), 
covalent attachment to papain was achieved via a thiol-specific thiosulfonate residue 
and, for the second anchor point, via a nonspecific photoreactive azido function. The 
thiosulfonate formed a reversible disulfide linkage, which could be cleaved again 
reductively by dithiothreitol. The spin label, a pyrroline-1-oxyl radical, was highly 
immobilized after attachment to papain by both functional groups and showed little if 
any relative motion with respect to the protein. The enzyme papain was utilized for 
experimental investigation both in the homogeneous state and on a modified 
polysulfone (MPS) membrane by Ganapathi-Desai et al ( 1998). Huckel et al (1996) 
have selected four different proteases (trypsin, chymotrypsin, papain and pepsin) and 
were covalently attached to the surface of a new type of porous zirconia, as well as a 
conventional porous silica, activated with 3-isothiocyanatopropyltriethoxy silane 
(NCS-silane). The immobilization efficiency onto the porous zirconia material was 
evaluated in terms of the amount of enzyme attached to the particles and from the 
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biological activity remaining after the immobilization step. Cysteine-proteinases (CP) 
of the papain family has also been adsorbed by egg white cystatin C coupled to 
Sepharose 4B, thus allowing their selective isolation from either tissue or cultured cell 
extracts as well as biological fluids and culture media. The method may be useful in 
the field of biochemistry, cell biology, and, possibly, clinical chemistry to perform 
rapid analysis of papain-like enzymes and to monitor changes in both cellular and 
extracellular CP profiles along with different physio pathological conditions 
(Tombaccini et al, 2001). Afaq and Iqbal (2001) have selected a method for 
immobilization of papain based on the interaction between its histidine, cysteine and 
tryptophan residues with the immobilized metal ion (IMI) carrier for maximum 
binding on a small volume of the carrier. The immobilized papain retained high 
activity has improved thermal stability and the carrier could be recovered from the 
spent bound enzyme, to be reused. 
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<EX<PE(RIM'Em)iL 
MATERIALS 
The chemicals used in the present study were obtained from various sources as shown 
below. Glass distilled water was used in all the experiments. 
Chemical Source 
Acetic acid 
Acetone 
Acrylamide 
Ammonium per sulphate 
Ascorbic acid 
Benzoyl-DL-Arginine-P-Nitroanilide 
Bovine Serum Albumin 
Bromophenol blue 
Calcium Chloride 
Casein 
Catalase 
Chelating Sepharose 
Copper Chloride 
Copper Sulphate 
L-Cysteine hydrochloride 
Cysteine 
Dimethyl Sulphoxide 
Di potassium hydrogen phosphate 
Dithionitrobenzoic acid (DTNB) 
Sisco Research Lab, India 
Qualigens Fine Chem., India 
Sisco Research Lab, India 
Sisco Research Lab, India 
Loba Chemical Ltd., India 
Sigma Chemical Co., USA 
Sigma Chemical Co., USA 
B.D.H. Poole, England 
Qualigens Fine Chem., India 
Sisco Research Lab, India 
Hi Media Laboratories Pvt. Ltd., Mumbai 
Pharmacia Co. Ltd. 
Qualigens Fine Chem., India 
Sisco Research Lab, India 
Sisco Research Lab., India 
Sisco Research Lab., India 
Qualigens Fine Chem., India 
Qualigens Fine Chem., India 
Sisco Research Lab., India 
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Ethyl alcohol 
Ethylene diamine tetra acetic acid 
(EDTA) 
Folin's Reagent 
Formaldehyde 
Gluteraldehyde 
Glycerol 
Glycine 
Histidine 
Mannitol 
P-Mercaptoethanol 
Methanol 
Naringin 
N,N,Methylene bisacrylamide 
Papain 
Potassium dihydrogen phosphate 
Potassium Iodide 
Quercetin 
Rutin 
Silver nitrate 
Sodium acetate 
Sodium alginate 
Sodium Carbonate 
Qualigens Fine Chem., India 
Sisco Research Lab., India 
Sisco Research Lab., India 
S.D. Fine, India 
Koch-Light, England 
Sisco Research Lab., India 
Sisco Research Lab., India 
Sisco Research Lab., India 
Qualigens Fine Chem., India 
Qualigens Fine Chem., India 
Qualigens Fine Chem., India 
Sigma Chemical Co., USA 
Sisco Research Lab., India 
E. Merck, India 
E. Merck, India 
Qualigens Fine Chem., India 
Sigma Chemical Co., USA 
Sigma Chemical Co., USA 
E. Merck, India 
Qualigens Fine Chem., India 
Loba Chemical Ltd., India 
Qualigens Fine Chem., India 
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Sodium Chloride 
Sodium Hydroxide 
Sodium Lauryl Sulphate 
Sodium Potassium Tartarate 
Sodium thiocyanate 
Superoxide Dismutase (SOD) 
TEMED 
Thiobarbituric acid (TBA) 
Thiourea 
Trichloroacetic acid 
Tris (hydroxymethyl amino ethane) 
E. Merck, India 
E. Merck, India 
Sigma Chemical Co., USA 
Sisco Research Lab., India 
Loba Chemicals, India 
Sigma Chemical Co., USA 
Sisco Research Lab., India 
Qualigens Fine Chem., India 
Qualigens Fine Chem,, India 
Qualigens Fine Chem., India 
Qualigens Fine Chem., India 
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METHODS 
PREPARATION OF PAPAIN 
Papain solutions were prepared in lOmM potassium phosphate buffer pH 7.4 and 50 
mM sodium acetate buffer pH 5.6 according to their use for respective experiments. 
ASSAY METHODS FOR PAPAIN 
Caseinolytic Method (Casein Hydrolysis Activity) - The proteolytic activity of 
papain was determined by using casein as substrate according to the method of Kunitz 
(1947) with slight modifications. The enzyme was taken in lOmM potassium 
phosphate buffer pH 7.4 and activated for 10 minutes at 37°C with 0.2 ml of 0.05M 
cysteine and 0.02 M EDTA after adjusting their pH to 7.4. The volume of the reaction 
mixture was made upto 1.0 ml with appropriate buffer. 1.0 ml of 2% (w/v) casein (pH 
adjusted to 7.4) was added to the activated enzyme solution and reincubated at 37°C 
for 15 minutes. The reaction was finally terminated by adding 1.0 ml of 10% 
trichloroacetic acid solution. After 20 minutes, the tubes were centrifiiged at 3000 rpm 
for 10 minutes. Appropriate volume of the supernatant was used for developing the 
colour by Lowry's procedure (1951). Control was prepared in an identical manner 
except that the substrate casein was added after adding the trichloroacetic acid and 
intensity of the colour was recorded at 660nm. One unit of enzyme activity is the 
amount of enzyme, which under experimental conditions give rise to the digestion 
product per minute at 37°C. 
Amidase Activity ( BAPNA Hydrolysis Activity) - The amidase activity of papain 
was determined by the method of Ganrot (1966) utilizing the synthetic substrate 
Benzoyl-DL-Arginine-P-Nitroanilide (BAPNA). The method is based upon the 
cleavage of an amide bond in a synthetic substrate BAPNA. Appropriate amount of 
papain in 50mM sodium acetate buffer, pH 5.6 was added to 0.4 ml of activating 
solution ( containing 0.05 M cysteine and 0.02M EDTA adjusted to pH 7.4) and 
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incubated at 37°C for 10 minutes. 2.0 ml of freshly prepared BAPNA solution ( 
prepared by dissolving 43.5 mg BAPNA in 1.0 ml DMSO and then the solution was 
brought to 100 ml with 50 mM acetate buffer pH 5.6) was added to the reaction 
mixture and the final volume made to 3.0 ml with the buffer after which the samples 
were incubated at 37°C for 30 minutes. The reaction was stopped by the addition of 
0.5 ml of 30% acetic acid and the absorbance of the yellow coloured p-nitroanilide 
formed was determined at 410 nm. The amount of substrate hydrolyzed by the 
enzyme was calculated using molar extinction coefficient of 8800M "'cm'' for p-
nitroanilide at 410 nm. 
DETERMINATION OF PROTEIN CONCENTRATION 
Protein was estimated by the method of Lowry et al (1951). Suitable aliquots of 
protein solution were taken in a set of tubes and final volume was made upto 1 ml 
with distilled water. To this 5.0 ml of freshly prepared alkaline copper reagent was 
added which was prepared by mixing 0.5% (w/v) copper sulphate in 1% (w/v) sodium 
potassium tartarate and 2% (w/v) sodium carbonate in 0.1 N NaOH in 1:50 (v/v) ratio. 
After incubation for 10 min at room temperature, 0.5 ml of 1.0 N Folins-Ciocalteu's 
phenol reagent was added. The tubes were instantly vortexed and the colour 
developed was read at 660 nm after 30 min against a reagent blank. A standard curve 
was prepared using BSA as standard and used for calculating the concentration of 
protein. 
IMMOBILIZATION OF PAPAIN ON DIFFERENT SUPPORTS 
In order to carry out the studies on immobilized papain, following methods and 
supports were used for papain immobilization. 
Chelating Sepharose 
Immobilization of papain on metal-chelating Sepharose activated by Cii^ ions 
The procedure for papain immobilization on chelating sepharose was followed as 
described by Garrison et al (1996). A 0.5 ml portion of chelating-Sepharose gel was 
washed with 1 ml of water and centrifiiged for 30 sec. This procedure was repeated 
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four times. The thoroughly washed matrix was loaded with metal ion (Cu^ "^ ) by 
following the manufacturer's (Pharmecia) protocol. An equal volume of matrix (0.5 
ml) was mixed with equal volume of 0.4 M CuCb (0.5 ml) and stirred at room 
temperature for 30 min, centrifuged briefly and supernatant was discarded. Washing 
of matrix was done with 1 ml of distilled water (4 times ) and finally with 1 ml of 10 
mM potassium phosphate buffer, pH 7.4. This matrix was mixed with 1.5 ml of 
papain solution (8.9 mg/ml), stirred at room temperature for 3 hours, centrifuged for 
30 sec and the supernatant was collected. The matrix was extensively washed with 1.5 
ml of lOmM phosphate buffer, pH 7.4, until no detectable activity was obtained in the 
washings. Finally the matrix was resuspended in the same buffer and the amount of 
enzyme immobilized was calculated by subtracting the activity remaining in the 
supernatant and washings from the units added to chelating Sepharose matrix. The 
actual units of bound papain were obtained by measuring the activity in the 
immobilized enzyme suspension. The enzyme activity was determined by caseinolytic 
method. 
Regeneration of matrix from immobilized papain'. 0.5 ml blue coloured enzyme 
bound matrix was regenerated by suspending in 2 ml eluant (0.05 M EDTA and 0.5M 
NaCl) for 1 hour at room temperature. It was then centrifuged, supernatant was 
collected and matrix was washed extensively with lOmM phosphate buffer, pH 7.4. 
The colourless matrix was resuspended in 0.5 ml of same washing buffer and enzyme 
activity was determined in the collected supernatant, eluant and colourless matrix. 
The whole matrix was reactivated with Cu^* ions as described earlier to perform a 
second cycle of papain immobilization by using the same enzyme concentration. The 
above procedure was repeated for a total of four cycles. 
Reimmobilization of papain on regenerated Sepharose activated by Co^^ ions: 0.2ml 
of regenerated (colorless) matrix was taken and washed with 1ml distilled water (3 
times). Supernatant was discarded and matrix was mixed with equal volume (0.2ml) 
of 0.4M CoCb. The solution was stirred at room temperature for 30 min., centrifuged, 
and supernatant was discarded. The matrix was washed twice with 1 ml distilled water 
and 10 mM phosphate buffer (pH 7.4). Finally, the whole matrix was suspended in 1.0 
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suspended in 1.0 ml papain solution (8.9 mg/ml). The same procedure was followed 
as outlined in the section "Papain immobilization on Cu^ "^  activated chelating 
Sepharose matrix". The matrix was resuspended in 0.8ml of same washing buffer. The 
assay for enzyme activity was done in supernatant, washings, matrix and stock 
enzyme solution as described earlier using casein as the substrate. 
ALGINATE GEL 
Entrapment of papain in calcium alginate beads: The procedure described by 
Hussain et al (1985) was used for entrapment of papain in alginate gel. 2.0 ml papain 
solution (10 mg/ml in sodium acetate buffer pH 5.6) was mixed with 2% sodium 
alginate solution. The suspension was thoroughly mixed by continuous stirring and 
finally treated with 0.2% gluteraldehyde solution for 2 hrs in order to introduce a 
cross linking and to prevent the enzyme leakage. 0.1% ethanolamine was added in 
order to block any unreacted aldehydic groups and suspension was again stirred for 2 
hours. This enzyme-alginate suspension was added drop wise to a stirred solution of 
0.2 M calcium chloride. A 20 ml syringe with attached No.20 needle was used for the 
preparation of alginate beads. The beads were stirred in calcium chloride solution for 
2 hours.washed and were suspended in 50 mM sodium acetate buffer, pH 5.6. 
GENERATION OF FREE RADICALS 
Effect of the ASA-Cu^* system on soluble papain: ASA-Cu^* is a known 
generator of free radicals. Free radicals were generated by the procedure of Kanazawa 
et al (1993). Therefore, to ascertain the effect of free radicals on papain activity, 25 \i 
M/lOO ^ M papain was preincubated at room temperature in 50 mM sodium acetate 
buffer, pH 5.6, with ASA at 1.25 mM and Cu^ "^  at 25 //M..Aliquots were periodically 
transferred to cysteine/EDTA solution (activating solution). This mixture was then 
assayed for papain activity by the indicated method. 
Effect of ASA-Cu^^ system on chelating Sepharose bound papain: In order to 
ascertain the effect of generated free radicals by ascorbic acid-Cu (ASA-Cu "^") system, 
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25 n M chelating Sepharsoe bound papain was incubated at room temperature in 50 
mM sodium acetate buffer, pH 5.6 containing 1.25 mM ascorbic acid and 25 ^ M 
Cu^ "". The reaction mixture was continuously stirred during the course of reaction. 
Appropriate volume of the reaction mixture was periodically transferred to cysteine-
EDTA solution and used for determining the papain activity by the method of Kunitz 
(1947). 
Effect of ASA-Cu^^ system on alginate entrapped papain: The similar procedure 
was repeated for generating the free radical by ASA-Cu^* system for its effect on 
alginate entrapped papain. Four beads equivalent to 100 ^ M were incubated at room 
temperature in 10 mM sodium acetate buffer pH 5.6 having 1.25 mM ascorbic acid 
and 25 |x M Cu^ "^ . After incubation period was over, the beads were transferred to 
cysteine/EDTA solution and papain activity was determined by the method of Ganrot 
(1966) utilizing synthetic substrate BAPNA. 
Effect of free-radical scavengers on the activity of ASA-Cu^* treated soluble and 
immobilized papain: In a total reaction mixture of 2 ml containing 50 mM sodium 
acetate buffer, pH 5.6, 25\iM /lOO ^M soluble or immobilized/ alginate entrapped 
papain, 1.25 mM ASA, 25^M Cu^* and different concentrations of free-radical 
scavengers were added. The final concentrations of the different scavengers were: 
sodium thiocyanate, 2.5 mM; potassium iodide, 2.5 mM; sodium benzoate, 2.5 mM; 
thiourea, 2.5 mM; histidine, 2.5 mM; catalase, 0.94 ^M ; mannitol, 2.5 mM; SOD, 
0.78 nM. At different time intervals the aliquots from the reaction mixture were 
periodically transferred to cysteine /EDTA (activating solution) solution and mixture 
was assayed for papain activity by the indicated method. 
HYDROXYL RADICAL ESTIMATION 
The method of Quinlan and Gutteridge (1987) was followed with slight modifications 
for the estimation of hydroxyl radical. The reaction mixture (1.0 ml) was prepared in 
10 mM Tris-Hcl buffer (pH 7.5) containing increasing concentrations of ascorbic 
acid,25 ^M copper chloride and 25 ^M Papain. After incubation for one hour at 37°C 
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the reaction was stopped by adding 28% TCA and 1% TBA. Finally the tubes were 
boiled at 100°C till pink- orange colour develops and the resulting adduct was 
determined colorimetrically at 532 nm. 
STUDIES ON PAPAIN-POLYPHENOLS INTERACTIONS 
Effect of quercetin on papain : In order to study the effect of quercetin on papain 
activity, 10 mM stock solution of quercetin was prepared in 10% ethanol and a 
suitable aliquot at final concentration of 200 |xM was added to the reaction mixture 
having varying concentrations of soluble and alginate entrapped papain prepared in 10 
mM phosphate buffer pH 7.4. The reaction mixture was incubated for different time 
intervals and aliquots were withdrawn at the indicated time intervals and papain 
activity was determined by the method of Ganrot (1966). In control set quercetin was 
replaced by 10 mM phosphate buffer pH 7.4. The alginate entrapped preparation were 
continuously stirred throughout the incubation period as well as during the assay 
method. 
In an another set of experiment 200 \i M quercetin at its final concentration was 
incubated with 100 ^M papain solution for 3 hours and the reaction mixture was 
dialyzed extensively against 10 mM phosphate buffer pH 7.4 in order to remove the 
quercetin from the reaction mixture. The dialyzed sample was used for the 
determination of enzyme activity, spectral analysis as well as for other estimations. 
Effect of Rutin on papain: Another flavonoid rutin was also selected for its 
interaction with soluble and alginate entrapped papain. The reaction mixture in a total 
volume of 3.5 ml containing 1 mM rutin, prepared in 10% ethanol, 100 ^M of soluble 
and alginate entrapped papain in 10 mM phosphate buffer pH 7.4 was incubated at 
room temperature for different durations. Suitable volume of the aliquots were 
withdrawn from the reaction mixture and papain activity was determined by 
bapnolytic method. In the control set of experiment, the rutin was replaced by 10 mM 
phosphate buffer having 10% ethanol and reaction mixture was incubated along with 
the test samples. The activity of papain was also determined after dialyzing the 
reaction mixture against 10 mM phosphate buffer pH 7.4 in order to remove the rutin 
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from the reaction mixture. The same sample was used for spectral studies and other 
estimations. 
Effect of naringin on papain: Papain was also treated with naringin following the 
same procedure as described for quercetin and rutin. The final concentration of 
naringin used was ImM in the presence of lOOjiM papain solution. 
THIOL GROUP ESTIMATION 
Free sulfhydryl in untreated and flavonoid treated papain was estimated according to 
the method of Ellman (1959) using standard plot of cysteine (1.2 mg/100 ml) of 100 
mM Tris buffer (pH 8.0). To the appropriate amount of papain was added 0.001 M 
DTNB in 0.1 M Tris EDTA buffer pH 8.0 in a total volume of 3.0 ml and the 
absorbance was measured after 30 min. The appearance of thionitrobenzoate ion was 
monitored at410nm. 
SPECTRAL STUDIES 
UV-Visible spectroscopy: The UV-Visible absorption spectra were recorded with a 
Cintra 5 UV-visible spectrophotometer using a matched pair of quartz cuvettes (1-cm 
optical length) placed in a thermostated cell holder at 25 ± 0.1 °C. The spectra were 
fitted to several overlapping Gaussian curves with the help of a Gaussian curve-fitting 
program that provided the amplitude, center, bandwidth at half the maximum 
amplitude, and area of each Gaussian function. 
Fluorescence spectroscopy: Untreated and various treated papain solutions were 
analyzed by measuring intrinsic fluorescence at 20±0.2°C in Hitachi F 2000 
spectrofluorimeter (Tokyo, Japan). The protein was excited (Xex) at 280 nm. 
Corrected emission spectra were recorded with excitation and emission bandwidths of 
10 nm. Appropriate controls containing the substances used for the treatment were run 
and corrections made wherever necessary .The time course of the change in intrinsic 
fluorescence at 20±0.2°C followed measuring the fluorescence in Hitachi F-2000 
spectrofluorimeter. To analyze the cumlative effect of tyrosine, tryptophan and 
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phenylalanine, the protein was excited at 280 nm. The temperature was maintained at 
22°C by thermostating the cuvette housing during the measurement. 
Circular dichroism spectroscopy: Circular dichroism spectra of native and untreated 
papain were measured in a Jasco J 720 spectropolarimater equipped with a 
temperature controlled sample cell holder. Spectra were collected with a scan speed of 
20 nm/min. and with a response time of Is. Measurements in the far UV (200-250 
nm) were taken with a 1 mm pathlength cell whereas cells with 10 mm pathlength 
were used in the near UV (250-300nm) region. 
The results were expressed in CD (m Deg). 
GEL ELECTROPHORESIS 
SDS-Polyacrylamide gel electrophoresis: SDS-PAGE was essentially performed by 
the method of Laemmli (1970) using mini slab gel apparatus manufactured by Atto 
Co., Japan. Stock solutions of 30% acrylamide containing 0.8% bisacrylamide, 1.5 M 
Tris-HCl (pH 8.8) and 10% SDS were prepared and mixed in appropriate ratios to 
give the desired percentage of the acrylamide. The cocktail was poured between glass 
plates and comb was inserted for making the wells which was allowed to polymerize 
within 30 minutes. Protein samples were prepared to give a final concentration of 1% 
SDS (w/v), 0.5% p- mercaptoethanol, 0.25 M Tris-HCl buffer pH 6.8, 10% (w/v) 
glycerol and traces of bromophenol blue as a tracking dye. The samples were boiled 
for 3 minutes and applied to the wells. Electrophoresis was performed at lOOV till the 
tracking dye reached the bottom of the gel. Running buffer used during 
electrophoresis contained 0.2% SDS in addition to 0.2 M glycine and 0.025 M Tris-
HCl. 
Silver nitrate staining of gel: The silver staining was done according to the protocol 
described by Nesterenko et al (1994) with few modifications. Once the gel was run, it 
is suspended in solution of 50% acetone (v/v), 1% TCA (w/v) and 0.015% 
formaldehyde (v/v) for 15-20 min. The gel was then washed thoroughly with distilled 
water 4-5 times and again suspended in 50%) acetone solution for about 20 minutes. 
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After this the gel was immersed in 0.016% (w/v) Na2S203.5H20 solution for 5 min. 
Again extensive washing of the gel was done with distilled water and gel was 
transferred in a solution of 0.27% silver nitrate (w/v) and 0.37% formaldehyde (v/v) 
and left for 15 min. with continuous shaking. After extensive washing with distilled 
water, finally the gel was suspended in a solution containing 0.18 M sodium 
carbonate, 0.015% (v/v) formaldehyde and 0.004% (w/v) Na2S203.5H20 with 
vigorous shaking for few seconds. When protein bands appeared, the gel was 
immersed in a solution of 1% (v/v) glacial acetic acid solution for 5 min. and finally 
washed properly with distilled water. 
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<R<ESVLTS 
Enzymes are biological catalyst and exist in different forms as well as in the different 
compartments of the cells. Some enzymes are cytosolic and exist in the soluble form 
while the enzymes of protein synthesis, electron transport chain, photosynthesis are 
generally bound to the membranes. It is not yet clear whether these enzymes existing 
in different forms within the cellular compartments have similar or different response 
to some oxidants/toxicants and other inhibitory compounds. The Immobilized 
enzymes are considered to be the best model for in vitro studies while comparing with 
the enzymes bound to the membranes or other carriers under in vivo conditions. The 
work carried out is based on the different immobilization procedures used for papain 
immobilization in order to see the effect of generated free radical as well as selected 
polyphenolic compounds. 
The following section deals with the immobilization of papain on metal-
chelate regenerable carriers and entrapment within the alginate gel polymer network 
for various studies. 
STUDIES ON IMMOBLIZED METAL ION (IMI)-CARRIER BOUND 
PAPAIN 
Immobilization of Papain : The immobilization of papain was carried out on 
chelating Sepharose, which was activated with Cu(II) ions, and the results are shown 
in Table-3. The r| value, ratio of actual and theoretical bound activities, was 0.80 
which was significantly higher in comparison to the other enzymes immobilized by 
different methods (Iqbal and Saleemuddin, 1983 a). A remarkable advantage of these 
carriers is its regeneration and recovery from spent immobilized enzyme. After the 
elution of papain from Cu(II) activated IMI carrier, the regeneration and reactivation 
with same metal ion was highly effective as evident by the activity yield of 
immobilized papain during subsequent cycles of reimmobilization (Table-4). The 
activity yields for If'', III"' and 4'*" cycles were 75, 72 and 74% respectively . This 
clearly indicates that the matrix can be regenerated and reutilized for immobilization. 
The potential of substituting the metal ion and higher enzyme loading was also 
investigated on the recovered carrier. In a different set of experiments, Co(II) was 
used for the reactivation of the regenerated matrix obtained from Cu(II) activated 
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Table-3 Immobilization of papain on chelating sepharose activated by 
Cu(II) ions 
Papain was immobilized on chelating sepharose activated by Cu(II) ions as 
described in the text. The amount of enzyme immobilized was calculated by 
subtracting the activity remaining in supernatant and washings from the units 
added to chelating-sepharose matrix. Activity of papain was measured by 
caseinolytic method as described in the text 
Enzyme 
activity 
units/0.5 gm 
gel 
30900 
Unit in 
supernatant 
and washings 
550 
Immobilized activity (Units) 
Theoretical 
(A) 
30350 
Actual 
(B) 
24500 
r|VaIue 
(B/A) 
0.80 
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Table-4 Immobilization and reimmobilization of papain on chelating 
Sepharose activated by Cu2+ ions. 
Immobilization, regeneration, reactivation and reimmobilization of 
papain was carried out by the procedure described in the text. Results 
represent the mean and standard deviation of three immobilized 
preparations. Activity and immobilization yields were calculated from 
mean values. 
No. of 
Cycles 
1st 
Ilnd 
mrd 
IVth 
Enzyme activity (units/ml gel) 
Added 
(A) 
65197 
69460 
69324 
67636 
Unbound 
(B) 
2313 
1494 
2910 
3266 
Immobilized 
Papain 
(C) 
50867 
51841 
49852 
50116 
Activity 
Yield (%) 
C/AxlOO 
78 
75 
72 
74 
Immobilization 
yield (%) 
(A-B)/AxlOO 
96 
98 
96 
95 
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papain bound IMI carrier. The results are shown in Table-5. As evident from the table 
the activity yield was comparable with the values of Table-3 where fresh as well as 
regenerated carrier was activated with Cu(II) ions, suggesting that metal replacement 
is feasible and effective for enzyme immobilization on IMI carrier. 
PROPERTIES OF PAPAIN IMMOBILIZED ON IMI CARRIER 
Effect of temperature : Figure-5 shows the effect of temperature on the reaction rate 
of native and chelating Sepharose bound papain. The temperature optimum for both 
forms was at 40 C. Thermal stability of soluble and chelating Sepharose bound papain 
was examined by heating at 65 C for longer duration. As shown in Figure 6, the 
immobilized papain exhibited a marked increase in thermostability and retained 87% 
of its original activity after one hour of incubation at 65 C, while its soluble 
counterpart lost almost 75% of its original activity. 
Storage stability : The usefiilness of a chelating Sepharose bound papain is 
dependent upon the retention of activity for considerable periods during its use and 
storage. Figure-7 shows the effect of storage at room temperature on the activity of 
soluble and immobilized preparation for papain. As evident from the figure the 
soluble as well as immobilized preparations did not loose much activity during the 
storage time. 
ASA-Cu2+ SYSTEM AND ITS EFFECT ON PAPAIN ACTIVITY 
Generation of free radicals by ASA-Cu^ "^  system : The ASA-Cu^ "*" system is a 
known generator of oxygen derived free radical. In order to see the effect of free 
radical on soluble as well as chelating Sepharose bound papain, we have selected a 
metal catalyzed oxidation (MCO) system involving Cu(II) and ASA. There are 
substantial evidences that the metal catalyzed oxidative modification of an enzyme is 
a site specific process and require an appropriate concentration of Cu(II) as well as 
ASA. The effect of varying Cu(II) concentrations in the presence of fixed ASA on the 
generation of free radical is shown in Table-6. As evident from the Table 6 that at a 
concentration of 25jaM copper and 1.25 mM ASA there was a maximum inactivation 
of a papain while at higher concentration of copper there was a marginal inactivation 
of the papain indicating that the efficiency of radical formation by this MCO system is 
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Table-5 Reimmobilization of papain on regenerated chelating 
Sepharose activated by Co2+ iQns. 
Reimmobilization of papain on regenerated and reactivated chelating Sepharose 
by using Co(II) was followed by the procedure described in the text. 
Measurement of papain activity was done by caseinolytic method. 
Enzyme activi 
Added 
(A) 
109685 
ty (units/ml gel) 
Unbound 
(B) 
10425 
Immobilized 
Papain 
(C) 
78750 
Activity 
Yield (%) 
C/AxlOO 
72 
Immobilization 
yield (%) 
(A-B)/AxlOO 
90 
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Fig. 5 Effect of temperature on the activity of soluble and chelating 
Sepharose bound papain 
The activity of soluble and chelating sepharose bound papain was 
measured by caseinolytic method at different temperatures under 
standard condition. The activity obtained at 40° was taken as 100 
for both soluble and chelating sepharose bound enzyme 
preparation respectively. 
(•) Soluble papain 
(o) Chelating sepharose bound papain 
54 
120 
100 H 
> 80 -{ 
^^ 
u 
< 
O) 
"E 
(0 
E 
u 
= 60 H 
40 
20 
— I — 
30 
— I — 
70 80 10 
I — 
20 40 50 60 
Temperature"C 
Fig. 6 Thermal inactivation of soluble and chelating Sepharose 
bound papain 
Thermal stability of soluble and chelating Sepharose bound 
papain was determined by incubating at 65°C for various 
durations. Papain activity was determined at the end of 
incubation under standard condition. 
(•) Soluble papain 
(o) Chelating Sepharose bound papain 
55 
120 
Time (minute) 
Fig. 7 Storage stability of soluble and chelating Sepharose bound 
papain. 
Soluble and chelating Sepharose bound papain (preparations were 
incubated at room temperature in lOmM phosphate buffer (pH 
7.4) and 0.2 ml aliquot were withdrawn at the indicated period of 
time and activity was determined by caseinolytic method. The 
day preparation was kept, was considered as 0 day and percent 
remaining activity of the subsequent days was calculated from 
that value. 
(•) Soluble papain 
(o) Chelating Sepharose bound papain 
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greatly reduced. The similar effect was observed at a fixed concentration of a Cu(II) 
while varying the concentration of ASA (Table-7). Based on the results of Table-6 
and 7, the concentration of Cu(II) used in this experiment was 25 ^M and the ascorbic 
acid was taken as 1.25 mM. 
The final concentration of ascorbic acid (ASA) and Cu(II) were 1.25 mM and 
25|aM respectively for subsequent experiments wherever the free radicals are 
generated by the ASA-Cu(II) system. The time required for the formation of free 
radicals and an inactivation of soluble papain was determined by the experiment in 
which the aliquots were withdrawn from the ASA-Cu(II)-enzyme (ASA- Cu(II)-E) 
reaction mixture at different time intervals and papain activity was determined. As 
shown in Table 8, at an enzyme/Cu^''' ratio of 1:1 there was a gradual increase in the 
inactivation of papain upto 6 minutes and beyond this time the enzyme activity 
remained constant. In order to optimize the time range at which maximum 
inactivation of papain could be observed at the given ASA/Cu^"^ concentrations, the 
incubation period was extended upto 60 minutes. Table-8 clearly indicated that longer 
incubation upto the period of 60 minutes was ineffective in any further increase in the 
percent inactivation of the papain. For the subsequent experiments the maximum time 
of incubation selected for ASA/Cu(II) system was 10 minutes. Table 9 shows the 
inactivation of soluble and chelating Sepharose bound papain in the presence of ASA-
Cu(II) system as a function of time. As evident from the table the immobilized papain 
was found to be more resistant against ASA-Cu(II) system generated free radicals, in 
comparision to the soluble papain. The soluble papain lost its 47% activity during the 
initial 6 minutes incubation with ASA Cu(II) system while the immobilized papain 
retained 80% of its original activity under identical conditions as well as for the 
similar duration. In order to confirm the generation of free radical by ASA-Cu(II) 
system, the hydroxyl radical was measured in the reaction mixture. Figure 8 shows 
the effect of increasing ASA concentration in the presence of fixed Cu(II) ion system 
on the generation of hydroxyl radical. As evident by the figure there was a rapid 
increase in the absorbance upto 1.25 mM ASA concentration which remained 
constant upto 5mM concentration of ascorbic acid used in this experiment. In order to 
confirm the role of ascorbic acid as well as papain in the generation of free radical by 
ASA-Cu(II) system, studies were carried out including ASA-Cu(II) system in the 
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Table-6 Effect of increasing copper concentration on the activity of 
soluble papain in the presence of ascorbic acid. 
A total volume of 2ml reaction mixture containing papain (25|JM), 1.25mM 
ascorbic acid and Cu^ "^  (increasing concentration) in 50mM sodium acetate 
buffer (pH 5.6) was incubated for 10 minutes at room temperature and 0.3ml 
aliquots were transferred to the activating solution and papain activity was 
determined by caseinolytic method as described in the text. 
Cu2+ 
(HM) 
25 
100 
150 
200 
250 
ASA 
(mM) 
1.25 
1.25 
1.25 
1.25 
1.25 
% 
inactivation 
45 
37 
32 
28 
21 
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Table-7 Effect of increasing ASA concentration on the activity of 
soluble papain in the presence of Cu(II) ions. 
A total volume of 2.0ml reaction mixture containing papain (25|aM), 25nM 
copper and ascorbic acid (increasing concentration) in 50 mM acetate buffer (pH 
5.6) was incubated for 10 minutes at room temperature and 0.3ml aliquots were 
transferred to the activating solution and papain activity was determined by 
caseinolytic method as described in the text. 
ASA 
(mM) 
1.25 
12.48 
33.0 
100.0 
Cu^^ 
(HM) 
25 
25 
25 
25 
% 
inactivation 
46 
39 
27 
20 
59 
Table-8 Studies on the inactivation of soluble papain in the presence of 
AS A-Cu(II) complex as a function of time. 
A total volume of 2.0ml reaction mixture contained 25nM soluble papain, 
1.25mM ascorbic acid, and 25^M Cu '^'" in 50mM acetate buffer (pH 5.6) was 
incubated at room temperature and 0.3ml aliquots were transferred periodically 
to the activating solution and papain activity was determined by caseinolytic 
method as described in the text. 
Time 
(Minutes) 
0 
2 
4 
6 
8 
10 
20 
30 
60 
% 
Inactivation 
0.0 
25.8 
33.2 
46.8 
47.2 
47.0 
46.0 
46.2 
45.5 
60 
Table-9 Studies on the inactivation of soluble and immobilized papain 
in the presence of the ASA-Cu(II) ions system as a function of 
time. 
A total volume of 2.0 ml reaction mixture containing 25 jaM soluble and 
chelating Sepharose bound papain, 1.25mM ascorbic acid and 25nM Cu2+ in 
50mM acetate buffer (pH 5.6) was incubated at room temperature and 0.3ml 
aliquots were transferred periodically to activating solution and papain activity 
was determined by caseinolytic method as described in the text. 
Time 
(Minutes) 
0 
2 
4 
6 
8 
10 
% Inactivation 
Soluble papain 
0.0 
26.4 
35.4 
47.0 
47.3 
47.1 
Immobilized papain 
0.0 
8.2 
18.2 
20.6 
20.4 
20.2 
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Fig. 8 Formation of hydroxyl radical (OH) by ASA-Cu^* system 
The reaction mixture (1.0 ml) contained papain 540|j.g, 10 
mM Tris-Hcl buffer (pH 7.5), 25)JM CU^^ and increasing 
concentration of ascorbic acid. Incubation was at room 
temperature for 10 minutes.Details are described in 
METHOD. 
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0.35 
1 2 3 4 
Concentration of ASA (mM) 
greatly reduced. The similar effect was observed at a fixed concentration of a Cu(II) 
while varying the concentration of ASA (Table-7). Based on the results of Table-6 
and 7, the concentration of Cu(II) used in this experiment was 25 |J.M and the ascorbic 
acid was taken as 1.25 mM. 
The final concentration of ascorbic acid (ASA) and Cu(II) were 1.25 mM and 
25|aM respectively for subsequent experiments wherever the free radicals are 
generated by the ASA-Cu(II) system. The time required for the formation of free 
radicals and an inactivation of soluble papain was determined by the experiment in 
which the aliquots were withdrawn from the ASA-Cu(II)-enzyme (ASA- Cu(II)-E) 
reaction mixture at different time intervals and papain activity was determined. As 
shown in Table 8, at an enzyme/Cu^"^ ratio of 1:1 there was a gradual increase in the 
inactivation of papain upto 6 minutes and beyond this time the enzyme activity 
remained constant. In order to optimize the time range at which maximum 
inactivation of papain could be observed at the given ASA/Cu^"^ concentrations, the 
incubation period was extended upto 60 minutes. Table-8 clearly indicated that longer 
incubation upto the period of 60 minutes was ineffective in any further increase in the 
percent inactivation of the papain. For the subsequent experiments the maximum time 
of incubation selected for ASA/Cu(II) system was 10 minutes. Table 9 shows the 
inactivation of soluble and chelating Sepharose bound papain in the presence of ASA-
Cu(II) system as a function of time. As evident from the table the immobilized papain 
was found to be more resistant against ASA-Cu(II) system generated free radicals, in 
comparision to the soluble papain. The soluble papain lost its 47% activity during the 
initial 6 minutes incubation with ASA Cu(II) system while the immobilized papain 
retained 80% of its original activity under identical conditions as well as for the 
similar duration. In order to confirm the generation of free radical by ASA-Cu(II) 
system, the hydroxyl radical was measured in the reaction mixture. Figure 8 shows 
the effect of increasing ASA concentration in the presence of fixed Cu(II) ion system 
on the generation of hydroxyl radical. As evident by the figure there was a rapid 
increase in the absorbance upto 1.25 mM ASA concentration which remained 
constant upto 5mM concentration of ascorbic acid used in this experiment. In order to 
confirm the role of ascorbic acid as well as papain in the generation of free radical by 
ASA-Cu(II) system, studies were carried out including ASA-Cu(II) system in the 
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presence and absence of ASA/Papain and the results are shown in Figure 9.The 
optical density of ASA-Cu(II) system was same in the presence and absence of papain 
and the values were comparable from the values obtained in the previous experiments. 
This experiment also indicates that ASA concentration is required for the generation 
of hydroxyl radical (Fig. 9.b). In order to determine the structural changes in the 
ASA-Cu^ "*" treated papain, the spectral studies were conducted. When the papain 
solution is excited at 280 nm, it exhibits the fluorescence emission spectrum with a 
maximum at 356nm (Fig. 10). The incubation of papain in ASA-Cu(ll) systems for 10 
minutes resulted in the maximum decrease in the magnitude of fluorescence. 
Effect of scavengers on the inactivation of papain by ASA-Cu(II) system : 
Experiments were also carried out where free radical scavengers were used in the 
presence of ASA-Cu(II) system in order to confirm the involvement of free radical 
and scavenging ability in preventing the inactivation of soluble and immobilized 
papain. The scavengers selected in our studies were sodium thiocyanate, potassium 
iodide, sodium benzoate, thiourea, histidine, catalase, mannitol and superoxide 
dismutase (SOD). The effect of these scavengers on free radicals and the retention of 
papain activity in the presence of ASA-Cu(II) system are shown in Table-10 and 
Figure 11-14. The data obtained in Table-10 clearly indicates that thiourea prevents 
50% inactivation of soluble papain when incubated along with the ascorbic acid and 
copper. The potassium iodide was least effective in the protection of soluble papain 
against free radical induced inactivation.Sodium thiocyanate and sodium benzoate 
also protected the enzyme from inactivation by ASA-Cu(II) system. Out of these four 
scavengers as shown in Table 10, the maximum protection of papain by free radicals 
was achieved by thiourea. The protective effect of all these scavengers were also 
observed in case of papain bound to the chelating Sepharose. In the presence of 
histidine (2.5mM), the enzyme was prevented from inactivation by the ASA-Cu(II) 
system (Figure 11). The immobilized papain was itself resistant to such inactivation 
when compared to the soluble papain so the effect of histidine on immobilized papain 
could not be well detected. The effect of catalase on the soluble and immobilized 
papain in the presence of ASA-Cu(II) system is shown in Figure 12. There was a 
rapid decline in the inactivation pattern of soluble and immobilized papain in the 
presence of 0.94)iM catalase. The effect was more pronounced in case of the soluble 
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Fig. 9 Generation of hydroxyl radical in ASA-Cu^* 
system 
The reaction mixture (1.0 ml) contained papain 540^g, 10 mM 
Tris-Hcl buffer (pH 7.5), 25^M Cu^"*" and increasing 
concentration of ascorbic acid. Incubation was at room 
temperature for 10 minutes.The formation of hydroxyl radical 
was monitored by change in color which was measured at 532 
nm. 
0-4-
(a) ASA- Cu system in absence of papain 
(b) Cu^"*^  in presence of papain 
(c) ASA- Cu^ "^  system in presence of papain 
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0.30 1 
Fig. 10 Changes in the fluorescence emission of soluble papain on 
addition of ASA and Cu^ * 
The reaction mixture (5.0 ml) contained 50 mM acetate buffer 
(pH 5.6) , 25^M papain, 1.25 mM ascorbic acid and 25 |JM 
Cu(II).Papain was excited at 280 nm and the emission spectra 
was recorded 10 minutes after the addition of ascorbic acid and 
Cu(II) 
(1) Papain alone 
(2) Papain + ASA + Cu^ * 
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Fig. 11 Effect of histidine on the inactivation of soluble and 
immobilized papain in the presence of ASA-Cu^^ system. 
The reaction mixture (total volume 2.0 ml) containing 25|aM 
soluble/or chelating Sepharose bound papain, 1.25mM ASA, 
25|iM Cu^ "*" and 2.5mM histidine in 50mM sodium acetate buffer 
(pH 5.6) was incubated at room temperature. Aliquots (0.3ml 
each) were transferred periodically to the activating solution and 
papain activity was determined by caseinolytic method as 
described in the text. 
(•) Soluble papain without histidine 
(A) Soluble papain with histidine 
(o) Immobilized papain without histidine 
(A) Immobilized papain with histidine 
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Fig. 12 Effect of catalase on the inactivation of soluble and 
immobilized papain in the presence of ASA-Cu^^ system. 
The reaction mixture (total volume 2.0 ml) containing 25)iM 
soluble/or chelating Sepharose bound papain, 1.25mM ASA, 
25nM Cu2+ and 0.94^M catalase in 50mM sodium acetate buffer 
(pH 5.6) was incubated at room temperature. Aliquots (0.3ml 
each) were transferred periodically to activating solution and 
papain activity was determined by caseinolytic method as 
described in the text. 
(•) Soluble papain without catalase 
(A) Soluble papain with catalase 
(o) Immobilized papain without catalase 
(A) Immobilized papain with catalase 
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Fig. 13 Effect of mannitol on the inactivation of soluble and 
immobilized papain in the presence of ASA-Cu^^ system. 
The reaction mixture (total volume 2.0 ml) containing 25nM 
soluble/or chelating Sepharose bound papain, 1.25mM ASA, 
25|aM Cu^"'' and 2.5mM mannitol in 50mM sodium acetate 
buffer (pH 5.6) was incubated at room temperature. Aliquots 
(0.3ml each) were transferred periodically to the activating 
solution and papain activity was determined by caseinolytic 
method as described in the text. 
(•) Soluble papain without mannitol 
(A) Soluble papain with marmitol 
(o) Immobilized papain without mannitol 
(A) Immobilized papain with mannitol 
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Fig. 14 Effect of superoxide dismutase (SOD) on the inactivation of 
soluble and immobilized papain in the presence of ASA-Cu '^*' 
system. 
The reaction mixture (total volume 2.0 ml) containing 25}iM 
soluble/or chelating Sepharose bound papain, 1.25mM ASA, 
25^M Cu2+ and 0.78^M SOD in 50mM sodium acetate buffer 
(pH 5.6) was incubated at room temperature. Aliquots (0.3ml 
each) were transferred periodically to the activating solution and 
papain activity was determined by caseinolytic method as 
described in the text. 
(•) Soluble papain without SOD 
( • ) Soluble papain with SOD 
(o) Immobilized papain without SOD 
(A) Immobilized papain with SOD 
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papain where a significant changes in the percent inactivation were observed in the 
presence and absence of scavenger. This much concentration of catalase was also 
protective for immobilized preparation of papain inactivated by ASA-Cu(II) system. 
Mannitol and SOD were not as effective in protecting the papain as other scavengers 
(Figure 13-14). 
IMMOBILIZATION OF PAPAIN ON CALCIUM ALGINATE GELS 
Earlier method of papain immobilization on IMI carrier exhibited high activity yield 
and was more economical in terms of binding capacity to the small volume of the 
matrix. Such matrices have their potential in the industrial utilization of immobilized 
enzyme and due to their dispersion in the aqueous environment could not be 
considered as an appropriate model for comparing with membrane bound enzyme. In 
the following section we have selected another improved and better model system by 
using spherical alginate beads which have received much academic and commercial 
interest due to their many existing and potential applications, especially in comparison 
with the in vivo system. For the preparation of alginate beads, increasing 
concentrations of papain were entrapped in the cross linked network of alginate and 
results are shown in Table-11. The low concentration of papain used for entrapment 
retained high fraction of catalytic activity as evident by high r|. value (Table-11). 
There was a decrease in the TJ. value by increasing the enzyme concentration which 
remained constant up to the saturating level of enzyme within the alginate polymeric 
network.For further studies, we have selected the alginate entrapped papain exhibiting 
the higher activity yield. 
STUDIES ON ALGINATE ENTRAPPED PAPAIN 
Effect of Temperature : The thermo stability of soluble and alginate entrapped 
papain was investigated at 85°C for different time intervals. The results are shown in 
FigurelS. As it is clearly evident from the figure the alginate entrapped papain 
exhibited marked increase in the thermostability and retained almost 60% activity 
after 2 hours of incubation while its soluble counterpart lost about 80% activity. The 
soluble and alginate entrapped papain preparations were preincubated for 30 minutes 
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Table-11 Entrapment of papain in cross linked alginate beads. 
Increasing concentrations of papain were mixed were 2% alginate suspension 
and cross linked with 0.2% gluteraldehyde for a period of 2 hours and finally 
treated with 1% ethanol amine. These different enzyme alginate suspensions 
were used for preparing the calcium alginate beads by the described procedure. 
The papain activity in solution and alginate beads was determined by 
bapnolytic method as described in the text. 
Enzyme units 
added 
(A) 
438 
657 
876 
1314 
Enzyme units in 
alginate entrapped and 
cross linked beads 
(B) 
358 
336 
440 
668 
r| values 
(B/A) 
0.79 
0.51 
0.50 
0.50 
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Fig. 15 Thermal inactivation of soluble and alginate entrapped papain 
Soluble and alginate entrapped papain preparations in 5 ml of 50 
mM sodium acetate buffer (pH 5.6) were incubated at 80 C. 0.4 
ml of soluble papain and 4 beads of entrapped papain equivalent 
to papain activity were removed at indicated time interval, chilled 
immediately and activity was determined by bapnolytic method. 
Activity of unincubated preparations was taken as 100 for both 
soluble as well as alginate entrapped papain. The values taken are 
the mean of three experiments performed independently. 
(•) Soluble papain 
(o) Alginate entrapped papain 
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at different temperatures from 40°C - 90°C (Figure 16). As siiown in Figure 16 the 
activity of alginate entrapped papain remained almost constant at temperature below 
60°C while its soluble counterpart lost more than 40% activity. Even at higher 
temperature (90°C) alginate entrapped papain was resistant to denaturation and 
retained 70% of its original activity while soluble papain lost its complete 
activity.The spectral studies of heat inactivated soluble papain were also carried out 
and the results of fluorescence and absorption spectra are shown in Fig. 17 and Fig. 
1 S.The native and heat inactivated papain solutions were excited at 280 nm and the 
results of the fluorescence emission spectra are shown in Fig. 17. There was a shift in 
the fluorescence emission from 364 nm to 371 nm indicating the red shift of 7 nm 
after heating the papain at 80°C for 60 minutes. The absorption maxima of soluble 
and heat inactivated papain is shown in Fig. 18. There was no change in the 
absorption maxima after thermal inactivation of papain at 80°C. 
Storage Stability : The alginate entrapped papain could be stored for longer duration 
without any substantial loss in the enzyme activity. As evident from the Table 12 the 
soluble counterparts lost 42% activity when stored at 4°C for 60 days while the 
alginate entrapped papain retained almost 90% of its activity for the same duration. 
Effect of Substrate Concentration : The Km and Vmax values of native and 
alginate entrapped papain were determined by double reciprocal plots using BAPNA 
as substrate (Fig. 19). The values obtained are given in Table 13. The observed Km 
values of alginate entrapped papain was identical to the soluble papain while there 
was a slight increase in the Vmax value of alginate entrapped papain in comparison to 
the soluble papain. 
EFFECT OF ASA-Cu2+ SYSTEM ON SOLUBLE AND ALGINATE 
ENTRAPPED PAPAIN 
In order to generate the free radical under in vitro conditions, we have selected the 
ASA-Cu(II) system as described in the earlier section. The final concentrations of 
ASA and Cu(II) were 1.25 mM and 25|xM respectively in order to achieve the 
maximum inactivation of papain. These concentrations were also used for the studies 
carried out in the following section, where papain activity was determined by 
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Fig. 16 Effect of pretreatment at various temperatures on soluble 
and alginate entrapped papain. 
Soluble and alginate entrapped papain preparations in 5 ml of 50 
mM sodium acetate buffer (pH 5.6) were incubated at various 
temperatures. 0.4 ml aliquots of soluble and 4 beads of alginate 
entrapped papain equivalent to soluble papain activity was 
removed after 30 minutes, chilled immediately and activity was 
determined by bapnolytic method as described in the text. 
Activity of unincubated preparations was taken as 100 for both 
soluble as well as alginate entrapped papain. The values are the 
mean of three experiments performed independently. 
(•) Soluble papain 
(o) Alginate entrapped papain 
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Fig. 17 Fluorescence emission spectra of native and Iieat treated papain 
25pM papain solution in 10 mM phosphate buffer pH 7.4 (5.0 
ml reaction volume) was treated at 80° C for 60 minutes, chilled 
immediately, excited at 280 nm and emission spectra was 
recorded. The control untreated papain was also used in a similar 
way for recording the emission spectra. 
(1) Untreated soluble papain 
(2) Soluble papain treated at 80°C 
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Fig. 18 Absorption spectra of native and heat treated papain 
25nM papain solution in 10 mM phosphate buffer pH 7.4 (S.Oml 
reaction volume) was treated at 80° C for 60 minutes, chilled 
quickly and spectra was recorded between 180 nm- 600 nm . The 
control untreated papain was also used in a similar way for 
recording the absorption spectra. 
(1) untreated soluble papain 
(2) soluble papain treated at 80° C 
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Table-12 : Storage stability of soluble and alginate entrapped papain at 4°C. 
Soluble and alginate entrapped papain preparations were stored in 50mM sodium 
acetate buffer (pH 5.6) at 4°C. 0.4 ml of soluble papain and 4 Beads of entrapped 
papain equivalent to soluble papain activity were withdrawn at the indicated 
period of time and activity was determined by bapnolytic method. The day 
preparation was kept was considered as 0 day and percent remaining activity of 
the subsequent days was calculated from that value. 
Storage time 
(Days) 
0 
15 
30 
45 
60 
% Remaining activity 
Soluble Papain 
100 
80 
72 
60 
58 
Alginate Entrapped 
Papain 
100 
98 
92 
88 
84 
79 
Fig. 19 Effect of substrate concentration on the peptidase activity of 
soluble and alginate entrapped papain preparations. 
Approximately equal units of soluble and alginate entrapped 
papain preparations were incubated in a series of tubes containing 
varying concentrations of substrate (BAPNA) in the standard 
assay mixture for 30 minutes at 37°C and extent of hydrolysis of 
BAPNA was determined. Reciprocal concentration of velocity 
were plotted as a function of the reciprocal of substrate to obtain 
a characteristic Line Weaver Burk plot. The lines were 
extrapolated to cut the X-axis in order to obtain the volume of 
l/Km from which the Km value was determined. 
(o) Soluble Papain 
(•) Alginate entrapped Papain 
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Table-13 : Km and Vmax values of papain with synthetic substrate 
(BAPNA) 
Appropriate amounts of soluble papain and papain entrapped in alginate beads were 
incubated with varying amounts of substrate. Km and Vmax were determined 
graphically from the Line Weaver Burk plots of the data. 
Papain Preparations 
Soluble Papain 
Alginate entrapped 
Papain beads 
Km(M) 
14.28x10"' 
15.3x10"^  
Vmax (M.min*) 
5.0x10-*' 
5.5x10-^  
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bapnolytic method and the concentration of papain was 4 times greater than the 
papain used in the earlier section where activity was determined by caseinolytic 
method.The results are shown in Table 14 as evident from the Table there was a 
gradual decrease in the activity of soluble papain upto 8 minutes and beyond this the 
activity remained constant. The percent inactivation of soluble papain in the presence 
of ASA-Cu(II) was 25% after 10 minutes of incubation. While the alginate entrapped 
papain was least affected by the generated fi-ee radical under identical condition as 
evident by the retention of its initial activity (Table 14). A negligible inactivation of 
alginate entrapped papain in the presence of ASA-Cu^ "*" system was obtained and the 
preparation appeared to be more resistant against the generated free radicals. 
Effect of scavengers on the inactivation of soluble and alginate entrapped papain 
by ASA-Cu(II) system: In order to determine the effect of free radical and 
scavenging ability in preventing the inactivation of soluble and alginate entrapped 
papain studies were carried out where free radical scavengers were used. Scavengers 
used were : Sodium thiocyanate, potassium iodide, sodium benzoate, thiourea, 
histidine, catalase, mannitol and superoxide dismutase (SOD). The results of these 
scavengers on free radicals and the retenion of papain activity in the presence of 
ASA-Cu(II) system are shown in Table 15 and Fig. 20-23.From the Table it is evident 
that thiourea protected the enzyme maximally from inactivation by ASA-Cu(II) 
system however alginate entrapped papain was less affected as compared to its 
soluble counterpart. From the Fig. 20 it is evident that histidine also protected the 
enzyme from inactivation by ASA-Cu(II) system. Catalase is one out of the 
scavengers tested in our observation which prevented the inactivation of soluble and 
alginate entrapped papain to its maximum extent (Fig. 21) while this scavenging 
effect is minimized in case of mannitol and SOD (Fig. 22-23). 
STUDIES ON FLAVONOID-PAPAIN INTERACTIONS 
Flavonoids, a group of phenolic compounds present in a wide variety of plant 
sources.such as vegetables,fiTiits,herbs and tea affect the activity of enzyme systems 
such as aldose reductase, protein kinase C, hyaluronidase, NADH oxidase and metal lo 
peptidases (Ferriola,etal 1989 ; Hodnick etal, 1987 ; Kuppusamy etal, 1990 ; H. 
Bormann and M.F. Melzig, 2000 ). In this section we have carried out some studies 
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Table-14 : Studies on the inactivation of soluble and alginate entrapped 
papain in the presence of ASA-Cu(n) system as a function of 
time. 
A total volume of 2.0 ml reaction mixture containing 100 |iM soluble or alginate 
entrapped papain; 1.25 mM ascorbic acid and 25 |JM CU(II) in 50 mM acetate 
buffer (pH 5.6) was incubated at room temperature and 0.3 ml aliquots of soluble 
papain and four beads of alginate entrapped papain were transferred periodically 
to activating solution and papain activity was determined by bapnolytic method 
as described in the text. 
Time (minutes) 
0 
2 
4 
6 
8 
10 
% Inactivation 
Soluble Papain 
0 
4.8 
10.2 
18.6 
24.8 
25.2 
Alginate entrapped 
Papain 
0 
2.2 
3.8 
4.8 
5.1 
5.9 
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Fig. 20 Effect of histidine on the inactivation of soluble and alginate 
entrapped papain in the presence of ascorbic acid- Cu ^  
system. 
The reaction mixture (total volume 2.0 ml) conained 100 pM 
soluble or immobilized papain, 1.25 mM ASA, 25 jiM Cu^ "^  , 
2.5 mM histidine in 50 mM sodium acetate buffer (pH 5.6) was 
incubated at room temperature. 0.3 ml aliquots were transferred 
periodically to the activating solution and papain activity was 
determined by bapnolytic method as described in the text. 
(•) Soluble papain without histidine 
(A) Soluble papain with histidine 
(o) Immobilized papain without histidine 
(A) Immobilized papain with histidine 
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Fig. 21 Effect of catalase on the inactivation of soluble and alginate 
entrapped papain in the presence of ASA- Cu^ *^  system. 
The reaction mixture (total volume 2.0 ml) contained 100 joM 
soluble or immobilized papain, 1.25 mM ASA, 25fjM Cu^"*" 
0.94 |iM catalase in 50 mM sodium acetate buffer (pH 5.6) 
was incubated at room temperature. 0.3 ml aliquots were 
transferred periodically to the activating solution and papain 
activity was determined by bapnolytic method as described in 
the text. 
(•) Soluble papain without catalase 
(A) Soluble papain with catalase 
(o) Immobilized papain without catalase 
(A) Immobilized papain with catalase 
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Fig. 22 Effect of mannitol on the inactivation of soluble and alginate 
entrapped papain in the presence of ASA- Cu^ * system. 
The reaction mixture (total volume 2.0 ml) contained 100 [JM 
soluble or immobilized papain, 1.25 mM ASA, 25|aM Cu^ "^  , 
2.5 mM mannitol in 50 mM sodium acetate buffer (pH 5.6) was 
incubated at room temperature. 0.3 ml aliquots were transferred 
periodically to the activating solution and papain activity was 
determined by bapnolytic method as described in the text. 
(•) Soluble papain without Mannitol 
(A) Soluble papain with Mannitol 
(o) Immobilized papain without Mannitol 
(A) Immobilized papain with Marmitol 
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Fig. 23 Effect of superoxide dimutase (SOD) on the inactivation of 
soluble and alginate entrapped papain in the presence of 
ASA- Cu^ "^  system. 
The reaction mixture (total volume 2.0 ml) contained 100 |JM 
soluble or immobilized papain, 1.25 mM ASA, 25|iM Cu^ "^  , 
0.78 pM SOD in 50 mM sodium acetate buffer (pH 5.6) was 
incubated at room temperature. 0.3 ml aliquots were 
transferred periodically to the activating solution and papain 
activity was determined by bapnolytic method as described in 
the text. 
(•) Soluble papain without SOD 
(A) Soluble papain with SOD 
(o) Immobilized papain without SOD 
(A) Immobilized papain with SOD 
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on selected flavonoids-papain interaction In terms of the enzyme inactlvatlon, protein 
degradation and conformational changes. The flavonoids selected for these studies 
were quercetin, rutin and naringin. 5mM solution of these flavonoids were prepared in 
10% ethanol as a stock solution. The other parameters selected for these experiments 
were similar in case of all the three flavonoids. 
Quercetin- Papain Interaction : The effect of quercetin on papain activity is shown 
in Fig,24. As evident from the figure by increasing the concentration of quercetin 
there was a gradual decrease in the activity of the soluble papain upto 200 yM of the 
flavonoid concentration which remained constant by doubling the concentration of 
quercetin.The alginate entrapped papain was quite stable at all the concentration of 
quercetin used m this experiment.By further increasing the concentration of this 
flavonoid a precipitate was formed. When the effect of quercetin on papain activity 
was determined as a function of time, maximum inactivation was achieved during 2 
hours of incubation at room temperature in case of soluble papain while alginate 
entrapped papain exhibited complete resistance against inactivation induced by 
quercetin( Fig 25). For further experiments the final concentration of quercetin was 
choosen to be 200^M and the time of incubation was 2 hours. In order to investigate 
the effect of protein concentration on the inactivation behaviour of papain in the 
presence of quercetin, an experiment was carried out where soluble papain 
concentration was increased from 150 tol200^g and was incubated with 200nM 
quercetin for 2 hours similiarly the increasing number of alginate entrapped papain 
beads (2-10) were also incubated under identical conditions. The results are shown in 
Table 16. As evident from the Table the percent inactivation in case of soluble papain 
remained constant at the maximum concentrations used in this experiment. Like other 
experiment the alginate entrapped papain was maximally stable against quercetin 
induced inactivation at all the concentrations of the papain. In order to obtain the 
possible mechanism of papain inactivation by quercetin we have all also performed 
the 15% SDS polyacrylamide gel electrophoresis of quercetin treated papain for 2 
hours and results are shown in Fig 26. It is clearly evident from the figure that 
decrease in the intensity of protein band was due to the fragmentation of papain after 
treatment with the quercetin. In order to determine whether quercetin-papain 
interaction leads to the binding, quenching or changes in the conformation of the 
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Fig. 24 Effect of quercetin on the activity of soluble and alginate 
entrapped papain. 
The total reaction mixture of 1 mi containing different 
concentrations of quercetin prepared in 10% ethanol and 100 \iM 
of soluble and alginate entrapped papain was incubated at room 
temperature for 2 hours. Suitable aliquots / alginate beads were 
withdrawn from the reaction mixture and the activity of papain 
was determined by bapnolytic method described in the text. 
(•) Soluble Papain 
(o) Alginate entrapped Papain 
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Fig. 25 Effect of quercetin on the activity of soluble and alginate 
entrapped papain as a function of time. 
The total reaction mixture of 1 ml containing 200 jxM of 
quercetin prepared in 10% ethanol and 100 |aM of soluble and 
alginate entrapped papain was incubated at room temperature for 
the indicated duration. Suitable aliquots / alginate beads were 
withdrawn from the reaction mixture and the activity of papain 
was determined by bapnolytic methods described in the text 
(•) Soluble Papain 
(o) Alginate entrapped Papain 
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TabIe-16 Effect of enzyme concentration on the quercetin induced 
inactivation of papain. 
The total reaction mixture of 1.0 ml containing 200nM quercetin, different 
concentrations of soluble papain/increasing number of alginate beads were incubated 
at room temperature for 2 hours. Suitable aliquots of soluble papain and alginate 
beads were withdrawn from the reaction mixture and activity of papain was 
determined by bapnolytic method as described in the text. For each set, control was 
run where volume of quercetin was replaced by the buffer. 
Cone, of Papain 
Soluble 
150 ^g 
300 ng 
540 ^g 
900 ^g 
1200 ^ ig 
Immobilized 
2B 
4B 
6B 
8B 
lOB 
% Inactivation 
Soluble 
27.8 
43.0 
48.0 
48.2 
49.2 
Alginate entrapped 
Papain 
0.8 
1.1 
1.5 
1.8 
1.5 
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Fig. 26 SDS-Polyacrylamide gel electrophoresis of native and 
quercetin treated Papain 
The procedure of treatment was same as described in earlier 
experiments. 5fig of native and quercetin treated papain were 
subjected to electrophoresis on 15% SDS PAGE as described in 
the text. Staining was done by silver nitrate method. 
(a) Papain treated with quercetin 
(b) Native Papain 
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protein , spectral studies were also carried out. The results of UV-visible absorption 
spectra of quercetin treated and untreated dialyzed papain preparations are shown in 
Fig. 27. A decrease in the X max towards the visible region (7nm) was observed in 
case of quercetin treated papain. The band intensity was also remarkably decreased in 
case of treated papain while comparing with the untreated one. The results of the 
intrinsic fluorescence emission spectra of the above samples were also determined 
and the results are showoi in Fig.28,The fluorescence emission spectra obtained for 
untreated papain alone gives emission maximum at 360nm when excited at 278nm 
(Fig.28). Treatment with 200^M quercetin caused a 4nm blue shift of the emission 
maximum and was accompanied by 67% decrease in the magnitude of the 
fluorescence. 
Rutin-Papain interaction : One more flavonoid, rutin was selected in order to 
investigate its effect on papain activity and the results are shown in Fig.29. As evident 
from the figure, there was no effect of rutin up to the concentration of ImM on the 
activity of the soluble papain. The activity remained unaltered even with the increase 
in time of incubation of papain with ImM rutin(Fig.30).From the above results, no 
change in the activity of soluble papain was found therefore studies were not 
performed with the alginate entrapped papain. In order to confirm the above results 
15% SDS Polyacrylamide gel electrophoresis was carried out in which papain was 
treated with ImM rutin for 2 hours at room temperature and the results are shown in 
Fig. 31. As evident from the figure there was no change in the intensity or the position 
of the band of rutin treated papain. The results of UV-Visible absorption spectra of 
rutin treated and untreated dialyzed soluble papain preparations are shown in Fig. 32. 
Two peaks were obtained in which major peak shows hypsochromic shift of 7 nm and 
the band intensity shows the hyperchromic in case of rutin treated papain. The minor 
peak also shows the deacrease in the A,max and the band intensity was increased while 
compairing the treated and untreated soluble papain.Fig.33 shows the intrinsic 
fluorescence emission spectra of the rutin treated and untreated dialyzed soluble 
papain. Untreated papain alone gives the emission spectra at 359 nm when excited at 
278 nm while the treatment with 1 mM rutin resulted in the 6 nm red shift of the 
emission maximum. 
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Fig. 27 Absorption spectral changes in the native and quercetin-
papain complex 
The total reaction mixture of 1ml containing 540 |ig of papain 
and 200 |iM of quercetin was incubated at room temperature for 
2 hours. After extensive dialysis against 10 mM potassium 
phosphate buffer pH 7.4, the absorption spectra was recorded. 
1. Native papain 
2. Papain-Quercetin complex 
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Fig. 28 Changes in fluorescence emission of papain on addition of 
quercetin 
Total reaction mixture of 1 ml containing 540 |ag papain, 200 [oM 
quercetin was incubated at room temperature for 2 hours. After 
extensive dialysis against 10 mM potassium phosphate buffer pH 
7.4, fluorescence emission (excitation wavelength 280 nm) was 
recorded. 
1 Native papain 
2 Papain-Quercetin Complex 
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Fig. 29 Effect of rutin on the activity of soluble papain 
The total reaction mixture of 1 ml containing different 
concentration of rutin prepared in 10% ethanol and 100 |iM of 
soluble papain was incubated at room temperature for 2 hours. 
Suitable aliquots were withdrawn from the reaction mixture and 
the activity of papain was determined by bapnolytic method as 
described in the text. 
(•) Soluble Papain 
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Fig. 30 Effect of rutin on the activity of soluble papain as a function 
of time 
The total reaction mixture of 1 ml containing 1 mM rutin 
prepared in 10% ethanol and 100 |JM of soluble papain was 
incubated at room temperature for the indicated duration .Suitable 
aliquots were withdrawn from the reaction mixture and the 
activity of papain was determined by bapnolytic method as 
described in the text. 
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Fig. 31 SDS Polyacrylamide gel electrophoresis of native and rutin 
treated Papain 
The procedure of treatment was same as described in the earHer 
experiments. 5 pig of soluble and rutin treated papain were 
subjected to 15% SDS PAGE as described in the text. Staining 
was done by silver nitrate method. 
(a) Native papain 
(b) Rutin treated papain 
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Fig. 32 Absorption spectral changes in the native and rutin-papain 
complex 
Total reaction mixture of 1 ml containing 540 fxg papain, 1 mM 
rutin was incubated at room temperature for 2 hours. After 
extensive dialysis against 10 mM potassium phosphate buffer pH 
7.4, the absorption spectra was recorded . 
1. Native papain 
2. Rutin-Papain Complex 
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Fig. 33 Changes in fluorescence emission of papain on addition of 
rutin 
Total reaction mixture of 1 ml containing 540 )j.g papain, 1 mM 
rutin was incubated at room temperature for 2 hours. After 
extensive dialysis against 10 mM potassium phosphate buffer pH 
7.4, fluorescence emission (excitation wavelength 280 nm) was 
recorded. 
1. Native papain 
2. Papain-Rutin Complex 
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Naringin-Papain interaction :The effect of naringin on papain activity was also 
carried out in these studies. The effect of increasing concentrations of naringin on 
papain activity is shown in Fig.34. Like other flavonoids, the inactivation of enzyme 
in this case is a dose dependent and with increasing concentration of naringin, there 
was a decrease in enzyme activity. When the effect of naringin on the activity of 
soluble papain was investigated, maximum inactivation was achieved at ImM 
concentration during 2 hours of incubation at room temperature. The alginate 
entrapped papain was relatively stable under similar experimental conditions (Fig. 
35). Effect of increasing concentration of soluble and alginate entrapped papain on 
naringin induced inactivation is shown in Table 17. As evident from the table the 
percent inactivation in case of soluble papain remained constant at the maximum 
concentrations of the protein while the alginate entrapped papain was stable at all the 
concentrations used in this experiment. SDS-Polyacrylamide gel electrophoretic 
pattern of papain with naringin is shown in Fig.36.Deacrease in the intensity of the 
protein band suggest for the possibility of fragmentation in protein molecule. Like 
rutin two peaks were obtained in UV-visble absorption spectra as shown in fig. 37. 
The major peak was at 204 nm and minor peak at 274 nm in untreated soluble papain 
while the naringin treated papain exhibited the bathochromic and hyperchromic shifts 
in both major and minor peaks.The quenching of papain with 1 mM naringin is shown 
by fluorescence emission spectra (Fig. 38). There was a marked decrease in the 
intensity of the fluorescence while no shift in the position of \max was observed. 
CIRCULAR DICHROISM OF FLAVONOID TREATED PAPAIN 
Circular Dichroism (CD) spectroscopy measures differences in the absorption of left 
handed polarized light versus right-handed polarized light which arises due to 
structural asymmetry. The absence of regular structure results in zero CD intensity, 
while an ordered structure results in a spectrum which can contain both positive and 
negative signals. 
Far-UV region : CD predominantly monitors secondary structures of proteins and 
peptides in the far-UV spectral region (190-250).Pure a helices show negative 
ellipticity at around 222 nm and 295 nm, whereas pure P-sheets generally show a 
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Fig. 34 Effect of naringin on the activity of soluble and alginate 
entrapped papain 
The total reaction mixture of 1ml containing different 
concentrations of naringin prepared in 10% ethanol and 100 
fjM of soluble and alginate entrapped papain was incubated at 
room temperature for 2 hours. Suitable aliquots/ alginate beads 
were withdrawn from the reaction mixture and the activity of 
papain was determined by bapnolytic method as described in 
the text. 
(•) Soluble Papain 
(o) Alginate entrapped Papain 
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Fig. 35 Effect of naringin on the activity of soluble and alginate 
entrapped papain as a function of time. 
The total reaction mixture of 1 ml containing 1 mM of naringin 
prepared in 10% ethanol and 100 fxM of soluble and alginate 
entrapped papain was incubated at room temperature for the 
indicated duration. Suitable aliquots/ alginate beads were 
withdrawn from the reaction mixture and the activity of papain 
was determined by bapnolytic method as described in the text. 
(•) Soluble Papain 
(o) Alginate entrapped Papain 
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Table-17 : Effect of enzyme concentration on the naringin induced 
inactivation of papain. 
The total reaction mixture of 1.0 ml containing 1 mM naringin, different 
concentrations of soluble papain/increasing number of alginate beads were incubated 
at room temperature for 2 hours. Suitable aliquots of soluble papain and alginate 
beads were withdrawn from the reaction mixture and activity of papain was 
determined by bapnolytic method as described in the text. For each set, control was 
run where volume of naringin was replaced by the buffer. 
Cone, of Papain 
Soluble 
150 ng 
300 ^g 
540 Mg 
900 ng 
1200 ^ g 
Immobilized 
2B 
4B 
6B 
83 
lOB 
% Inactivation 
Soluble 
30.4 
33.9 
34.1 
19.2 
27.1 
Alginate entrapped 
Papain 
1.4 
3.6 
0.5 
0.8 
1.1 
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Fig. 36 SDS- Polyacrylamide gel electrophoresis of native and 
naringin treated papain 
The procedure of treatment was same as described in the 
earlier experiments. 5 ^g of soluble and naringin treated 
papain were subjected to 15% SDS PAGE as described in the 
text. Staining was done by silver nitrate method. 
(a) Native papain 
(b) Papain treated with naringin 
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Fig. 37 Absorption spectral changes in the native and naringin-
papain complex 
Total reaction mixture of 1 ml containing 540 jig papain, 1 mM 
naringin was incubated at room temperature for 2 hours. After 
extensive dialysis against 10 mM potassium phosphate buffer pH 
7.4, the absorption spectra was recorded . 
1. Native papain 
2. Naringin-Papain Complex 
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Fig. 38 Changes in fluorescence emission of papain on addition of 
naringin 
Total reaction mixture of 1 ml containing 540 ^g papain, 1 mM 
naringin was incubated at room temperature for 2 hours. After 
extensive dialysis against 10 mM potassium phosphate buffer pH 
7.4, fluorescence emission (excitation wavelength 280 nm) was 
recorded. 
1. Native Papain 
2. Papain-Naringin complex 
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shallow minima in CD (Greenfield and Fasman,1969).At these wavelengths the 
chromophore is a peptide bond, and the signal arises when it is located in a regular, 
folded environment. The spectra for soluble papain is characterized by the presence of 
minima at 228 nm while reaction with quercetin resulted in 4 nm blue shift as shown 
in Fig.39-A,while the interaction of soluble papain with 1 mM rutin and 1 mM 
naringin resulted in 2 nm and 6 nm blue shift respectively (Fig. 40A,41 A). 
Near-UV region:The circular dichromic spectra in the near UV region reflects the 
contribution of aromatic side chains, disulphide bonds and of prosthetic groups 
(Kuwajima,1989; Dryden and Weir, 1991). Fig. 39-B shows the Near-UV CD spectra 
of soluble papain and papain treated with quercetin in 250-300 nm range. Near UV-
CD spectra of soluble papain is characterized by a band at 272 nm showing the 
asymmetric environment of tyrosine. Interaction of papain with quercetin resulted in 2 
nm blue shift (Fig. 40-B). There was no change in the CD spectral band of papain 
treated with 1 mM rutin (Fig. 41-B). On the other hand soluble papain treated with 
ImM naringin showed a minute change of 1 nm blue shift (Fig. 41-B). 
ESTIMATION OF SULFHYDRYL GROUPS 
Free sulfhydryl groups present on the active site of papain were partially modified by 
the treatment of flavonoids using the procedure of Ellman (1959). The number of 
sulfhydryl groups present on the active site of native and flavonoid treated papain 
were calculated from the standard graph of cysteine (Fig. 42). The values are shown 
in Table 18 clearly indicates SH group modification. 
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Fig. 39 Far and Near-UV region circular dichroism (CD) spectra of 
native and quercetin treated papain. 
Total reaction mixture of 1 ml containing 25 i^M papain and 200 
pM quercetin was incubated at room temperature for 2 hours. 
After extensive dialysis against 10 mM potassium phosphate 
buffer pH 7.4 (A) Far-UV CD spectra (B) Near-UV CD spectra 
was taken in which cells with 0.1 cm and 1 cm pathlength was 
used. The unit on ordinate is given in CD (m deg). 
1. Native papain 
2. Papain treated with quercetin 
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Fig. 40 Far and Near-UV region circular dichroism (CD) spectra of 
native and rutin treated papain. 
Total reaction mixture of 1 ml containing 25 (JM papain and 1 
mM Rutin was incubated at room temperature for 2 hours. After 
extensive dialysis against 10 mM potassium phosphate buffer pH 
7.4 (A) Far UV CD spectra (B) Near UV CD spectra was taken 
in which cells with 0.1 cm and 1 cm pathlength was used. The 
unit on ordinate is given in CD (m deg). 
1. Native Papain 
2. Papain treated with rutin 
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Fig. 41 Far and Near-UV region circular dichroism (CD) spectra of 
native and naringin treated papain. 
Total reaction mixture of 1 ml containing 25 foM papain and 1 
mM naringin was incubated at room temperature for 2 hours. 
After extensive dialysis against 10 mM potassium phosphate 
buffer pH 7.4 (A) Far UV CD spectra (B) Near UV CD spectra 
was taken in which cells with 0.1 cm and 1 cm pathlength was 
used. The unit on ordinate is given in CD (m deg). 
1. Native papain 
2. Papain treated with naringin 
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Fig. 42 Estimation of sulfhydryl groups of native and partially 
modified papain from cysteine standard plot. 
Increasing concentration of cysteine (1.2 mg/100 ml) was 
incubated with DTNB as described by Ellman (1959) and 
absorbance was recorded at 412 nm. Absorbance was plotted 
against [x mole of sulfhydryl groups present in the cysteine 
standard. This plot was used for calculating the number of 
sulfhydryl groups present in the native and partially modified 
papain. 
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Table-18 Sulfhydryl groups in native and flavonoid treated 
papain. 
Aliquots of native and respective flavonoid treated papain (1080 ^g) were 
analyzed for SH groups using DTNB as described in the text. Number of \x mole 
of SH groups/ \x mole of protein were determined from the cysteine standard plot. 
Papain Preparations 
Native papain 
Papain-Quercetin Complex 
Papain-Rutin Complex 
Papain-Narangin Complex 
ft mole of SH/fi mole of protein 
1 
0 
1 
1 
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(DISCUSSION' 
Many enzymes, such as the enzymes of mitochondria, the enzyme participating in 
photosynthesis and in protein synthesis, and the enzymes responsible for active 
transport, act in vivo while embedded in membranes or attached to subcellular 
particles. The understanding of the action of such enzymes in situ requires the 
determination of the correlation between the flow of substrate and enzyme activity, 
elucidation of the concentration of substrate, product, and pH within the domain of 
the membrane, estimation of the rate of flow of product out of the membrane into the 
surrounding medium, and investigation of the effect of the structure of the membrane 
on its mode of action. It is now well established that oxygen free radicals are 
produced under aerobic and diseased conditions, damaging various macromolecules, 
including enzymes (Stadman and Oliver, 1991; Halliwell and Gutteridge, 1985; Seven 
et al., 1998; Morrison and Morrison, 1999). It is not very clear whether membrane 
bound enzymes behave differently from the soluble enzymes when exposed to free 
radical species. Similarly, the flavonoids,a class of plant polyphenols have been 
found to inhibit some matrix-proteases instrumental in inflammation and cancer 
invasion, as well as to other enzymes under in vivo conditions (Bormann and 
Melzig,2000; Parellada and Guinea, 1995). The understanding of the relative 
contribution of each one of these parameters to enzyme activity in the organized cell 
structure is at this stage beyond the scope of available experimental techniques. With 
the aid of simple model systems in which enzymes are bound to various synthetic 
carriers or immobilized on different supports, it may be possible to study some of the 
parameters individually and thus obtain a better insight into the factors governing the 
activity of enzymes in biological membranes. 
Papain, a cysteine proteinase, is well known for its established structure, 
function and pharamaceutical potential (Khan and Iqbal, 2000). Lysosomal cysteine 
proteinases, also known as cysteine cathapsin, belong to the papain family of 
proteinases and share a similar protein structure and mechanism of action. Cysteine-
proteinases (CP) are probably the most widely represented class of hydrolytic 
enzymes, mainly located in the lysosomes, and devoted to degradation of both 
intracellular and extracellular proteins. However, CP activities can not be confined 
only to catabolism since they have relevant roles in synthetic processes (Chapman et 
al., 1997) such as in the synthesis of cytokines and prohormones (Thomberry et 
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a/., 1992). CP have also been strongly implicated in normal and pathological processes 
involving antigen presentation (Riese and Chapman, 2000), metabolism of amyloid 
precursor proteins (Bernstein et al., 1996), and formation of amyloidogenic peptides 
(Klafki et al., 1995; Munger et al, 1995), apoptosis (Petel et al, 1996), complement 
activation (Frade et al, 1998), aging (Di Polo et al, 1992) osteoclast-mediated bone 
resorption (Gamero et al, 1998), and eventually, tumor cell invasion (Lah and Kos, 
1998; Koblinsky et al, 2000). Papain has also been considered an important enzyme 
for its industrial and medicinal utilization including its potential as a meat tenderizer 
and chill proofing agent during beer finishing operation (Wiseman, 1993; Swanson et 
al, 1992). 
In view of the above facts this third protease, papain has been selected as a 
model in our studies for its immobilization on different supports. The properties of 
soluble and bound papain have been investigated in terms of their relative stability, 
free radical induced inactivation as well as interaction with certain dietary 
polyphenolic compounds. The bound papain model systems have been prepared for 
these studies. 
The first portion of this dissertation deals with the immobilization of papain on 
chelating Sepharose, which was activated with Cu(II) ions. The results of papain 
immobilization on IMI carrier are shown in Table 3. The t) value, the ratio of actual 
and theoretical bound enzyme activities, was 0.80 which was significantly higher 
when compared with other enzymes immobilized by different methods or covalently 
coupled papain (Iqbal and Saleemuddin, 1983 b; Zhuang and Butterfield, 1992). One 
possible explanation of getting high TI value could be related to higher accessibility of 
the enzyme to the substrate. Zhuang and Butterfield (1992) have suggested that direct 
immobilization of papain leads to protein binding to the support with lesser enzyme 
activity. Rajalakshmi et al, (1995) have shown that papain immobilized on matrix 
retained greater than 80% catalytic activity with no change in pH optima and kinetic 
constant, indicating that the gross tertiary structure was not altered by the 
modification of the enzyme. Our results of Table 3 are closely related to the values 
obtained by the Rajalakshmi et al, (1995) and the possibility of retaining the tertiary 
structure of papain after its binding to the chelating sepharose could not be ruled out. 
The immobilization of enzymes on the matrix used in this method is based on the 
116 
formation of co-ordinated complex between exposed immidazole, tiiiol and indole 
groups of enzyme and the agarose-fixed metal ions. The retention of papain activity 
after binding to IMI carrier indicated the protection of active site and the involvement 
of other groups during binding process. Chaga (1994) has used these matrices for 
immobilization of glycoproteins. This method is superior over other methods because 
small amount of matrix (IMI) is sufficient to immobilize maximum units of papain, 
which undoubtedly minimizes the cost of immobilization over the other conventional 
methods. 
A remarkable advantage of these carrier is its regeneration and recovery from 
spent immobilized enzyme. After the elution of papain from Cu (II) activated IMI 
carrier, the regeneration and reactivation with same metal ion was highly effective as 
evident by the activity yield of immobilized papain during subsequent cycles of 
reimmobilization (Table 4). The activity yields for 2"'', 3"* & 4"" cycles were 75, 72 
and 74% respectively. This clearly indicated that the matrix can be efficiently 
regenerated, which is not possible in the case of covalently and crosslinked 
preparations (Iqbal and Saleemuddin, 1983a; Iqbal and Saleemuddin, 1983b). The 
potential of substituting the metal ion and higher enzyme loading was also 
investigated on the recovered carrier (Table-5). When Co(II) was used for the 
reactivation of the regenerated matrix obtained from Cu (II) activated papain bound 
IMI carrier, the comparable activity yield suggested that metal replacement is feasible 
as well as effective for enzyme immobilization on IMI carrier. Such replacement of 
metal ion is essential in certain cases, where enzymes are inactivated by binding to 
specific types of metal ion bound to IMI carrier (Chaga, 1994). 
The immobilized papain on IMI carrier also exhibited a marked increase in 
thermostability, when compared with its soluble counter part (Fig. 5). The higher 
stability of the IMI bound papain could be due to the diminished autolysis of the 
enzyme fixed to the support. The second possible explanation is related to the rigidity 
of the conformation of the enzyme molecules resulting from the binding to the matrix. 
Most proteolytic enzymes studied in their soluble form are highly susceptible to 
autolysis leading to the inactivation at elevated temperatures (Zhuang and Butterfield, 
1992). The enhancement in thermal stability of membrane bound papain and 
covalently coupled chymotrypsin has also been reported in many other enzyme 
117 
immobilization studies (Butterfield et al, 1994; Schnapp and Shalitin , 1976). When 
the activity of these enzyme preparations was measured at different temperatures, the 
maximum enzyme activity was observed at 40°C in both soluble and immobilized 
forms suggesting no alteration in the temperature activity profile after adsorbing the 
enzyme on IMI carrier (Fig.6). 
Damaging free radicals are formed in many biological processes, as accidental 
byproducts of aerobic metabolism as cytotoxic weapons of the immune system and 
inflammatory responses and through the action of environmental agents (Sies ,1991). 
The key reactive species are superoxide radical (O2'), hydrogen peroxide, hydroxyl 
radical and nitric oxide.These reactive species can produce damage in most major 
cellular macromolecules including DNA, lipids and proteins (Sies, 1991). Since the 
extent of damage to the protein by these radicals depends on the orientation as well as 
compartmentation of these proteins. In order to investigate the effect of these radicals 
on proteins located in different compartments in free as well as bound forms, there is 
a need to develop an in vitro model system. The immobilized enzyme system is 
considered to be the best model system to compare with in vivo bound enzymes and 
metal catalyzed oxidation (MCO) systems have been widely used as a model of 
biological oxidation. Some amino acids such as histidine, tyrosine, methionine, 
cysteine, proline and tryptophan were preferentially oxidized by MCO system 
(Stadtman, 1990; Berlett and Stadtman, 1997; Kato et al., 1992; Uchida et al., 1990). 
The transition metal ion-ascorbic acid (ASA) model system has been studied 
in order to better understand the mechanism of enzyme inactivation by generating free 
radicals (Levine et al., 1981; Shainer et al., 1983; Nakanishi et al., 1985). We have 
selected ascorbic acid-Cu(II) (ASA-Cu(II)) system for generating free radicals and its 
effect on soluble as well as immobilized metal ion (IMI) carrier bound papain. It has 
been reported that papain was irreversibly inactivated by the ASA-Cu(II) system 
under aerobic conditions. For this inactivation Cu(II) ions were essential and there is a 
formation of free radicals on the basis of redox reaction between ASA and Cu(II) 
(Kanazawa et al, 1993). The results of generated free radicals and the inactivation of 
soluble and IMI carrier bound papain by ASA-Cu(II) system are shown from Table 6-
9. The time required for the formation of free radical and the inactivation of soluble 
papain was determined by the experiment in which the aliquots were withdrawn from 
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the Ascorbic acid-Cu(II)-enzynie (ASA-Cu(II)-E) reaction mixture at different time 
intervals and papain activity was determined. As shown in Table-8 that at an 
enzyme/Cu(II) ratio of 1:1 there was a gradual increase in the inactivation of papain 
upto 6 minutes, beyond this time enzyme activity remained constant, suggesting that 
the radical formation and its effect on soluble papain is a rapid process. The 
persistence in the activity of the papain after certain time intervals could be explained 
on the basis of short half life of the free radical and the rapid oxidation of ASA, 
generating significant amount of free radicals which partially damage the enzymes 
active site, as evident by loss in enzyme activity. A similar experiment was repeated 
by using immobilized papain on IMI carrier just to explore our basic notion 
underlying this investigation. As shown in Table-9, there was a drastic decrease in 
papain inactivation at the same ASA-Cu(II) ratio in comparison with its soluble 
counterpart. Several studies have shown that immobilized enzymes including papain, 
exhibited marked stability against different forms of denaturation (Zhuang and 
Butterfield, 1992). Under the experimental conditions described, the biological 
damage represented by the inactivation of the papain was obtained only when both 
Cu(II) ions and ASA were added to the enzyme solution. Kanazawa et al (1993) have 
proposed the possible mechanism of papain inactivation under these conditions. 
Firstly, monoionic ASA (AH") is attracted to the enzyme at a locus near bound Cu(II) 
ions to form a ternary complex. Secondly, the redox reaction between Cu(II) ions and 
ASA at the locus generates the highly reactive free radical that will be involved in the 
inactivation. Thirdly, an ASA radical in its ionized form (A'), which is produced by 
the redox reaction of (AH") with the surpulus Cu(II), competes with (AH") at the 
binding site for ASA, thereby preventing the formation of the ternary complex 
responsible for the inactivation. The immobilized papain resists such inactivation and 
do not fully support the above proposed mechanism. Kato et al (2001) have 
demonstrated the proteins oxidation studies by different metal catalyzed oxidation 
(MCO) systems and measured the loss of tyrosine residues. 
Anraku et al (2001) have shown the effect of oxidative stress on the structure 
and function of human serum albumin involving the MCO system and observed the 
significant structural changes in the protein.Kim et al (2001), while studying the metal 
catalyzed oxidation of human serum albumin, have investigated the production of 
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hydroxyl radical (OH) or H2O2. We have also confirmed the possibility of the 
hydroxyl radical formation during papain inactivation by ASA-Cu(II) system. The 
results of Fig.8 confirm the above findings of Kim et al (2001) that hydroxyl radicals 
are generated by the MCO system used in our investigation. These results also 
confirm the findings of Kanazawa et al (1993) as well as our results of Table-7 that 
radical formation is not directly proportional to the ascorbic acid concentration in 
ASA-Cu(II) system. The intrinsic fluorescence spectrum of ASA-Cu(II) treated and 
untreated papain were different in terms of fluorescence intensity when excited at 280 
nm. This decrease in fluorescence suggested that some conformational changes 
occured as a consequence of exposure to this MCO system within the environment of 
the hydrophobic amino acid. A deviation in the fluorescence intensity as well as 
fluorescence spectra was also reported by others in case of papain exposed to other 
agents (Joshi et al, 1999; Edwin and Jagannadhan, 1998). 
The possibility of radical formation by ASA-Cu(II) system and their effect on 
soluble as well as IMI bound papain was also tested in presence of certain radical 
scavengers (Table 10 and Fig. 11-14). Among the scavengers tested in our studies, 
catalase, histidine and thiourea were found to be most protective against ASA-Cu(II) 
mediated inactivation of soluble papain. Effect of catalase on soluble papain 
inactivation by the system was also described by Kanazawa et al (1994). From this 
finding, it is possible to presume that secondary highly reactive species, probably OH 
radical is involved in the inactivation of enzyme (Asada, 1976; Rowley and Halliwell, 
1983). According to the several inactivation schemes proposed by Kanazawa et al 
(1994), it could be suggested that hydroxyl radical is not formed via a copper 
catalyzed Haber-Weiss reaction (Rowley and Halliwell, 1983) and that OH, formed 
mainly via Haber-Weiss reaction (Haber and Weiss, 1934) at the specific site for the 
inactivation, is probably responsible for the inactivation of the enzyme by ASA-Cu(II) 
system. However, the immobilized papain was less affected by the ASA-Cu(II) 
system in comparison with its soluble counterpart as evident by its relative activity. It 
is very likely that the active sites of the enzyme are not fully exposed and that the 
attachment of the enzyme to the solid support minimizes the conformational changes 
induced by environmental factors and, in this particular case, by free radicals. The 
immobilized papain activity was relatively much improved in the presence of these 
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scavengers in comparison with the soluble enzyme although this preparation was 
already protected from the inactivation by the free radicals generated by our system. 
Some different hydroxyl radical scavengers such as sodium benzoate, mannitol etc. at 
concentrations that are usually effective in scavenging OH failed to provide any 
protection. Similar to the findings that the site specific inactivation of enzymes by 
MCO system is insensitive to inhibition by free radical scavengers (Stadtman and 
Oliver, 1991; SXainer etal, 1983;Nakanishi, 1985). 
The effect of sodium thiocyanate on the protection of papain inactivation 
could be explained on the basis of similar results obtained by Kanazawa et al (1994). 
This is possibly explained by the hypothesis that the thiourea and thiocyanate ion can 
trap Cu^ "^  and thereby prevent a ternary complex being formed and that the Cu^ "^  to be 
trapped is reduced by ASA to give a cuprous complex (Cheng, 1961).Histidine was 
the another scavenger which prevented the papain from inactivation by ASA-Cu(II) 
system and again the pronounced effect could be well observed in case of soluble 
papain while the immobilization by itself without scavengers almost equally 
protective against the ASA-Cu^ "^  induced inactivation of enzyme. The histidine may 
be able to form Cu(II) -histidine complex, responsible for the oxidation of ASA, and 
this redox reaction is not involved in inactivation because the oxidation of ASA by 
Cu^ "^  at specific site on the enzyme is responsible for the inactivation (Kanazawa et 
al, 1993). These studies, however, clearly support our presumption that in biological 
systems, membrane embedded enzymes are least affected by the radicals generated 
under aerobic or diseased conditions and require little or no scavengers for their 
protection. 
An another approach for papain immobilization is based on the entrapment in 
calcium alginate gels. This biopolymer is unique in its properties and comparable with 
other gelling polysaccharides as well as biological membranes. The properties of 
alginate gels have also been reported for biomedical and pharmaceutical uses (Draget 
et al., 1997). The entrapment of papain in calcium alginate gel has certain additional 
advantages in comparison to IMI bound papain and has been selected as a second 
model system for studying the dynamic functions of cellular enzymes in vivo . 
This entrapment method allows the kinetics of papain reaction to be almost the same 
as that in free solution, since papain is entrapped within a relatively large space of 
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polymer network and the gel matrix is not charged. Further, gel membranes with 
widely different pore sizes can be produced by adjusting the concentrations of 
alginate and calcium chloride during polymerization. Alginates are a family of linear 
polymer of (1-4) linked P-D mannuronic acid and a-L-guloronic acid (Martinsen et 
al, 1989; Smidsrod and Skjack-Braek, 1990). When divalent ions such as calcium are 
added, crosslinking occurs at the carboxyl side chain, forming a three dimensional 
matrix that changes the alginate from a liquid to solid. Increasing concentrations of 
papain were entrapped in the crosslinked network and the results are shown in Table-
11. The lower concentration of papain used for entrapment retained large fraction of 
catalytic activity as evident by high TI value (Table 11). This could be due to 
entrapment of most of the enzyme molecules within the crosslinked network without 
producing any stearic hinderance. These enzyme molecules consequently would be 
readily accessible to substrate leading to relatively high ri value. The decrease in TI 
value with the increase of enzyme concentration suggested for unfavourable 
orientation or location of bound enzyme within the polymeric network. Giomo et al 
(2001) have performed a study on an enzyme membrane reactor with immobilized 
fumarase for the production of L-Malic acid and enzyme was entrapped in 
asymmetric capillary membranes made of polysillfone. They have clearly 
demonstrated that enzymes work better in dilute solutions rather than in concentrated 
ones and this effect is more accessterated when enzyme is immobilized. The reason 
described by Giomo et al (2001) for this is that when too much enzyme is in the 
support the mass transport resistance is increased and reagents can not reach 
(substrate) or release (product) to the reaction site, with an overall effect of reducing 
reactor performance. A similar pattern of activity yields was obtained upon 
insolubilization of low and high concentrations of papain with antipapain antibodies 
(Khan and Iqbal, 2000). Chen and Su (2001) have immobilized a-chymotrypsin on 
latex particles and has shown the effect of enzyme loading on immobilization as well 
as activity yields. There was a considerable high activity yield of immobilized a-
chymotrypsin at low enzyme loading which dropped at higher concentration and then 
leveled off by increasing enzyme loading and approaching the maximum surface 
density of protein obtainable from monolayer coverage. Hence, the available surface 
area but not the available functional groups of the matrix inherently limit the amount 
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of enzyme that can be immobilized. For our studies we have selected the alginate 
entrapped papain exhibiting the higher activity yield. 
Like the IMI bound papain, alginate entrapped papain also exhibited a 
remarkable thermal stability (Fig 15, 16) which could again be explained on the basis 
of the rigidity or the conformation of the enzyme molecule resulting from entrapment 
within the alginate network. When thermal inactivation of soluble papain was 
compared with the spectral studies. It was observed that not only inactivation occurs 
before significant conformational change of the molecules as a whole, the unfolding 
as monitored by the fluorescence are not the parallel events . Similar results have been 
obtained for creatine kinase during denaturation by guanidine-HCl and urea (Yao et 
al, 1984) and appears to be the case for many other enzymes (Luang et al., 1990; 
West et al., 1990; Kelly and Price, 1991).The unaltered K ,^ and Vmax values of soluble 
and alginate entrapped papain suggest that the kinetics of papain reaction remained 
unchanged after entrapment within the alginate network due to no limitation of 
diffusion resistance (Table-13). Hyashi et al (1993) have shown an increase in Km of 
porous beads entrapped papain . 
The effect of free radicals on soluble and alginate entrapped papain were also 
investigated involving ASA- Cu (II) system. The mechanism of radical generation 
has already been described where IMI bound papain was used as model for in vivo 
behaviour of enzymes. The alginate entrapped papain exhibited much higher 
resistance against these radicals when compared with the soluble as well as IMI 
bound papain (Table-14). As the orientation and localization of enzymes entrapped in 
the alginate beads is closely related to the membrane bound enzymes, our 
presumptions for their stability could be compared with results of the Table 14. This 
compatibility might be attributed due to the mechanical rigidity as well as other 
properties of alginate gel ( Smidsrod and Haug, 1972; Draget et al, 1997). The same 
free radical scavengers were selected for these studies used in previous section, 
exhibiting almost identical results except to the alginate entrapped papain preparation 
(Table 15 and Fig 20-23). A slight decrease in the percent inactivation of soluble 
papain in presence of ASA-Cu^* system while comparing with the results of Table-10 
could possibly be explained on the basis of its higher concentration used for these 
experiments. The alginate entrapped papain was itself protected from inactivation by 
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the free radicals generated in our system and no scavengers was effective to increase 
the resistance or further protection by the free radicals. 
Flavonoids are phenolic compounds occuring ubiquitously in vascular plants. 
They show a broad spectrum of pharmacological effects. A variety of medicinal plant 
are therapeutically used because of their anti-inflammatory, anti-carcinogenic, 
spasmolytic, vessel stabilizing or diuretic actions. Certain flavonoids are known to 
interfere including the metallo-peptidases and other proteases (Parellada and Guinea, 
1995; Bormann and Melzig, 2000). At high doses flavonoids may also act as mutagen, 
proxidants that generate free radicals and as the inhibitors of the enzymes involved in 
hormone metabolism (Skibola and Smith, 2000). Among the flavonoids tested 
quercetin has been reported for inhibiting variety of enzymes (Ferrola et al., 1989). In 
our studies we have selected quercetin, rutin and naringin for their effect on soluble 
and alginate entrapped papain. Like other enzymes tested elsewhere, soluble papain 
has been shown to be maximally affected in the presence of quercetin (Fig. 24-26). 
Igarshi et al (1983) have shown the inhibition of papain by quercetin. Mantle et al 
(1989) have reported that a range of proteolytic enzyme types in human skeletal 
muscle tissue showed some degree of inhibition by certain flavonoids. Rutin was non-
inhibitory to papain while the Naringin was not as effective as quercetin in reducing 
the activity of papain (Fig. 29, 34). Whenever the soluble papain lost its activity in the 
presence of flavonoid, alginate entrapped papain has been shown to be fully protected 
by the action of flavonoid mainly due to the orientation and conformation of enzyme 
molecule. Since the interaction of flavonoids with enzyme molecule mainly depends 
upon its structure, different flavonoids act differently on the same enzyme molecule. 
Xu et al (2000) have tested many flavonoids for their inhibitory activity 
against human immuno deficiency virus (HIV)-l protease. Quercetin was the most 
potent inhibitor of the target enzyme while Butein and Luteolin showed moderate 
activity. Similarly Sartor et al (2002) have tested 27 different flavonoids for their 
inhibitory activity on some matrix proteases with great variations. Imamura et al 
(2000) have proposed the mechanism for the inhibitory activity of the flavonoids 
based on the number and position of the hydroxyl group in the phenyl rings (B-ring) 
of flavonoids and the existence of 2,3 double bond in the (C-ring) which are important 
for enzyme inhibition. The structural activity relationship of different flavonoids has 
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also been suggested by Robak et al (1986).The inhibitory activities of hydroxylated 
flavonoids may also be explained on the formation of the hydrogen bridge between 
the flavonoids and amino acids near or at the active site of enzyme molecules. The 
SDS gel electrophoretic pattern of quercetin treated papain indicated a significant 
fragmentation as evident by the decreased intensity of the papain band, among the 
flavonoids tested in these studies. 
Proteins contain three aromatic amino acid residues (tryptophan, tyrosine, 
phenylalamine) which may contribute to their intrensic fluorescence. Changes in 
intrinsic fluorescence can be used to monitor structural changes in protein (Creighton, 
1991). The fluorescence of a folded protein is a mixture of the fluorescence from 
individual aromatic residues. Protein fluorescence is generally excited at 280 nm, 
most of the emissions are due to excitation of tryptophan residues, with a few 
emissions due to tyrosine and phenylalanine (Creighton, 1991). The intrinsic 
fluorescence spectra were clearly different for quercetin, rutin and naringin treated 
papain as shown in Figs 28, 33, 38. The emission maximum for untreated papain is 
359 nm (at Xex 280 nm). Treatment of soluble papain with quercetin caused a 
decrease in fluorescence intensity with a blue shift of 6 nm (Fig 28). This decrease in 
fluorescence suggests that some conformational changes occur as a consequence of 
dissociation in which the environment of the hydrophobic amino acid is altered. 
Interaction of rutin and naringin with papain showed a drastic decrease in intensity 
with a small red shift (Fig 33, 38). Exposure of aromatic amino acids to a polar 
environment resulted in a decrease in fluorescence intensity (Friedfelder, 1984). The 
observed decrease in fluorescence intensity in reaction of papain with quercetin, rutin 
and naringin might be related to movement of tryptophan and tyrosine in the 
proximity of ionized amino acids thereby resulting in the quenching of the 
fluorescence. However, it is also possible that tryptophans shift in a region of a 
protein where movement of the indole ring is hindered (Friedfelder, 1984). 
Significant changes in the shape and magniude in circular dichroism spectra of 
untreated and flavonoids treated soluble papain has been observed (Fig. 39,40,41 ). 
The differences observed among far ultra violet spectra (200-250 nm) are mainly due 
to the modifications in the conformation of the polypeptide backbone, while the 
spectral changes in the near- ultra violet region (250-300 nm) reflected alternations of 
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the asymmetrical environment of aromatic side chains (Hernandez-Arana and 
Soriano-Garcia, 1988). In far UV-CD spectra the spectrum obtained for rutin treated 
papain is approximately similar to that of untreated papain. Thus, from this it is clear 
that this protein maintained its native structure when treated with rutin while there 
seems induction of some non native secondary structure when treated with quercetin 
and naringin as monitored by changes in the CD values expressed in m deg.(Ghosh 
and Chattopadhyaya, 2001; Rawel et al, 2002). In the near- ultra violet region there 
seems to be the induction of non native tertiary structure. Negative broad band may 
be due to the three disulfide bonds of the molecule, since the cystinyl CD bands are 
usually much broader than the bands observed for aromatic side chains 
(Struckland,1974). The near-UV CD spectral changes may not be the true 
representation of major conformational changes in the protein. The spectra indicated 
alterations in the immediate structural and electronic environment of the aromatic 
amino acid residue resulting from interaction of papain with quercetin and naringin 
(Creighton, 1991). 
All these above CD findings suggested structural changes to be least affected 
by the rutin which is in line with other spectral studies which implicate rutin to cause 
minimal changes as compared to quercetin and naringin. 
From the studies related to the flavonoids it can be demonstrated that in 
addition to their well described antioxidant characteristics, flavonoids also possess 
novel antiproteolytic inhibitory activity in vitro, which may in part explain some of 
the beneficial effects of these plant derived compounds in vivo. At higher doses, 
flavonoids may act as mutagens, pro-oxidants that generate free radicals, and as 
inhibitors of key enzymes involved in hormone metabolism. Thus, in high doses, the 
adverse effects of flavonoids may outweigh their beneficial ones, and caution should 
be exercised in ingesting them at levels above that which would be obtained from a 
typical vegetarian diet. The unborn fetus may be especially at risk, since flavonoids 
readily cross the placenta. More research on the toxicological properties of flavonoids 
is warranted given their increasing level of consumption. 
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Enzymic reactions play a vital role in the regulation and control of living systems at 
the cellular level. Often the enzymes are localized within particular regions of the 
cells (e.g. membranes or organelles) and the reactions they catalyze are intimately 
coupled with diffusion. It has long been recognized that the bound enzymes 
containing enzymes immobilized in vitro, can serve as a convenient and versatile 
model system for studying the dynamic functions of cellular enzymes in vivo. Work 
described in this thesis represents the immobilization of papain on Immobilized Metal 
Ion (IMI) chelating Sepharose as well as entrapment on the alginate beads in order to 
develop an in vitro model for comparing the in vivo behaviour of membrane bound 
enzymes. Detailed investigations were made on the nature, catalytic, thermal and free 
radicals stability of the bound enzyme preparations in comparison to the soluble 
enzyme. The potential of free radical scavengers on the free radical induced 
inactivation of soluble and bound papain has also been discussed. The interaction of 
some polyphenolic compounds with soluble and bound papain has been investigated 
in terms of enzyme inactivation as well as changes in the conformation of protein was 
determined by spectral studies. 
The papain has been immobilized on IMI carrier and the immobilization 
method is based on the interaction of histidine, cysteine and tryptophan residues of 
papain with the metal ions of the carrier. The immobilized preparation exhibited high 
activity as evident by high r\ value, a ratio of bound to theoretical activity. The 
immobilized preparation exhibited higher thermal stability as well as could be stored 
for longer duration. The remarkable advantage of the carrier was its recovery from the 
bound enzyme. The recovered matrix was reused for subsequent cycles of 
immobilizations. The similar activity yields of immobilized papain were obtained up 
to the fourth cycles used in the present investigations. The recovered matrix was also 
effective in binding with different metal ion. 
It is well known that free radicals are the species responsible for harmful 
biological processes such as aging, carcinogenesis and numerous other diseases. The 
mechanism of biological damage produced in such processes has been investigated in 
a variety of systems, including studies on proteins, enzymes, nucleic acids and 
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carbohydrates. Therefore, in these studies we have selected an ascorbic acid-transition 
metal ion Cu^* (ASA-Cu^ "^ ) system for generating the free radicals. There was a 
gradual increase in the inactivation of soluble papain upto 6 minutes and beyond this 
time the enzyme activity remained constant. The papain bound to IMI carrier was 
more resistant to free radical induced inactivation in comparison to the soluble papain. 
The intrinsic fluorescence spectrum of ASA-Cu(II) treated and untreated papain was 
different in terms of fluorescence intensity when excited at 280 nm. This decrease in 
fluorescence suggested that some conformational changes occurred as a consequence 
of exposure to this MCO system within the environment of hydrophobic amino acids. 
There was a marked decrease in the free radical induced inactivation of soluble 
papain, that was most affected in comparison to the bound one, in the presence of free 
radical scavengers. Among the scavengers selected in these studies hystidine, catalase 
and thiourea were most protective suggesting the role of hydroxyl radical in the 
inactivation of papain. The mechanism of protection by radical scavengers has also 
been discussed. 
Alginates are a family of linear polymer of (1-4) linked P-D mannuronic acid 
and a-L-guloronic acid. The second approach used for papain immobilization is based 
on its entrapment within the alginate network. The entrapped papain exhibited 
significant activity and the maximum activity yield was obtained at lowest 
concentration used in our studies. The TI value of the preparation used for these 
studies was 0.79 suggesting that the enzyme is located in the most favorable 
environment with more access of substrate while higher concentrations of papain used 
for entrapment restricted the availability of substrate. The thermostability of alginate 
entrapped and soluble papain was investigated at 80°C for different durations, where 
entrapped papain exhibited higher stability in comparison to the soluble papain. No 
significant conformational changes were observed in the heat inactivated papain, 
when observed by fluorescence spectra. The alginate entrapped papain also exhibited 
much higher resistance against free radicals generated by ASA-Cu(II) system when 
compared with the soluble as well as IMI-carrier bound papain. The soluble papain 
was protected by radical scavengers against free radical induced inactivation, while 
the alginate entrapped papain was by itself protected from inactivation and no radical 
128 
scavenger was effective to increase the resistance or further protection by the free 
radicals. 
Flavonoids, a group of phenolic compounds present in a wide variety of plant 
sources such as vegetables, fruits, herbs and tea affect the activity of certain enzymes. 
Studies were also conducted on the flavonoid-papain interaction in terms of the 
enzyme activity, protein degradation and conformational changes determined by 
spectral studies. The flavonoids selected in these studies include quercetin, rutin and 
naringin. The quercetin was the one, which maximally inactivated the soluble papain 
activity in a concentration dependent manner while the alginate entrapped papain was 
maximally protected from such inactivation. Treatment of soluble papain with 
quercetin caused a decrease in fluorescence intensity with a blue shift of 6nm 
indicating for some conformational changes in the enzyme molecule. Changes in the 
shape and magnitude of circular dichroism spectra of untreated and flavonoid treated 
soluble papain revealed significant structural changes in the protein. The spectra 
indicated alterations in the immediate structural and electronic environment of the 
aromatic amino acid residues resulting from the interaction of papain with quercetin 
and naringin. 
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ABSTRACT 
Lvnzymic reactions ptay a vital role in the 
regulation and control of living system at the 
cellular level. Often the enzymes are 
localized within parti'cufar regi"on of ffie 
cells and the reactions they catalyze are 
intimately coupled with diffusion. It has 
been recognized that an enzyme membrane 
i.e. a synthetic membrane containing enzyme 
immobilized in vitro can serve as a 
convenient and versatile model system for 
studying the dynamic function of cellular 
enzymes in vivo. It is also well established 
ihat oxygen free radicals are produced under 
aerobic and diseased conditions damaging 
various macromolecules including enzymes. 
In order to understand the mechanism of free 
radical induced inactivation of membrane 
bound enzymes, we have selected a model 
enzyme, papain. The papain was entrapped 
Into alginate gels, which is considered to be 
a most convenient model to compare with the 
membrane bound enzymes in vivo. The 
present paper deals with the free radical 
generation, entrapment of papain in alginate 
gel and its inactivation behaviour in the 
presence of oxygen derived free radicals. 
Keywords: Papain, Ascorbic acid. Alginate, 
Entrapment , Ascorbic acid-Cu^* complex 
I.NTRODUCTION 
Free radicals have been defined as the 
species that have one or more unpaired 
electrons. These free radicals arc 
continuously formed under in vitro 
conditions and in the absence of proper 
scavenging mechanism, are capable to 
modify the proteins in various ways [1-4] 
including loss of enzyme activity [5] or 
protein coagulation [6] . The metal ions 
Cu(I[) or Fc(III) with ascorbic acid generate 
free radicals and this system is extensively 
used in order to understand the mechanism 
of enzyme inactivation [7]. It is not very 
well under stood, whether all enzymes 
present in different cellular compartments 
behave differently or have similar effect in 
response tothese continuously generated free 
radicals. The soluble enzymes are generally 
present in cytoplasm while the enzymes 
involved in active transport or 
photosynthesis are embedded in the 
membrane. 
The enzyme immobilization technology has 
wide applications including the 
pharmaceutical and industrial potential [8]. 
The immobilized enzymes are generally 
considered as the best model system in order 
to investigate the behaviour of membrane 
bound enzymes. In order to understand the 
mechanism of soluble and membrane bound 
enzyme inactivation by free radicals, a 
preliminary study was carried out by Hussain 
elal [9] by immobilizing papain on chelating 
sepharose. The sepharose beads are generally 
dispersed in the aqueous environment and 
cannot be considered a best support for such 
studies. In the present paper, we have 
selected a much improved model by 
entrapping papain into alginate beads and 
free radicals arc generated by Cu(Il)-
Ascorbic acid system. The effect of 
generated free radicals on soluble and 
entrapped papain has been investigated in 
order to explore the mechanism of enzyme 
inactivation under in vitro conditions where 
enzymes are present in soluble as well as in 
bound forms. 
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Reactive ox)gen species, such as superoxide radicals, are thouglu to undeilie the pathogene-
sis of vaiious diseases Almost '\ to 10% of the oxygen utili/ed by tissues is tonveited to its 
reactive intermediates, which impaii the functioning ol cells and tissues Supeioxide disiiui 
tase (SOD) catalyzes the conveision ol single election ieduced species ol moletiilai oxygen to 
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binding ability, distribution in diffeient cell compaitments, and sensitivity to vatious leageius 
Among these, Cu, Zn supei oxide dismutase (SODl) is widely distiibuted and compiises 90'^ 
ol the total SOD 1 his iibiciuitous cii/yme, which iec]uues (.u and Zn loi its activity, has gieat 
physiological significance and theiapeutic potential 1 he jjiesent ie\iew desciibes the lole ol 
SODs, especially Cu, Zn SOD, in seveial diseases, such as lamilial amjotiophit laieial stleiosis 
(FALS), Parkinson's disease, Al/heimei's disease, dengue levei, cancer, Down's syndiome, 
cataiact, and seveial neuiological disoideis Mutations in the SODl gene cause a lamihal 
foim of amvotiophic lateial scleiosis The mechanism by which mutant SODl causes the 
degeneiation of motoi neuions is not well iindeistood liansgenic mice expiessnig multiple 
co|)ies of fALS-miitant SOD Is develop an AL.S-like motoi neui on disease Vacuolai dcgciici 
ation ol mitochondiia has been identified as the mam pathological featuie associated with 
motoi neuion death and paialysis in seveial lines ol lAl.S-SOl^l mice \aiious obseivations 
and conclusions linking mutant SODl and FALS aie discussed in this leview in detail 
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BACKGROUND 
Superoxide dismutase (SOD) is an enzyme catalysing 
the disproportion of superoxide radicals to dioxygen 
and hydrogen peroxide, according to the following for-
mulae 
M'* + O, - M *^ + O^ 
M - * + 0 + 2 H + - M ' + + H,0^ 
SOD is found abundantly in many oiganisms, from 
microorganisms to plants and animals, since superoxide 
radicals are toxic to living cells, oxidi/ing and degrading 
biologically important molecules, such as lipids and pro-
teins [1-4] Several types of SOD, have been reported, 
based on the requirement of the metal species at the 
active site 
(a) copper-and zmc-containing superoxide dismutase 
(Cu, Zn SOD) 
(b) Iron-containing superoxide dismutase (Pe SOD) 
(c) manganese-containing superoxide dismutase (Mn 
SOD) [5-7] 
In addition, Ni containing superoxide dismutase has 
recently been found in Slreplomyces giTieus and S coelicolor 
[8-10] 
Cu, Zn SODs have been isolated fiom a wide range of 
organisms, including yeast, spinach, chicken li\er and 
bo\ine blood In all these cases, a homodimenc enzyme 
IS obtained with a moleculai weight of ~'^2,000 daltons 
and containing one C u (II) and one Zn (II) pei subunit 
The subunits aie stabilized by an mtiachain disuKide 
bond, but associated by nonco\alent forces This 
enzyme requires Cu and Zn for its biological activity, 
and the loss of Cu lesults in us complete inactivation, 
leading in many cases to the de\elopment ol human dis-
eases [II] Cu, Zn SOD has great physiological sia;nili-
cance and therapeutic potential The lole ol this enzyme 
has been investigated in various specific red blood cell 
(RBC) disorders, such as iion deficiency anemia oxida-
ti\e hemolytic anemia, thalassemia, sickle cell anemia, 
molecular dystiophy and c)siic fibiosis, [12 15] In 
recent studies, this enzyme has also been shown to be 
associated with dengue fever, postcholecystectomy pain 
s\ndrome, malign breast disease, steroid sensitive 
nephrotic syndoime and amyotrophic lateral scleiosis 
[lb-18] In rheumatoid arthritis, ischemic injurv and 
cancer, SOD actnity is considerably increased, suggest-
ing a superoxide-related pathology and the in\ol\ement 
of SOD in these diseases The principle aim of this ai ti-
de IS to highlight the diseases associated with the 
expression of Cu, Zn SOD, as well as other superoxide 
dismutases 
DISEASES ASSOCIATED WITH CU, ZN SUPEROXIDE DISMUTASE 
I'uon diseases aie tharacteuzed by neuiodegeneration, 
gliosis and accumulation of extiacellular deposits of the 
abnormal isoform of the prion protein (p^P^), some-
times in the form of plaques Human prion diseases 
include Creutzfeldt-Jakob disease, Gerstmann-
Straussler-Scheinker Syndrome, and Fatal I-amihal 
Insomnia [19,20] It has been confirmed that prion pro-
tein expression regulates Cu incorporation into Cu Zn 
SOD, thereby modulating its activity This reduces cellu-
lar resistance to oxidative stress and ma) regulate otiiei 
copper-dependent aspects of cell metabolism I here is a 
strong link between Al/heimer s disease and the activity 
of supti oxide dismutase A stud) of several elements of 
the antioxidative system - Cu, Zn superoxide dismutase 
(SOD), catalase (CAT), the glutathione system (GI U), 
chemiluminescence (CHh), and antioxidant capacity 
(AOX) - was conducted in patients with dementia of the 
Alzheimer type (DAT) and vascular dementia (VD) [21] 
A significant association was found between the antioxi-
dant variables measured in blood samples taken fiom 
these patients, demonstrating that VD and DAT dis-
eases are accompanied by oxidative disoiders In a dif-
ferent study, the activity of Cu, Zn SOD was determined 
in red blood cell (RBC) homogenate obtained from 
demented patients with DAT, from their first degree 
relatives, and from healthy, non-related controls [22] A 
statistically significant increase in SOD activitv was 
found in RBC homogenate between the families of DAT 
patients and controls This inciease probably represents 
a general alteration of the oxidative piocesses charactei-
istic of this demenua, which supports the proposal that 
this enzyme could be used as a peripheial early diagnos-
tic marker of Alzheimer's disease (AD) In an animal 
model of Al/heimer like vasculai pathology and inflam-
matory reaction, the possibility has been explored of 
deleterious vascular actions and inflammatory response 
to the cytokine tumor neciosis factor, interleukin-I, and 
amyloid-beta, as well as the piotective effects of super-
oxide dismutase [23] Zenilan et al [24] have monitoied 
the activity of Cu, Zn SOD in fibioblast cell lines deuved 
from familial Alzheimer's patients and normal controls 
C u, Zn SOD activity v\as found to be significandy elevat-
ed in the patients, suppoiting the earliti theorv that 
paired helical filaments aie synthesized in Al/heimer's 
disease by free ladical h)diox)lation of pioline residues 
in paired helical filament precuisoi piotein 
In addition to all these findings, one remarkable study 
has desciibed the localization of ( u, Zn SOD in the 
biain tissues of patients with Alzheimer s disease [25] 
Immunostaining experiments showed that large pyia-
midal neurons, which are potentiallv susceptible to 
degenerative processes in AD, contain higher amounts 
of Cu, Zn SOD than othei brain cells 
Recently, extensive work has been carried out on the 
link between amyotrophic lateral scleiosis (ALS) and 
SOD ALS IS a devastating neurological disease that 
lapidly pi ogresses from mild motoi svmptoms to severe 
motor paialysis and prematuie death kruman et al 
[2b] have employed a mouse model of AIS in oidei to 
test the extitotoxicit) hypothesis of ALS In this model 
oveiexpiession of a mutant familial ALS-linked Cu, Zn 
SOD leads to piogressive motoi neuion (MN) loss and a 
clinical phenotype remarkabh similai to that of human 
EQ 
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ALS patients Under basal culture conditions, MNs in 
mixed spinal cord culture from the Cu, Zn SOD mutant 
mice exhibited enhanced oxyradical production, lipid 
peroxidation, increased intracellular calcium levels, 
decreased intramitochondnal calcium levels, and mito-
chondrial dysfunction In an another study related to 
ALS, Vukosavic et al [27] have pioposed that a mutation 
in the gene for Cu, Zn SOD, the only proven cause of 
ALS, induces the disease by a toxic propeity that pro-
motes apoptosis I urther studies have been carried out 
in polypeptides of mutant Cu, Zn SOD \v\ \elation to 
ALS [28] Ratovitski et al [28] have shown that a muta-
tion in the gene for Cu, Zn SOD causes a form of famil-
ial am)otrophic lateral scletosis (I ALS) In diffeient kin-
dreds, harboring diffeient mutations, the duiation of 
illness tends to be similai foi a given mutation Por 
example, patients inheriting a substitution of vahne for 
alanine at position 4 average a 1 5-year life expectancy 
after the onset of the symptoms, wheieas patients har-
boring a substitution of arginine for histidine at position 
46 (H46R) have an a\erage 18-)ear life expectancy after 
disease onset These studies shov\ that 9 diffeient hALS 
variants of SOD polypeptides appear to be soluble, but 
different mutant enzymes show a remaikable degiee of 
variations with respect to activity, polypeptide half life, 
and resistance to pioteolysis Othei studies related to 
ALS ha\e confirmed that ALS is caused b) a mutation in 
the gene for Cu, Zn SOD [29] Transgenic mice expiess-
ing ALS-linked Cu, Zn SOD mutauon exhibit a pheno 
type analogous to that of human ALS patients In a 
lecent study i elated to SOD and Al S [18], the aggrega 
tion of ubiquitin and a mutant ALS-lmked Cu, Zn SOD 
protein correlates with disease progiession and frag-
mentation of the Golgi appaiatus (GA) In these studies, 
the transgenic mice that expiess the G93A mutation of 
human Cu, Zn SOD found in FAI S showed the clinical 
symptoms and histopathological changes of spoiadic 
ALS, including fiagmentation of the neuional GA The 
finding of fragmented neuronal GA in asymptomatic 
mice, months befoie the onset of paialysis, suggests that 
the GA IS an eai ly tai gel of the pathological processes 
causing neuronal degeneiation A subset of familial 
cases of ALS are linked to a missense mutation in the 
gene for Cu, Zn SOD [30] Patients with such a missense 
mutation develop a paialytic disease indistinguishable 
from spoiadic ALS, caused by the addition of an 
unknoun function, which is toxic Nunc oxide reacts 
with the superoxide anion to form the strong oxidant 
peiownitiite, which is implicated in neuronal injur) in 
a variety of model systems Perox) nitrite is an altei nate 
substrate for Cu, Zn SOD, causing catalytic nitration of 
Its tMOSine residues in some patients A mutation in the 
gene foi Cu, Zn SOD may disrupt the active site of the 
enz)me and peimit gi eater access of peroxynitiite to 
copper, leading to inci eased nitration b) peroxymtrite 
of critical cellulai targets Kato et al [31] have chaiaclei-
i/ed the neuional Lew> body-like hyaline inclusions 
(LBHI) and astioc)tic hyaline inclusions, which aie the 
neuiopathological maikers of mutant SOD linked 
lALS 
The I-ALS mutations in the gene foi Cu Zn SOD aie 
dominant, and aie curientl) believed to exert then 
effects because of a gam of function rather than a loss of 
activity The most convincing evidence for such a gain 
of toxic function is the observation that the expression 
of PALS mutant human Cu, Zn SODs in transgenic mice 
causes motor neuron disease, while expiession of wild 
type (wt) human Cu, Zn SOD does not [32-34] 
Knockout mice that do not express Cu, Zn SOD also do 
not develop motoi neuron disease [35] The gain of 
function hypothesis is also supported by the observation 
that expression of I ALS mutant human Cu, Zn SOD is 
pio apoptotic in culluied neuional tells, while wl 
human Cu, Zn SOD is antiapoptotic [36] The expres-
sion of the PALS mutant but not wt human Cu, Zn SOD 
in a human neuroblastoma cell line induced a loss of 
mitochondiial membrane potential and an increase in 
cytosolic calcium concentration [37] It is also veiy likely 
that oxidative damage occurs as a result of the perox-
idatne activity of I Al S mutant Cu, Zn SOD and can be 
hypothesized to aiise fiom eithei oi both of the follow-
ing two mechanisms 1) increased access of the substiate 
to the active site, leading to inci eased oxidation of the 
substiate 2) incieased formation of OH radical due to 
the presence of Cu rather than Zn at the zinc site lead-
ing to a subpopulation of Cu, Cu-SOD that is moie 
leactive An intriguing third possibility is that inci eased 
production of OH ladicals could lead to damaged inac-
tive mutant SOD enzyme, which could slowly lelease 
fiee Cu ions catalyzing deleteiious Penton-type oxida-
tion reactions at oi near the sites wheie they are 
leleased In this legaid, fuither work is needed to test 
the abilit) of a vaiiet) of hydrox)l ladital stavengeis to 
slow the inactivation of wt and mutant enzymes in their 
Cu, Cu and Cu, Zn forms b) leaction with hydrogen 
pel oxide 
Based on the studies by Jaarsma et al [38] i elated to C u, 
Zn SOD and FAI S, the obseuation has been made that 
one of the most puzzling aspects of SODl-lmked PALS 
IS the laige number of diffeient mutations that yield 
mutants having a inaiked vailability of biochemical/bio-
physical propel ties, but all causing a lathei similai dis-
ease phenotype [39-42] Studies so far have failed to 
identify a ciitical toxic pioperty that links the diffeient 
mutants to the disease [41,42] This may indicate that 
this common toxic piopeity aiises eithei fiom a eithei to 
iiniecognized function or piopeity of the SODl 
Piotein, or from multiple factois that contiibute to the 
deleterious action of mutant SOD Is Since SOD I is both 
potentially dangerous (because of its capacity to bind Cu 
and Zn) and abundant, it is highly likely that abnoimali-
ties 1 elated to its synthesis oi degiadation could disturb 
cell function 
The lole of Cu, Zn SOD in several other diseases has 
also been thoioughly studied Plasma and total antioxi-
dant status in patients w iih benign and malignant bi east 
disease has been studied by Afiasyap et al [43] The 
studv was earned out on 25 women with bieast cancel, 
25 with fibiocystic breast disease, and 19 healthy sub-
jects Antioxidant enzyme activities and total antioxidant 
status were measuied in the eiythiocytes and plasma of 
patients and healthy indi\iduals A positive con elation 
was found between eiythiocytes and plasma Cu, Zn 
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SOD activity in all groups, indicating that enzymatic and 
non-enzymatic antioxidants are difTerentially altered in 
human bieast tumors Superoxide dismutase activity 
has been determined by Gonzales et al [17] in RBC iso-
lated fiom patients with acute myelogenous leukemia, 
chronic lymphocytic leukemia, Hodgkin's disease, lym-
phosaicoma and various visceral cancels SOD activity 
was found to be significantly elevated in RBC from 
patients with acute myelogenous leukemia and lympho-
proliferative syndromes SOD activity levels furthei 
decrease w ith an increase in the dui ation of treatment 
These results suggest an abnoimality in the regulation 
of the expiession of the SOD gene in the plunpotent 
stem cells Built-in cellular defense mechanisms play a 
major role in tumor piotection against non-surgical 
antineoplastic therapies Of these, the overexpression of 
antioxidant en/ymes such as SOD may be the most 
important [44] 
The role of free radicals and Cu, Zn SOD has also been 
investigated in neuronal injuiy [45] Fiee ladicals may 
play an impoitant role in several pathological conditions 
of the central nervous system (CNS), wheie the) direcdy 
injure tissue, and wheie then formation may also be a 
consequence of tissue injury Free radicals pioduce tis-
sue damage through multiple mechanisms and can 
worsen acute neuiodegeneiative disorders including 
Parkinson's disease These diseases are linked to a 
missence mutation of Cu, Zn SOD A coi relation 
between OH ladicals and Cu, Zn SOD activity in 
Parkinson's disease (PD) has also been suggested by the 
studies of Ihara et al [46] The higher OH level and 
lovvei Cu, Zn SOD activity ma) play a role in the onset 
of progiession of PD, and pergolite may act neuiopro-
tectively b) inducing Cu, Zn SOD In general, therapeu-
tic approaches which limit oxidative stiess may be 
potentially beneficial in seveial neuiological diseases 
Giasbon Fiodl et al [47] have identified two polvmoi-
phisms of the MnSOD gene associated with Paikinson s 
disease The Nobel Piize ioi phvsiolog) and medicine in 
2000 was awarded for findings showing that Paikinson 
patients have abnormally low concentrations of 
dopamine in the basal ganglia [48] As a consequence L 
Dopa was developed, as a diug against Paikinson's 
Disease, and it lemains to this dav the most impottant 
tieatment method foi this disease 
Recent findings on the etiolog) of cataiact and age-
1 elated muscular degeneiation (AMD) suggest the lole 
of an oxidative mechanism in these diseases [49] In 
these studies high levels of erythioc)te SOD activit) was 
associated with a two-fold inciease in nucleai cataract 
Pitkanan and Robinson [50] have studied complex I 
(NADH- CoQ reductase) m patients with fatal infantile 
lactic acidosis (FILA), cardiom)opathy with cataiact 
(CC), hepatopath) with tubulopathy (H f), Leigh s dis-
ease (LD), cataiacts and developmental delay (CD) and 
lactic acidemia in the neonatal peuod followed by mild 
symptoms (MS) The production of superoxide ladicals, 
m addition to NADH, was measured Superoxide pio 
duction rates were highest with CD and decieased in 
the Older CD >> MS >1 D >Control > HT > FILA = 
CC The quantity of Mn superoxide dismutase 
(MnSOD) was highest m CC and FILA and lowest in 
CD Given these observations, they hypothesized that 
oxygen radical production increases when complex I 
activity IS compromised Klaeger et al [51] have also 
confirmed that a higher level of Cu, Zn SOD can reduce 
the seventy of oxygen-induced letinopathy in a mouse 
model 
The diseases associated with dengue fevei include the 
classical dengue (DbN), dengue heminihagic level 
(DHF) and dengue shock syndiome (DSS) SOD and 
other antioxidant proteins have been found to be 
abnormal in these diseases [16] The preliminaiy report 
of dengue confirms the assumption of free ladical gen-
eration and alteiation m antioxidant status duiing acute 
illness Howevei, fuither studies aie lequned to under-
stand their complex interaction in disease piogression 
and the possible theiapeutic utility of the findings 
Changes in Cu, Zn SOD activity have also been found in 
children with steroid-sensitive nephrotic syndrome 
(NS), implicating the role of free ladicals in the develop-
ment of this syndrome [52] Lr)throcyte antioxidant 
activity and trace element levels aie also the best mark-
ers in Behcet's disease [53] Selenium (Se), Zinc (Zn), 
Coppei (Cu) and antioxidant en/)mes, including SOD 
levels in sera, have been detected in Behcet patients In 
this stud), the SOD level was low in the serum of 
Behcet s disease patients It has been suggested that 
decreased SOD activity and inci eased pioduction of 
free oxygen ladicals may play a role in the etiopatho 
genesis of this disease 
Antioxidant enzyme activity, especially Cu, Zn and Mn 
SOD, has also been studied in human abdominal aortic 
aneurysmal and occlusive diseases [54] The activitv of 
these enzymes was loweied m the tissue of these 
patients, which points to the involvement office ladi 
cals The plasma extracellulai SOD levels in an 
Australian population with coionaiy artery disease weie 
measuied [55] The results of these studies show an 
association between extracellulai SOD (LC-SOD) and 
coronal y artery disease EC-SOD is consideied to be 
more protective, contiibuting to ieduced coionaiv risk 
Down's syndrome (DS), which is characterized b\ pre-
mature aging has also been i elated to oxidative stress, 
resulting fiom the abeiiant expiession of Cu, Zn SOD 
[56] SOD activity has also been measuied in the blood 
of different individuals between 50 to 93 years of age 
and the level of this impoitant enz)me was found to 
decrease with age [57] In diabetes, the persistence of 
hvperglycemia has been repoited to cause increased 
production of oxygen free radicals thiough glucose 
autooxidation and nonenzymatic gl) cation The highest 
enthiocyte SOD activity has been found in diabetic chil-
dien at the onset of chnical diabetes In diabetic adoles-
cents, SOD activity is also significanth higher than in 
control subjects Deci eased antioxidant defenses may 
increase the suscepubilit) of diabetic patients to o\ida-
Uve injuiy Appropriate suppoit foi enhancing anuoxi-
dant supply m these young diabetic patients mav help 
in pi eventing chnical complications during the couise of 
the disease [58] 
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There are other diseases that have close association with 
SOD, but our goal in this article is to focus on the most 
recent literature available related to those diseases dis-
cussed in the previous section. Studies on SOD in bio-
logical systems and the deleterious effect of the O.^  gen-
erating system on biological macromolecules, subcellu-
lar components, cells and tissues suggest that O^ can be 
an initiating or contributing factor in most of these dis-
eases. Superoxide-related pathology may result either 
from increased production of O, due to hyperoxia, acti-
vation of granulocytes and macrophages, conversion of 
xanthine dehydrogenase to xanthine oxidase, exposure 
to ionizing radiation and redox cycling oi xenobiotics, 
or from decreased activity of SOD. 
THERAPEUTIC POTEfJTiAL 
various diseases. The functional status of SOD 1 could be 
considered a reliable index of the ability of the organism 
to withstand various pathological conditions. The full 
significance of SOD in the diagnosis and prophylaxis of 
various disease conditions is among the most crucial 
areas in modern biomedical and environmental 
research. 
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Studies on the inactivation of soluble and immobilized papain 
by the ascorbic acid-Cu^+ system: a model to propose the 
effect of free radicals on membrane-bound enzymes in vivo 
Sazid Hussain, Rana Noor and Jawaid Iqbal' 
Biochemistry Department, Faculty of Life Sciences, Aligarh Muslim University, Aligarh-202002, Lfttar Pradesh, India 
Free radicals have been suggested to be widely imp l i ' 
cated as the species responsible for harmful biological 
processes, such as aging, carcinogenesis and numerous 
other diseases. The mechanism of biological damage 
produced in such processes has been investigated in a 
wide variety of systems, including studies on proteins, 
enzymes, nucleic acids and carbohydrates. In the pres-
ent study we selected jm ascorbic acid-transit ion-metal 
ion (ASA-Cu^*) system In order to understand the 
mechanism of soluble and membrane-bound enzyme 
inactivation by generating free radicals. Papain, a thiol 
protease, was immobi l ized on an immobil ized-metal-
ion carrier and used as a model to examine the 
inactivation behaviour of membrane-bound enzymes. 
A comparison was made between the inactivation of 
soluble and immobi l ized papain by free radicals, and the 
potential of different radical scavengers to prevent the 
inactivation of enzyme was examined. 
Introduction 
Studies on the oxidative modification of enzymes have 
suggested that free radicals are responsible for harmful 
biological processes such as aging, carcinogenesis and 
numerous other diseases [1-5] The mechanism of the 
biological damage produced in such processes has been 
investigated in a wide variety of systems, including studies on 
proteins, enzymes, nucleic acids and carbohydrates [6—8] 
L-Ascorbic acid (ASA) has been extensively used in order to 
understand the mechanism of enzyme inactivation by free 
radicals, particularly in the presence of Cu^* [9] There is 
substantial evidence that metal-catalysed oxidative (MCO) 
modification of enzyme is a site-specific process In the case 
of the ASA-Cu^* model system, Cu^* binds to a metal-
binding site on the enzyme molecule and then hydroxyl 
radical (OH ), repeatedly formed via a redox reaction 
between the bound Cu'* and ASA, preferably attacks a 
specific site near the metal-binding site on the enzyme in 
a multi-hit manner It has also been shown that both Cu^* and 
ASA bind to papain to form a ternary complex and that free 
radicals are site-specifically formed and react preferentially 
with the enzyme at the site of their formation, impairing its 
activity [9] 
A major challenge in the development of enzyme 
immobilization technology has been to overcome the 
instability of enzymes under certain physical and chemical 
conditions Instability is often due to denaturation or 
inactivation brought about by adverse conditions such as 
heat, pH, proteolysis, organic solvents and oxygen Im-
mobilized enzymes are currently the subject of considerable 
interest because of their advantages over soluble enzymes or 
alternative technologies, and the steadily increasing number 
of applications for immobilized enzymes [10] In addition to 
the convenient handling of the enzyme preparation, the two 
mam targeted benefits of immobilized enzymes are (i) easy 
separation of enzyme from the product and (ii) the re-use of 
the enzyme Easy separation of the enzyme from the product 
simplifies enzyme applications and permits reliable and 
efficient reaction technology Enzyme re-use provides a 
number of cost advantages, which are often an essential 
prerequisite for establishing an economically viable enzyme-
catalysed process Papain is well characterized structurally 
and kinetically [ I 1,12] Various attempts have been made to 
stabilize papain for more efficient use [13,14] The bio-
matnces with entrapped enzymes tend to leak, proteins with 
time, resulting in activity losses as well as contamination of 
the product with the enzyme, which is not acceptable for 
pharmaceutical applications The covalent coupling of en-
zyme can produce a considerable loss of activity, owing to 
the influence of coupling conditions and to conformational 
changes in the enzyme structure [IS] Immobilized-metal-
lon (IMI) carriers have been used for immobilizing several 
enzymes, including papain, which has shown great potential 
in terms ofhigh activity yield, regenerabilityand reusability of 
the carrier [16] 
Ke> words enzyrne inactivation catalase immobilized metal ion earner 
radical scavengers stability 
Abbreviations used IMI immobilized metal ion MCO metal catalysed 
oxidatjve modification O H hydroxy) radical ASA L ascorbic acid MHC 
major histocompatibility complex 
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Many enzymes, such as respiratory enzymes of mito-
chondria, the enzymes participating in photosynthesis, 
enzymes involved in protein synthesis and the enzymes 
responsible for active transport are embedded in membrane 
or attached to subcellular particles. It is now well established 
that oxygen free radicals are produced under aerobic and 
diseased conditions, damaging various macromolecules, 
including enzymes [1,5]. It is not yet clear whether these 
membrane-bound enzymes behave differently from the 
soluble enzymes vyhen exposed to free-radical species. In 
order to understand the mechanism of inactivation of free 
and bound enzymes by free radicals, we have selected a 
model thiol protease, papain, because of its well established 
structure, function and pharmaceutical potential [14]. Here, 
immobilization of papain has been achieved by using chelating 
Sepharose activated by Cu^* ions and free radicals are 
generated by an ASA-Cu^* system in order to explore the 
extent of free and bound enzyme damage caused by free 
radicals. This model will give better insight into the factors 
governing the activity of enzymes in biological membranes. 
Materials and Methods 
Papain and BSA were obtained from Sigma Chemical Co., St 
Louis, MO, U.SA. Chelating Sepharose was the product of 
Pharmacia Fine Chemicals, Uppsala, Sweden. Casein, his-
tidine, cysteine hydrochloride and ASA were from Sisco 
Research Laboratories, Mumbai, India. All other reagents 
used were of analytical grade. 
Immobilization of papain on metal-chelating 
Sepharose activated by Cu^* ions 
A 0.5 ml portion of chelating-Sepharose gel was washed with 
I ml of water and centrifuged for 30 s. This procedure 
was repeated four times. The thoroughly washed matrix v«s 
loaded with metal ion (Cu^*) by following the manufacturer's 
(Pharmacia) protocol. An equal volume of matrix (0.5 ml) 
was mixed with equal volume of 0.4 M CuClj (0.5 ml) and 
stirred at room temperature for 30 min, centrifuged briefly 
and supernatant was discarded. Washing of matrix v«s done 
with I ml of water four times and finally with I ml of 10 mM 
sodium phosphate buffer, pH 8.2. This matrix was mixed 
with 1.5 ml of papain solution (8.9 mg/ml), stirred at room 
temperature for 3 h, centrifuged for 30 s and the supernatant 
was collected. The matrix was finally washed repeatedly with 
I ml of lOmM phosphate buffer, pH 8.2, until no detectable 
activity was obtained in the washings. Finally the matrix was 
suspended in the same buffer and the amount of enzyme 
immobilized vns calculated by subtracting the artivity 
remaining in the supernatant and washings from the units 
added to chelating Sepharose matrix. 
Effect of the ASAr-Cu'* system on soluble and 
immobilized papain 
ASA-Cu^* is a known generator of free radicals. Therefore, 
to ascertain the effect of free radicals on papain activity, 
25//M papain was preincubated at room temperature in 
50 mM sodium acetate buffer, pH 5.6, with ASA at 1.25 mM 
and Cu^* at 25 / iM. Aliquots were periodically transferred 
to cysteine/EDTA solution (activating solution) in order to 
stop the reaction. This mbcture was then assayed for papain 
activity. A similar procedure was followed to assay the activ-
ity of ASA-Cu'*-treated immobilized papain, where the 
concentration of immobilized papain was also 25 filA and 
the reaction mixture was shaken continuously. 
Effect of free-radical scavengers on the activity of 
ASA-Cu'^-treated soluble and immobilized papain 
In a total reaction mixture of 2 ml containing 50 mM sodium 
acetate buffer, pH 5.6,25 /<M soluble or immobilized papain, 
1.25 mM ASA, 25 /iM Cu'* and different concentrations of 
free-radical scavengers were added. The final concentrations 
of the different scavengers were: catalase, 0.094 /^M; sodium 
thiocyanate, 2.5 mM; Kl, 2.5 mM; sodium benzoate, 2.5 mM; 
and histidine, 2.5 mM. At different times portions of the 
reaction mixture were periodically transferred to cysteine/ 
EDTA solution and mixture was assayed for papain activity. 
Determination of enzyme activity 
Papain activity was determined using casein as substrate by 
the method of Kunitz as described by Keay and Wildi [17] 
with slight modifications. Suitable aliquots of papain 
solution/matrix bound papain were taken into 10 mM 
sodium phosphate buffer, pH 8.2, containing 0.2 ml of 0.05 M 
cysteine and 0.02 M EDTA. The reaction mixture was 
incubated for 10 min at 37 °C and the volume of reaction 
mixture was made up to I ml. A 1.0 ml portion of 2% (w/v) 
casein was added and reincubated for 15 min at 37 °C. The 
reaction was stopped by adding I ml of 10% (w/v) t r i -
chloroacetic acid solution. After 20 min, the tubes were 
centrifuged at 10000 g for 15 min. A suitable volume of 
supernatant was estimated by the procedure of Lowry et al. 
[18]. 
Results and Discussion 
The immobilization of papain was carried out on chelating 
Sepharose, which was activated with Cu^* ions, and the 
results obtained are shown in Table I. The rj value, the ratio 
of actual and theoretical bound enzyme activities, was 0.80, 
which was significantly higher when compared with other 
enzymes immobilized by different methods [19]. One 
' 2001 Portland Press Ltd 
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Table I Immobilization of papain on chelating Sepharose activated by Cu'* 
ions 
Papain was immobilLzed on chelating Sepharose activated by Cu'* ions as 
descnbed in the text The amount of enzyme immobilized was calculated by 
Subtracting the activity nemainrig m supernatant and washings from the units 
added to chelatmg-Septurose matnx. Activity of papain was measured under 
standard conditions as descnbed in the text 
Units 
added 
30900 
Units m Supernatant 
and washing 
550 
Bound units 
Theoretical (A) 
30350 
Actual (B) 
21500 
17 value 
(B/A) 
080 
possible explanation of getting high ri value could be related 
to the higher accessibility of enzyme to the substrate. 
Zhuang and Butterfield [20] immobilized papain on various 
supports, including the direct covalent coupling. They have 
suggested that direct immobilization leads to protein binding 
to the support yyrith lesser enzyme activity. Rajalakshmi et at. 
[21] have shown that papain immobilized on matrix retained 
> 80% intrinsic catalytic activity with no change in pH 
optima and kinetic constant, indicating that the gross tertiary 
structure was not altered by modification of enzyme. The 
resulu in Table I were closely related to the values obtained 
by Rajalalcshmi et al. [21], and the possibility of retaining the 
tertiary structure could not be ruled out. The immobilization 
of enzymes on the matrix used in our method is based on the 
formation of a co-ordinate complex between exposed 
imidazole, thiol and indole groups of enzyme and the 
agarose-fixed metal ions. The retention of papain activity 
after binding to IMI carrier indicate the protection of active 
site and involvement of other groups during binding process. 
The retention of papain activity has already been shown by 
Afeq and Iqbal [16]. Chaga [22] has used these matrices for 
immobilization of glycoproteins. This method is superior to 
the other methods because small amount of matrix (IMI) is 
sufficient to immobilize maximum units of papain, which 
undoubtedly minimizes the cost of immobilization over the 
other conventional methods. A remarkable advantage of 
these carriers is the regeneration and recovery of enzyme 
and matrix from the enzyme-matrix complex in intact form. 
Afeq and Iqbal [16] have shown the repeated use of matrix-
bound enzyme as well as the regeneration of the same 
matrix for re-immobilization. 
The pressure to immobilize papain has also been driven 
by its great industrial and medical potential. The bio-
pharmaceutical potential of papain is clear from its use in 
transplantation immunology. Acute immunological rejection 
events of transplanted allogeneic organs are strongly de-
pendent on T<el l reactivity against foreign major-histo-
compatibility-complex (MHC) products. The recognition 
requirements of alloreactive cytotoxic T-cells are of par-
ticular interest for finding approaches to modulating allo-
reactivrty. The role of allogenic MHC molecules themselves 
and/or associated peptides in the interaction with the T-cell 
Inactivation pt) 
Soluble papain 
00 
261 
351 
170 
173 
171 
Immobilized papain 
00 
82 
182 
20 6 
201 
20 2 
Table 2 Studies on the nactivation of soluble and immobilized papain in the 
presence of the ASA-Cu'* system 
The reaction mixture (2.0 ml total volume) contained 25 fiM soluble/ 
immobilized paparv 1.25 mM ASA and 25 / iM OP* in 50 mM sodium acetate 
buffer. pH 5 6, and was incubated at room temperature, 0 3 ml aliquots were 
transferred periodically to activating solution and papain activity v^s determined 
as descnbed in the text 
Time (mm) 
0 
2 
1 
6 
8 
10 
receptor has been shown by the work of Hausman et al. [23] 
through the interaction of papaln-digested histocompati-
bility-locus-antigen class-1 molecules with alloreactive clus-
ter of differentiation and cytotoxic T-lymphocytes. The 
immobilized papain product with maximum stability and 
reusability v/ill be a better option than using a soluble papain 
for such studies in order to separate the enzyme from the 
reaction mixture. 
It was reported that papain was Irreversibly Inactivated 
by the ASA-Cu^* system under aerobic conditions [24]. 
For this Inactivation Cu^* Ions were essential, and there Is a 
formation of free radicals on the basis of a redox reaction 
between ASA and Cu^*. The time required for the formation 
of free radicals and Inactivation of soluble papain was 
determined by the experiment In which the aliquots were 
withdrawn from the ASA-Cu'*-enzymc (ASA-Cu^*-£) re-
action mixture at different time intervals and papain activity 
was determined. As shown in Table 2 at an enzyme/Cu^* 
ratio of I : I there was a gradual Increase in the inactivation 
of papain up to 6 min; beyond this time the enzyme activity 
remained constant, suggesting that radical formation and its 
effect on soluble papain Is a rapid process. The persistence In 
the activity of papain after certain time intervals could be 
explained on the basis of a short half-life of the free radical 
and rapid oxidation of ASA, generating significant amounts of 
free radicals which partially damage the enzyme active site, 
as evident by a loss in enzyme activity. A similar experiment 
was repeated by using immobilized papain on IMI carrier just 
to explore our basic notion underlying this Investigation. The 
results are shown in Table 2. As the Table shovw, there was 
a drastic decrease In papain inactivation at the same 
ASA-Cu^* ratio in comparison with its soluble counterpart. 
Several studies have shown that immobilized enzymes, 
including papain, exhibit marked stability against different 
forms of denaturation [20]. This is our first report showing 
the effect of free radicals on immobilized papain. Under the 
experimental conditions described, the biological damage 
© 2001 Portland Press Ltd 
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Table 3 Effect of free-radical scavengers on the inactivation of soluble and immobilaed papain in the presence of ASA-Cu'* system 
The reaction mixture (total volume 2.0 mQ contained 25 /JM soluble or immobilized papaia I 25 mM ASA. 25 fiM Cu'*. 25 mM sodium thiocyanate/KUsodium 
benzoate in 50 mM sodium acetate buffer, pH 5 6. and was incubated at room temperature, 0 3 ml aliquots were transfenned penodically to the actvating solution 
and papain activity was determined as descnbed in the text. These values were compared with the control. wt>ere none of these scavengers were added to the 
reaction mixture Each value represents the average for at least three independent expenments done separately 
Inactivaton (%) 
Soluble papain Immobilized papain 
Time (min) Control Sodium thiocyanate Kl Sodium benzoate Control Sodium thiocyanate Sodium ber,zoate 
2 
•) 
6 
8 
10 
264 
354 
470 
473 
47 1 
201 
24 3 
369 
3ZI 
313 
25 1 
34 6 
39 7 
404 
409 
22 1 
217 
27 7 
30 6 
329 
82 
182 
205 
204 
200 
20 
84 
102 
120 
37 
30 
62 
62 
44 
42 
26 
24 
64 
84 
97 
Figure I Effea of catalase on the inactivation of soluble and immobilized 
papain m the presence of the ASA-Cu'* system 
The reaction mixture (total volume 2 0 ml) contained 25 ftt^ soluble/or 
immobilized papain. 1 25 mM ASA 25 /iM Cu^* and 0 94 //M catalase in 
50 mM sodium acetate buffer, pH 5 6. and was incubated at room temperature. 
Aliquots (0 3 ml each) were transferred periodically to activating solution and 
papain activity was determined as descnbed in the text O. Soluble papain 
without catalase. D. soluble papain with catalase, • , immobilized papain 
without catalase, • , immobilized papain with catalase. 
Figure 2 Effect of histidine on the inactivation of soluble and immobilized 
papain in the presence of the ASA-Cu** system 
The reaction mixture (total volume 2 0 ml) contained 25 /iM soluble/or 
imnvDblized papain. I 25 mM ASA. 25 ;iM Cu'* and 2 5 mM histidme in 50 mM 
sodium acetate buffer. pH 5 6. and was incubated at room temperature 
Aliquots (0 3 ml each) were transferred penodically to activatng soluton and 
papain activity was determined as descnbed in the text O. Soluble pap 
am without histidme. Q. soluble papain with histidine, • , immobilized papain 
without hisbdine. • . immobilized papain with histdine 
represented by the inactivation of papain was obtained only 
when both Cu^* and ASA were added to the enzyme 
solution. Kanazawa et al. [24] have proposed the possible 
mechanism of enzyme inactivation under these conditions. 
Firstly, monoionic ASA (AH') is attracted to the enzyme at 
a locus near bound Cu'* to form a ternary complex. 
Secondly, the redox reaction between Cu^* and ASA at the 
locus generates the highly reactive free radical that will be 
involved in the inactivation. Thirdly, an ASA radical in its 
ionized form (A" ), which is produced by the redox reaction 
of AH" with the surplus Cu'*, competes with AH" at the 
binding site for ASA, thereby preventing the formation of 
the ternary complex responsible for the inactivation. The 
immobilized papain or certain membrane-bound enzymes 
resist such inactivation and do not fully support the above-
proposed mechanism. 
Experiments were also carried out where free-radical 
scavengers were used in the presence of ASA-Cu^* in order 
to confirm the involvement of free radical and scavenging 
ability in preventing the inactivation of soluble and im-
mobilized papain. The scavengers selected in our studies 
were sodium thiocyanate, Kl, sodium benzoate, catalase and 
histidine. The effects of these scavengers on free radicals 
and the retention of papain activity in the presence of the 
ASA-Cu'* system are shown in Table 3 and in Figures I and 
2. Catalase is one out of the scavengers tested in our 
observations which protected the enzyme maximally from 
inactivation in the presence of the ASA-Cu^* system. From 
these findings it could be presumed that either HiOj or a 
secondary highly reactive species such as OH are re-
sponsible for papain inactivation. It is possible, however, that 
catalase prevented the reduction of Cu^ '^  to Cu*. However, 
the immobilized papain was less affected by the ASA-Cu^* 
system in comparison with its soluble counterpart, as evident 
by its rela^^ activity. It is very likely that the active sites of 
the ernq«ae~are not fuU)( exposed and that attachment 
of enzyeMtto a solid support minimizes the conformational 
© 2001 Portland Press Ltd 
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changes induced by environmental factors and, in this 
particular case, by free radicals. Our previous observations 
have shown that insoiubiiization of papain with polyclonal 
antibodies develop more resistance to thermal denaturation 
[14]. The immobilized papain activity was relatively much 
improved in the presence of these scavengers in comparison 
with the soluble enzyme, although this preparation was 
already protected from inactivation by the free radicals 
generated in our system. 
These studies, however, are preliminary, but clearly 
support our presumption that, in biological systems, mem-
brane-embedded enzymes in are least affected by the radicals 
generated under aerobic or diseased conditions and require 
little or no scavengers for their protection. The properties 
of immobilized enzymes are in general comparable with 
those of membrane-bound enzymes. Biofunctional mem-
branes can also be generated by immobilizing enzymes on to 
porous polymeric membranes and might be a better model 
for such studies Work in this direction is currently in 
progress. 
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